molregno shortName Count(chemblActivityScoreC) for N Count(chemblActivityScoreC) for Y Gene names EntryNameFull chemblActivityScoreC smn2Score predictionRFRegression countOfScores drugName drugIndication concatenatedMoA concatenatedActionType maxPhase UniqueConcatenate(Protein names) for countRatio ActualPlusPredictedSMN2Score kindOfValue moleculeType molName canonical_smiles 111 0 38 NotRecorded 4.8916919928766 5.35 5.35 38 1 5.35 actual molregno [molregno] [Na+].Cc1cc(CC(=O)[O-])n(C)c1C(=O)c2ccc(Cl)cc2 111 RXRA 0 1 RXRA NR2B1 RXRA_HUMAN 4.8000008748032 5.35 5.35 1 Retinoic acid receptor RXR-alpha (Nuclear receptor subfamily 2 group B member 1) (Retinoid X receptor alpha) 1 5.35 actual molregno [molregno] [Na+].Cc1cc(CC(=O)[O-])n(C)c1C(=O)c2ccc(Cl)cc2 111 NF2L2 0 3 NFE2L2 NRF2 NF2L2_HUMAN 5.20852322749435 5.35 5.35 3 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.35 actual molregno [molregno] [Na+].Cc1cc(CC(=O)[O-])n(C)c1C(=O)c2ccc(Cl)cc2 111 ANDR 0 3 AR DHTR NR3C4 ANDR_HUMAN 4.78559242181604 5.35 5.35 3 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 1 5.35 actual molregno [molregno] [Na+].Cc1cc(CC(=O)[O-])n(C)c1C(=O)c2ccc(Cl)cc2 111 CP1A2 0 1 CYP1A2 CP1A2_HUMAN 4.9 5.35 5.35 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 5.35 actual molregno [molregno] [Na+].Cc1cc(CC(=O)[O-])n(C)c1C(=O)c2ccc(Cl)cc2 111 NR1H4 0 1 NR1H4 BAR FXR HRR1 RIP14 NR1H4_HUMAN 4.55000045168903 5.35 5.35 1 Bile acid receptor (Farnesoid X-activated receptor) (Farnesol receptor HRR-1) (Nuclear receptor subfamily 1 group H member 4) (Retinoid X receptor-interacting protein 14) (RXR-interacting protein 14) 1 5.35 actual molregno [molregno] [Na+].Cc1cc(CC(=O)[O-])n(C)c1C(=O)c2ccc(Cl)cc2 111 GEMI 0 3 GMNN GEMI_HUMAN 4.53246769248591 5.35 5.35 3 Geminin 1 5.35 actual molregno [molregno] [Na+].Cc1cc(CC(=O)[O-])n(C)c1C(=O)c2ccc(Cl)cc2 111 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.35 5.35 5.35 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.35 actual molregno [molregno] [Na+].Cc1cc(CC(=O)[O-])n(C)c1C(=O)c2ccc(Cl)cc2 111 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 7.05 5.35 5.35 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 5.35 actual molregno [molregno] [Na+].Cc1cc(CC(=O)[O-])n(C)c1C(=O)c2ccc(Cl)cc2 27626 ESR1 0 230 ESR1 ESR NR3A1, Esr1 Esr Estr Estra Nr3a1, Esr1 Esr Estr Nr3a1 ESR1_HUMAN, ESR1_MOUSE, ESR1_RAT 8.32969055604713 5.42499999999999 5.42500000000003 230 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1), Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1) (Fragment) 1 5.42499999999999 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 SC6A3 0 2 SLC6A3 DAT1 SC6A3_HUMAN 4.88 5.425 5.42500000000003 2 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Sodium-dependent dopamine transporter (DA transporter) (DAT) (Solute carrier family 6 member 3) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 ESR2 0 204 ESR2 ESTRB NR3A2, Esr2 Erbeta Nr3a2, Esr2 Estrb Nr3a2 ESR2_HUMAN, ESR2_MOUSE, ESR2_RAT 8.38497966492308 5.42499999999999 5.42500000000003 204 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Estrogen receptor beta (ER-beta) (Nuclear receptor subfamily 3 group A member 2) 1 5.42499999999999 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 ANDR 0 18 AR DHTR NR3C4, Ar Nr3c4 ANDR_HUMAN, ANDR_RAT 5.98071907796806 5.425 5.42500000000003 18 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 SO1A1 0 2 Slco1a1 Oatp1 Oatp1a1 Slc21a1 SO1A1_RAT 5.07695437047216 5.425 5.42500000000003 2 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Solute carrier organic anion transporter family member 1A1 (Organic anion-transporting polypeptide 1) (OATP-1) (Sodium-independent organic anion transporter 1) (Solute carrier family 21 member 1), Solute carrier organic anion transporter family member 1A1 (Sodium-independent organic anion-transporting polypeptide 1) (OATP-1) (Solute carrier family 21 member 1) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 AOXA 0 6 AOX1, AOX1 AO, Aox1 Ao AOXA_HUMAN, AOXA_MACFA, AOXA_RABIT, AOXA_RAT 5.56 5.425 5.42500000000003 6 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Aldehyde oxidase (EC 1.2.3.1) (Aldehyde oxidase 1) (Azaheterocycle hydroxylase) (EC 1.17.3.-), Aldehyde oxidase 1 (EC 1.2.3.1) (Azaheterocycle hydroxylase 1) (EC 1.17.3.-), Aldehyde oxidase 1 (EC 1.2.3.1) (Azaheterocycle hydroxylase 1) (EC 1.17.3.-) (Retinal oxidase), Aldehyde oxidase 1 (EC 1.2.3.1) (Azaheterocycle hydroxylase 1) (EC 1.17.3.-) (Retinal oxidase) (Retinoic acid synthase) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 ST1A1 0 4 SULT1A1 STP STP1 OK/SW-cl.88 ST1A1_HUMAN 5.90587156438028 5.425 5.42500000000003 4 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Sulfotransferase 1A1 (ST1A1) (EC 2.8.2.1) (Aryl sulfotransferase 1) (HAST1/HAST2) (Phenol sulfotransferase 1) (Phenol-sulfating phenol sulfotransferase 1) (P-PST 1) (ST1A3) (Thermostable phenol sulfotransferase) (Ts-PST) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 LMNA 0 4 LMNA LMN1 LMNA_HUMAN 5.225 5.425 5.42500000000003 4 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 GEMI 0 4 GMNN GEMI_HUMAN 4.53059584150005 5.425 5.42500000000003 4 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Geminin 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 MRP7 0 1 ABCC10 MRP7 SIMRP7 MRP7_HUMAN 5.18879614069983 5.425 5.42500000000003 1 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Multidrug resistance-associated protein 7 (ATP-binding cassette sub-family C member 10) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 GPER1 0 10 GPER1 CEPR CMKRL2 DRY12 GPER GPR30 GPER1_HUMAN 6.27039244929027 5.425 5.42500000000003 10 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 G-protein coupled estrogen receptor 1 (Chemoattractant receptor-like 2) (Flow-induced endothelial G-protein coupled receptor 1) (FEG-1) (G protein-coupled estrogen receptor 1) (G-protein coupled receptor 30) (GPCR-Br) (IL8-related receptor DRY12) (Lymphocyte-derived G-protein coupled receptor) (LYGPR) (Membrane estrogen receptor) (mER), G-protein coupled estrogen receptor 1 (Chemoattractant receptor-like 2) (G protein-coupled estrogen receptor 1) (G-protein coupled receptor 30) (G-protein coupled receptor 41) (Membrane estrogen receptor) (mER) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 ERR1 0 5 ESRRA ERR1 ESRL1 NR3B1 ERR1_HUMAN 6.978 5.425 5.42500000000003 5 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Steroid hormone receptor ERR1 (Estrogen receptor-like 1) (Estrogen-related receptor alpha) (ERR-alpha) (Nuclear receptor subfamily 3 group B member 1) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 LUCI 0 2 LUCI_PHOPY 4.50658513237175 5.425 5.42500000000003 2 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 BLM 0 2 BLM RECQ2 RECQL3 BLM_HUMAN 7.65 5.425 5.42500000000003 2 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 SO1B3 0 1 SLCO1B3 LST2 OATP1B3 OATP8 SLC21A8 SO1B3_HUMAN 4.81120385930017 5.425 5.42500000000003 1 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Solute carrier organic anion transporter family member 1B3 (Liver-specific organic anion transporter 2) (LST-2) (Organic anion transporter 8) (Organic anion-transporting polypeptide 8) (OATP-8) (Solute carrier family 21 member 8) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 APEX1 0 1 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 8.49485002168009 5.425 5.42500000000003 1 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 THB 0 1 THRB ERBA2 NR1A2 THR1 THB_HUMAN 4.8000008748032 5.425 5.42500000000003 1 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Thyroid hormone receptor beta (Nuclear receptor subfamily 1 group A member 2) (c-erbA-2) (c-erbA-beta) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 SMAD3 0 1 SMAD3 MADH3 SMAD3_HUMAN 5.49999693194831 5.425 5.42500000000003 1 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 SMN 0 2 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.425 5.425 5.42500000000003 2 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 ERR2 0 3 ESRRB ERRB2 ESRL2 NR3B2 ERR2_HUMAN 8.29666666666667 5.425 5.42500000000003 3 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Steroid hormone receptor ERR2 (ERR beta-2) (Estrogen receptor-like 2) (Estrogen-related receptor beta) (ERR-beta) (Nuclear receptor subfamily 3 group B member 2) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 SCN1A 0 6 SCN1A NAC1 SCN1 SCN1A_HUMAN 4.69647925661465 5.425 5.42500000000003 6 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Sodium channel protein type 1 subunit alpha (Sodium channel protein brain I subunit alpha) (Sodium channel protein type I subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.1) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 SCN2A 0 6 SCN2A NAC2 SCN2A1 SCN2A2 SCN2A_HUMAN 4.69647925661465 5.425 5.42500000000003 6 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Sodium channel protein type 2 subunit alpha (HBSC II) (Sodium channel protein brain II subunit alpha) (Sodium channel protein type II subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.2), Sodium channel protein type 2 subunit alpha (Sodium channel protein brain II subunit alpha) (Sodium channel protein type II subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.2) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 SCN3A 0 6 SCN3A KIAA1356 NAC3 SCN3A_HUMAN 4.69647925661465 5.425 5.42500000000003 6 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Sodium channel protein type 3 subunit alpha (Sodium channel protein brain III subunit alpha) (Sodium channel protein type III subunit alpha) (Voltage-gated sodium channel subtype III) (Voltage-gated sodium channel subunit alpha Nav1.3) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 KPCG 0 6 Prkcg Pkcc Pkcg Prkcc KPCG_RAT 5.71638010532079 5.425 5.42500000000003 6 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Protein kinase C gamma type (PKC-gamma) (EC 2.7.11.13) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 KPCB 0 6 Prkcb Pkcb Prkcb1 KPCB_RAT 5.71638010532079 5.425 5.42500000000003 6 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 KPCA 0 8 PRKCA PKCA PRKACA, Prkca Pkca KPCA_HUMAN, KPCA_RAT 4.78728507899059 5.425 5.42500000000003 8 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Protein kinase C alpha type (PKC-A) (PKC-alpha) (EC 2.7.11.13) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 CP2B6 0 1 CYP2B6 CP2B6_HUMAN 5.39 5.425 5.42500000000003 1 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Cytochrome P450 2B6 (EC 1.14.13.-) (1,4-cineole 2-exo-monooxygenase) (CYPIIB6) (Cytochrome P450 IIB1) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 SHBG 0 2 SHBG SHBG_HUMAN 8.065 5.425 5.42500000000003 2 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Sex hormone-binding globulin (SHBG) (Sex steroid-binding protein) (SBP) (Testis-specific androgen-binding protein) (ABP), Sex hormone-binding globulin (SHBG) (Sex steroid-binding protein) (SBP) (Testis-specific androgen-binding protein) (ABP) (Testosterone-estradiol-binding globulin) (TeBG) (Testosterone-estrogen-binding globulin) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 SC6A4 0 2 SLC6A4 HTT SERT SC6A4_HUMAN 5.105 5.425 5.42500000000003 2 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Sodium-dependent serotonin transporter (SERT) (5HT transporter) (5HTT) (Solute carrier family 6 member 4) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 RECQ1 0 1 RECQL RECQ1 RECQL1 RECQ1_HUMAN 4.5 5.425 5.42500000000003 1 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 ATP-dependent DNA helicase Q1 (EC 3.6.4.12) (DNA helicase, RecQ-like type 1) (RecQ1) (DNA-dependent ATPase Q1) (RecQ protein-like 1) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 PPARD 0 1 PPARD NR1C2 PPARB PPARD_HUMAN 4.8000008748032 5.425 5.42500000000003 1 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 IDHC 0 1 IDH1 PICD IDHC_HUMAN 4.53621298582672 5.425 5.42500000000003 1 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 ST1E1 0 1 SULT1E1 STE ST1E1_HUMAN 8.39794000867204 5.425 5.42500000000003 1 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Estrogen sulfotransferase (EC 2.8.2.4) (EST-1) (Sulfotransferase 1E1) (ST1E1) (Sulfotransferase, estrogen-preferring), Estrogen sulfotransferase, testis isoform (EC 2.8.2.4) (Sulfotransferase 1E1) (ST1E1) (Sulfotransferase, estrogen-preferring) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 S22A3 0 2 SLC22A3 EMTH OCT3, Slc22a3 Oct3 S22A3_HUMAN, S22A3_RAT 5.75 5.425 5.42500000000003 2 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Solute carrier family 22 member 3 (Extraneuronal monoamine transporter) (EMT) (Organic cation transporter 3), Solute carrier family 22 member 3 (Organic cation transporter 3) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 LOX15 0 1 ALOX15 LOX15_RABIT 4.95 5.425 5.42500000000003 1 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (12/15-LO) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Probable linoleate 9S-lipoxygenase 5 (EC 1.13.11.58) (Leaf lipoxygenase) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 TAU 0 2 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.2 5.425 5.42500000000003 2 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 S22A1 0 2 SLC22A1 OCT1 S22A1_HUMAN 5.47210126563485 5.425 5.42500000000003 2 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Solute carrier family 22 member 1 (Organic cation transporter 1) (hOCT1), Solute carrier family 22 member 1 (Organic cation transporter 1) (mOCT1), Solute carrier family 22 member 1 (Organic cation transporter 1) (rOCT1) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 SO2B1 0 1 SLCO2B1 KIAA0880 OATP2B1 OATPB SLC21A9 SO2B1_HUMAN 4.95479259752035 5.425 5.42500000000003 1 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Solute carrier organic anion transporter family member 2B1 (Organic anion transporter B) (OATP-B) (Organic anion transporter polypeptide-related protein 2) (OATP-RP2) (OATPRP2) (Solute carrier family 21 member 9), Solute carrier organic anion transporter family member 2B1 (Organic anion transporter moatp1) (Solute carrier family 21 member 9) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 4.70000050388302 5.425 5.42500000000003 1 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 TADBP 0 1 TARDBP TDP43 TADBP_HUMAN 5.49999693194831 5.425 5.42500000000003 1 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 TAR DNA-binding protein 43 (TDP-43) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 DHB1 0 1 HSD17B1 E17KSR EDH17B1 EDH17B2 EDHB17 SDR28C1 DHB1_HUMAN 7.52287874528034 5.425 5.42500000000003 1 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Estradiol 17-beta-dehydrogenase 1 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 1) (17-beta-HSD 1), Estradiol 17-beta-dehydrogenase 1 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 1) (17-beta-HSD 1) (20 alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (E2DH) (Placental 17-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 28C member 1) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 ABCG2 0 1 ABCG2 ABCP BCRP BCRP1 MXR ABCG2_HUMAN 5 5.425 5.42500000000003 1 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 ATP-binding cassette sub-family G member 2 (Breast cancer resistance protein 1 homolog) (Urate exporter) (CD antigen CD338), ATP-binding cassette sub-family G member 2 (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 CBG 0 1 SERPINA6 CBG CBG_HUMAN 5 5.425 5.42500000000003 1 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Corticosteroid-binding globulin (CBG) (Serpin A6) (Transcortin) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 1564 ANDR 10 0 AR DHTR NR3C4 ANDR_HUMAN 5.02000160595037 4.68 4.68 10 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CP19A 4 0 CYP19A1 ARO1 CYAR CYP19 CP19A_HUMAN 5.7425 4.68 4.68 4 Aromatase (EC 1.14.14.14) (CYPXIX) (Cytochrome P-450AROM) (Cytochrome P450 19A1) (Estrogen synthase) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 LOX1 6 0 LOX1.1 LOX1 LOX1_SOYBN 5.38046389485736 4.68 4.69444444444444 6 Seed linoleate 13S-lipoxygenase-1 (EC 1.13.11.12) (Lipoxygenase-1) (L-1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 TAU 8 0 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.94375 4.68 4.68 8 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 NPSR1 1 0 NPSR1 GPR154 GPRA PGR14 NPSR1_HUMAN 4.6 4.68 4.68 1 Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14), Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14) (G-protein coupled receptor for asthma susceptibility) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 LUCI 2 0 LUCI_PHOPY 4.65 4.68 4.68 2 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 SMN 5 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.68 4.68 4.68 5 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 PPARD 4 0 PPARD NR1C2 PPARB PPARD_HUMAN 4.57751260503078 4.68 4.68 4 Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GBRA2 32 0 GABRA2, Gabra2 Gabra-2 GBRA2_HUMAN, GBRA2_RAT 5.815 4.68 4.68 32 Gamma-aminobutyric acid receptor subunit alpha-2 (GABA(A) receptor subunit alpha-2) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GBRA6 32 0 GABRA6, Gabra6 Gabra-6 GBRA6_HUMAN, GBRA6_RAT 5.815 4.68 4.68 32 Gamma-aminobutyric acid receptor subunit alpha-6 (GABA(A) receptor subunit alpha-6) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GBRB1 32 0 GABRB1, Gabrb1 Gabrb-1 GBRB1_HUMAN, GBRB1_RAT 5.815 4.68 4.68 32 Gamma-aminobutyric acid receptor subunit beta-1 (GABA(A) receptor subunit beta-1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GBRG2 32 0 GABRG2, Gabrg2 GBRG2_HUMAN, GBRG2_RAT 5.815 4.68 4.68 32 Gamma-aminobutyric acid receptor subunit gamma-2 (GABA(A) receptor subunit gamma-2) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GBRB2 32 0 GABRB2, Gabrb2 Gabrb-2 GBRB2_HUMAN, GBRB2_RAT 5.815 4.68 4.68 32 Gamma-aminobutyric acid receptor subunit beta-2 (GABA(A) receptor subunit beta-2) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GBRP 32 0 GABRP, Gabrp GBRP_HUMAN, GBRP_RAT 5.815 4.68 4.68 32 Gamma-aminobutyric acid receptor subunit pi (GABA(A) receptor subunit pi) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GBRA3 32 0 GABRA3, Gabra3 Gabra-3 GBRA3_HUMAN, GBRA3_RAT 5.815 4.68 4.68 32 Gamma-aminobutyric acid receptor subunit alpha-3 (GABA(A) receptor subunit alpha-3) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GBRG1 32 0 GABRG1, Gabrg1 GBRG1_HUMAN, GBRG1_RAT 5.815 4.68 4.68 32 Gamma-aminobutyric acid receptor subunit gamma-1 (GABA(A) receptor subunit gamma-1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GBRE 32 0 GABRE, Gabre GBRE_HUMAN, GBRE_RAT 5.815 4.68 4.68 32 Gamma-aminobutyric acid receptor subunit epsilon (GABA(A) receptor subunit epsilon) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GBRG3 32 0 GABRG3, Gabrg3 GBRG3_HUMAN, GBRG3_RAT 5.815 4.68 4.68 32 Gamma-aminobutyric acid receptor subunit gamma-3 (GABA(A) receptor subunit gamma-3) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GBRA5 32 0 GABRA5, Gabra5 Gabra-5 GBRA5_HUMAN, GBRA5_RAT 5.815 4.68 4.68 32 Gamma-aminobutyric acid receptor subunit alpha-5 (GABA(A) receptor subunit alpha-5) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GBRD 32 0 GABRD, Gabrd GBRD_HUMAN, GBRD_RAT 5.815 4.68 4.68 32 Gamma-aminobutyric acid receptor subunit delta (GABA(A) receptor subunit delta) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GBRA4 32 0 GABRA4, Gabra4 GBRA4_HUMAN, GBRA4_RAT 5.815 4.68 4.68 32 Gamma-aminobutyric acid receptor subunit alpha-4 (GABA(A) receptor subunit alpha-4) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GBRA1 32 0 GABRA1, Gabra1 Gabra-1 GBRA1_HUMAN, GBRA1_RAT 5.815 4.68 4.68 32 Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) receptor subunit alpha-1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GBRB3 32 0 GABRB3, Gabrb3 Gabrb-3 GBRB3_HUMAN, GBRB3_RAT 5.815 4.68 4.68 32 Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GBRT 16 0 GABRQ GBRT_HUMAN 5.52 4.68 4.68 16 Gamma-aminobutyric acid receptor subunit theta (GABA(A) receptor subunit theta) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 Q91ZM7 16 0 Gabrq Q91ZM7_RAT 6.11 4.68 4.68 16 GABA theta subunit 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GCR 6 0 NR3C1 GRL GCR_HUMAN 4.78045629597049 4.68 4.68114583333333 6 Glucocorticoid receptor (GR) (Nuclear receptor subfamily 3 group C member 1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 ACES 2 0 ACHE, ache ACES_ELEEL, ACES_HUMAN 6.13656383212784 4.68 4.41875 2 Acetylcholinesterase (AChE) (EC 3.1.1.7), Acetylcholinesterase (AChE) (EC 3.1.1.7) [Cleaved into: Acetylcholinesterase 16 kDa subunit; Acetylcholinesterase 55 kDa subunit] 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 MPP8 1 0 MPHOSPH8 MPP8 MPP8_HUMAN 6.10001543745061 4.68 4.68 1 M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM) (Twa3) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 POLK 1 0 POLK DINB1 POLK_HUMAN 4.70000050388302 4.68 4.68 1 DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 AA3R 1 0 ADORA3 AA3R_HUMAN 5.23113882538659 4.68 4.68 1 Adenosine receptor A3, Adenosine receptor A3 (A3AR), Adenosine receptor A3 (TGPCR1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 HCD2 3 0 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 5.13333333333333 4.68 4.68 3 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 Q7ZJM1 3 0 pol Q7ZJM1_9HIV1 5.07264666955735 4.68 4.68 3 Integrase (Fragment) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 NF2L2 7 0 NFE2L2 NRF2 NF2L2_HUMAN 4.8765136204809 4.68 4.68 7 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 RXRA 4 0 RXRA NR2B1 RXRA_HUMAN 4.70000004884498 4.68 4.68 4 Retinoic acid receptor RXR-alpha (Nuclear receptor subfamily 2 group B member 1) (Retinoid X receptor alpha) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 DHB2 2 0 HSD17B2 EDH17B2 SDR9C2 DHB2_HUMAN 4.61323447362655 4.68 4.68 2 Estradiol 17-beta-dehydrogenase 2 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 2) (17-beta-HSD 2) (20 alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (E2DH) (Microsomal 17-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 9C member 2) (Testosterone 17-beta-dehydrogenase) (EC 1.1.1.239), Estradiol 17-beta-dehydrogenase 2 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 2) (17-beta-HSD 2) (Testosterone 17-beta-dehydrogenase) (EC 1.1.1.239) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CCNB3 4 0 CCNB3 CYCB3 CCNB3_HUMAN 5.4 4.68 4.68 4 G2/mitotic-specific cyclin-B3 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CDK1 4 0 CDK1 CDC2 CDC28A CDKN1 P34CDC2 CDK1_HUMAN 5.4 4.68 4.68 4 Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (Cell division control protein 28) (Cell division protein kinase 1), Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CCNB1 4 0 CCNB1 CCNB CCNB1_HUMAN 5.4 4.68 4.68 4 G2/mitotic-specific cyclin-B1 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CCNB2 4 0 CCNB2 CCNB2_HUMAN 5.4 4.68 4.68 4 G2/mitotic-specific cyclin-B2 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 PGDH 4 0 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.7875 4.68 4.68 4 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 DHB1 2 0 HSD17B1 E17KSR EDH17B1 EDH17B2 EDHB17 SDR28C1 DHB1_HUMAN 5.09787874528033 4.68 4.68 2 Estradiol 17-beta-dehydrogenase 1 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 1) (17-beta-HSD 1), Estradiol 17-beta-dehydrogenase 1 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 1) (17-beta-HSD 1) (20 alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (E2DH) (Placental 17-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 28C member 1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 MK09 3 0 MAPK9 JNK2 PRKM9 SAPK1A MK09_HUMAN 6.06069784035361 4.68 4.68 3 Mitogen-activated protein kinase 9 (MAP kinase 9) (MAPK 9) (EC 2.7.11.24) (JNK-55) (Stress-activated protein kinase 1a) (SAPK1a) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2), Mitogen-activated protein kinase 9 (MAP kinase 9) (MAPK 9) (EC 2.7.11.24) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 MK10 3 0 MAPK10 JNK3 JNK3A PRKM10 SAPK1B MK10_HUMAN 6.06069784035361 4.68 4.68 3 Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (MAP kinase p49 3F12) (Stress-activated protein kinase 1b) (SAPK1b) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3), Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (MAP kinase p49 3F12) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3), Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (SAPK-beta) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3) (p54-beta) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 MK08 3 0 MAPK8 JNK1 PRKM8 SAPK1 SAPK1C MK08_HUMAN 6.06069784035361 4.68 4.68 3 Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (JNK-46) (Stress-activated protein kinase 1c) (SAPK1c) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1), Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (SAPK gamma) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1) (p54 gamma), Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 AL1A1 6 0 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 5.05833333333333 4.68 4.68 6 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GLCM 5 0 GBA GC GLUC GLCM_HUMAN 4.94999923876871 4.68 4.68 5 Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase), Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (D-glucosyl-N-acylsphingosine glucohydrolase) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 TPO 2 0 THPO MGDF TPO_HUMAN 6.3 4.68 4.68 2 Thrombopoietin (C-mpl ligand) (ML) (Megakaryocyte colony-stimulating factor) (Megakaryocyte growth and development factor) (MGDF) (Myeloproliferative leukemia virus oncogene ligand) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CD5R1 2 0 CDK5R1 CDK5R NCK5A CD5R1_HUMAN 5.8 4.68 4.68 2 Cyclin-dependent kinase 5 activator 1 (CDK5 activator 1) (Cyclin-dependent kinase 5 regulatory subunit 1) (TPKII regulatory subunit) [Cleaved into: Cyclin-dependent kinase 5 activator 1, p35 (p35); Cyclin-dependent kinase 5 activator 1, p25 (p25) (Tau protein kinase II 23 kDa subunit) (p23)] 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CDK5 3 0 CDK5 CDKN5, Cdk5 Cdkn5 CDK5_HUMAN, CDK5_RAT 5.06735333044265 4.68 4.68 3 Cyclin-dependent-like kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 AA1R 2 0 Adora1 AA1R_RAT 5.26 4.68 4.68 2 Adenosine receptor A1 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 KSYK 3 0 SYK KSYK_HUMAN 5.72625120031761 4.68 4.68 3 Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72-Syk), Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72Syk) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 LMNA 3 0 LMNA LMN1 LMNA_HUMAN 4.91666666666667 4.68 4.68 3 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 PPARG 3 0 PPARG NR1C3, Pparg Nr1c3 PPARG_HUMAN, PPARG_MOUSE 4.66666668686774 4.68 4.68 3 Peroxisome proliferator-activated receptor gamma (PPAR-gamma) (Nuclear receptor subfamily 1 group C member 3) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 O97447 1 0 ald O97447_GIAIN 5.2 4.68 4.68 1 Putative fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 JUN 1 0 JUN JUN_HUMAN 4.70418668639037 4.68 4.68 1 Transcription factor AP-1 (AH119) (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (Jun A), Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog), Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (p39), Transcription factor AP-1 (Proto-oncogene c-Jun) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GSK3B 4 0 GSK3B GSK3B_HUMAN 5.62240898203535 4.68 4.68 4 Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Factor A) (FA) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1), Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GSK3A 2 0 GSK3A GSK3A_HUMAN 5.85 4.68 4.68 2 Glycogen synthase kinase-3 alpha (GSK-3 alpha) (EC 2.7.11.26) (Factor A) (FA) (Serine/threonine-protein kinase GSK3A) (EC 2.7.11.1), Glycogen synthase kinase-3 alpha (GSK-3 alpha) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3A) (EC 2.7.11.1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 TTHY 3 0 TTR PALB TTHY_HUMAN 5.84333333333333 4.68 4.68 3 Transthyretin (ATTR) (Prealbumin) (TBPA), Transthyretin (Prealbumin) (TBPA) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 NANH 2 0 nanH NANH_CLOPF 4.76 4.68 4.68 2 Sialidase (EC 3.2.1.18) (N-acylneuraminate glycohydrolase) (Neuraminidase) (NANase) (STNA), Sialidase (EC 3.2.1.18) (Neuraminidase), Sialidase (EC 3.2.1.18) (Neuraminidase) (NANase) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 HIF1A 4 0 HIF1A BHLHE78 MOP1 PASD8 HIF1A_HUMAN 5.3 4.68 4.68 4 Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein), Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CDK6 2 0 CDK6 CDKN6 CDK6_HUMAN 5.77 4.68 4.68 2 Cyclin-dependent kinase 6 (EC 2.7.11.22) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 MK11 1 0 MAPK11 PRKM11 SAPK2 SAPK2B MK11_HUMAN 5.82557590031178 4.68 4.68 1 Mitogen-activated protein kinase 11 (MAP kinase 11) (MAPK 11) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 beta) (MAP kinase p38 beta) (p38B), Mitogen-activated protein kinase 11 (MAP kinase 11) (MAPK 11) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 beta) (MAP kinase p38 beta) (p38b) (Stress-activated protein kinase 2b) (SAPK2b) (p38-2) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 ESR1 9 0 ESR1 ESR NR3A1 ESR1_HUMAN, ESR1_SHEEP 5.21222188157128 4.68 4.68 9 Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1), Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1) (Fragment) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 AHR 2 0 AHR BHLHE76 AHR_HUMAN 4.50000046405718 4.68 4.68 2 Aryl hydrocarbon receptor (Ah receptor) (AhR), Aryl hydrocarbon receptor (Ah receptor) (AhR) (Class E basic helix-loop-helix protein 76) (bHLHe76) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 AA2AR 1 0 Adora2a AA2AR_RAT 5.12 4.68 4.68 1 Adenosine receptor A2a 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CP1A2 3 0 CYP1A2 CP1A2_HUMAN 6.73333333333333 4.68 4.68 3 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 IDHC 3 0 IDH1 PICD IDHC_HUMAN 5.67665246652633 4.68 4.68 3 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 MK01 2 0 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 5.1943145854989 4.68 4.68 2 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 BACE1 3 0 BACE1 BACE KIAA1149 BACE1_HUMAN 4.58884579835818 4.68 4.68 3 Beta-secretase 1 (EC 3.4.23.46) (Aspartyl protease 2) (ASP2) (Asp 2) (Beta-site amyloid precursor protein cleaving enzyme 1) (Beta-site APP cleaving enzyme 1) (Memapsin-2) (Membrane-associated aspartic protease 2) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 MK13 1 0 MAPK13 PRKM13 SAPK4 MK13_HUMAN 5.90799732148669 4.68 4.68 1 Mitogen-activated protein kinase 13 (MAP kinase 13) (MAPK 13) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 delta) (MAP kinase p38 delta) (Stress-activated protein kinase 4) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CY24B 4 0 CYBB NOX2 CY24B_HUMAN 5 4.68 4.68 4 Cytochrome b-245 heavy chain (EC 1.-.-.-) (CGD91-phox) (Cytochrome b(558) subunit beta) (Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 MAPK2 1 0 MAPKAPK2 MAPK2_HUMAN 6.00479888288177 4.68 4.68 1 MAP kinase-activated protein kinase 2 (MAPK-activated protein kinase 2) (MAPKAP kinase 2) (MAPKAP-K2) (MAPKAPK-2) (MK-2) (MK2) (EC 2.7.11.1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 ESR2 5 0 ESR2 ESTRB NR3A2, ESR2 NR3A2 ESR2_HUMAN, ESR2_SHEEP 5.79 4.68 4.68 5 Estrogen receptor beta (ER-beta) (Nuclear receptor subfamily 3 group A member 2) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 RGS4 1 0 RGS4 RGS4_HUMAN 4.77382299674291 4.68 4.68 1 Regulator of G-protein signaling 4 (RGP4) (RGS4) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 KS6A5 2 0 RPS6KA5 MSK1 KS6A5_HUMAN 5.15806815492241 4.68 4.68 2 Ribosomal protein S6 kinase alpha-5 (S6K-alpha-5) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 5) (Nuclear mitogen- and stress-activated protein kinase 1) (RSK-like protein kinase) (RSKL) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GEMI 1 0 GMNN GEMI_HUMAN 4.9 4.68 4.68 1 Geminin 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 ROCK2 1 0 ROCK2 KIAA0619 ROCK2_HUMAN 5.86530142610254 4.68 4.68 1 Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2), Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (RhoA-binding kinase 2) (p150 ROK-alpha) (ROKalpha) (p164 ROCK-2) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 MRP2 1 0 ABCC2 CMOAT CMOAT1 CMRP MRP2 MRP2_HUMAN 6.19497660321606 4.68 4.68 1 Canalicular multispecific organic anion transporter 1 (ATP-binding cassette sub-family C member 2), Canalicular multispecific organic anion transporter 1 (ATP-binding cassette sub-family C member 2) (Canalicular multidrug resistance protein) (Multidrug resistance-associated protein 2) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 ATX2 2 0 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 5.17499815754325 4.68 4.68 2 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CP1A1 2 0 CYP1A1 CP1A1_HUMAN 6.39 4.68 4.68 2 Cytochrome P450 1A1 (CYP1A1) (EC 1.14.14.1) (CYPIA1) (Cytochrome P450-C) (Cytochrome P450MT2) [Cleaved into: Cytochrome P450MT2A; Cytochrome P450MT2B], Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1), Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450-P1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 PDPK1 1 0 PDPK1 PDK1 PDPK1_HUMAN 5.78837041556533 4.68 4.68 1 3-phosphoinositide-dependent protein kinase 1 (hPDK1) (EC 2.7.11.1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 AAPK2 1 0 PRKAA2 AMPK AMPK2 AAPK2_HUMAN 5.1224064000929 4.68 4.68 1 5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 RORG 4 0 RORC NR1F3 RORG RZRG, Rorc Nr1f3 Rorg Thor RORG_HUMAN, RORG_MOUSE 5.23126712389685 4.68 4.68 4 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 KAPCG 3 0 PRKACG KAPCG_HUMAN 5.82557590031178 4.68 4.68 3 cAMP-dependent protein kinase catalytic subunit gamma (PKA C-gamma) (EC 2.7.11.11) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 KAPCA 3 0 PRKACA PKACA KAPCA_HUMAN 5.82557590031178 4.68 4.68 3 cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 KAPCB 3 0 PRKACB KAPCB_HUMAN 5.82557590031178 4.68 4.68 3 cAMP-dependent protein kinase catalytic subunit beta (PKA C-beta) (EC 2.7.11.11) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 BRCA1 1 0 BRCA1 RNF53 BRCA1_HUMAN 4.65000022087346 4.68 4.68 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 HSPB1 1 0 HSPB1 HSP27 HSP28 HSPB1_HUMAN 4.86005168376475 4.68 4.68 1 Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 LCK 2 0 LCK LCK_HUMAN 4.91465188641551 4.68 4.68 2 Proto-oncogene tyrosine-protein kinase LCK (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (p56-LCK), Tyrosine-protein kinase Lck (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (Protein YT16) (Proto-oncogene Lck) (T cell-specific protein-tyrosine kinase) (p56-LCK) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 MRP1 2 0 ABCC1 MRP MRP1 MRP1_HUMAN 5.465 4.68 4.68 2 Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 MAPK5 1 0 MAPKAPK5 PRAK MAPK5_HUMAN 6.12338490853968 4.68 4.68 1 MAP kinase-activated protein kinase 5 (MAPK-activated protein kinase 5) (MAPKAP kinase 5) (MAPKAP-K5) (MAPKAPK-5) (MK-5) (MK5) (EC 2.7.11.1) (p38-regulated/activated protein kinase) (PRAK) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 TNKS1 2 0 TNKS PARP5A PARPL TIN1 TINF1 TNKS1 TNKS1_HUMAN 5.505 4.68 4.68 2 Tankyrase-1 (TANK1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (Poly [ADP-ribose] polymerase 5A) (TNKS-1) (TRF1-interacting ankyrin-related ADP-ribose polymerase) (Tankyrase I), Tankyrase-1 (TANK1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (TRF1-interacting ankyrin-related ADP-ribose polymerase 1) (Tankyrase I) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 FFP 1 0 ffp sfp FFP_BACIU 4.5 4.68 4.68 1 4'-phosphopantetheinyl transferase ffp (EC 2.7.8.-) (Fengycin synthase-activating enzyme) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 AOFA 1 0 MAOA AOFA_HUMAN 5.77 4.68 4.68 1 Amine oxidase [flavin-containing] A (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 AOFB 1 0 MAOB AOFB_HUMAN 4.89 4.68 4.68 1 Amine oxidase [flavin-containing] B (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 SO1B1 1 0 SLCO1B1 LST1 OATP1B1 OATP2 OATPC SLC21A6 SO1B1_HUMAN 5.72679069346755 4.68 4.68 1 Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 Q4Q090 1 0 PGAM LMJF_36_6650 Q4Q090_LEIMA 4.72098361611599 4.68 4.68 1 2,3-bisphosphoglycerate-independent phosphoglycerate mutase (EC 5.4.2.1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 RUNX1 4 0 RUNX1 AML1 CBFA2 RUNX1_HUMAN 4.97499943716937 4.68 4.68 4 Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 PEBB 4 0 CBFB PEBB_HUMAN 4.97499943716937 4.68 4.68 4 Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CSK21 6 0 CSNK2A1 CK2A1 CSK21_HUMAN 5.94206773334882 4.68 4.68 6 Casein kinase II subunit alpha (CK II alpha) (EC 2.7.11.1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 KS6A1 2 0 RPS6KA1 MAPKAPK1A RSK1 KS6A1_HUMAN 5.78837041556533 4.68 4.68 2 Ribosomal protein S6 kinase alpha-1 (S6K-alpha-1) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 1) (p90-RSK 1) (p90RSK1) (p90S6K) (MAP kinase-activated protein kinase 1a) (MAPK-activated protein kinase 1a) (MAPKAP kinase 1a) (MAPKAPK-1a) (Ribosomal S6 kinase 1) (RSK-1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 NOX4 1 0 NOX4 RENOX NOX4_HUMAN 5.95 4.68 4.68 1 NADPH oxidase 4 (EC 1.6.3.-) (Kidney oxidase-1) (KOX-1) (Kidney superoxide-producing NADPH oxidase) (Renal NAD(P)H-oxidase) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 KS6B1 1 0 RPS6KB1 STK14A KS6B1_HUMAN 5.26884531229258 4.68 4.68 1 Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (S6K) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA), Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (Serine/threonine-protein kinase 14A) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 MDR1 1 0 ABCB1 MDR1 PGY1 MDR1_HUMAN 5 4.68 4.68 1 Multidrug resistance protein 1 (EC 3.6.3.44) (ATP-binding cassette sub-family B member 1) (P-glycoprotein 1) (CD antigen CD243) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CFTR 2 0 CFTR ABCC7 CFTR_HUMAN 4.57 4.68 4.68 2 Cystic fibrosis transmembrane conductance regulator (CFTR) (ATP-binding cassette sub-family C member 7) (Channel conductance-controlling ATPase) (EC 3.6.3.49) (cAMP-dependent chloride channel) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 FLT3 1 0 FLT3 CD135 FLK2 STK1 FLT3_HUMAN 5.84 4.68 4.68 1 Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase 2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Tyrosine-protein kinase receptor flk-2) (CD antigen CD135), Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase-2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Stem cell tyrosine kinase 1) (STK-1) (CD antigen CD135) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CHK1 1 0 CHEK1 CHK1 CHK1_HUMAN 5.30756086282294 4.68 4.68 1 Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Cell cycle checkpoint kinase) (Checkpoint kinase-1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 NRAM 1 0 NA NRAM_I34A1 4.58705606918888 4.68 4.68 1 Neuraminidase (EC 3.2.1.18) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 IMPA1 1 0 Impa1 Imp IMPA1_RAT 5.4 4.68 4.68 1 Inositol monophosphatase 1 (IMP 1) (IMPase 1) (EC 3.1.3.25) (D-galactose 1-phosphate phosphatase) (EC 3.1.3.94) (Inositol-1(or 4)-monophosphatase 1) (Lithium-sensitive myo-inositol monophosphatase A1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 KDM4E 1 0 KDM4E KDM4DL KDM4E_HUMAN 4.95 4.68 4.68 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 FEN1 1 0 FEN1 RAD2 FEN1_HUMAN 4.97382232428338 4.68 4.68 1 Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (DNase IV) (Flap structure-specific endonuclease 1) (Maturation factor 1) (MF1) (hFEN-1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 UBP1 1 0 USP1 UBP1_HUMAN 5.35000349253396 4.68 4.68 1 Ubiquitin carboxyl-terminal hydrolase 1 (EC 3.4.19.12) (Deubiquitinating enzyme 1) (hUBP) (Ubiquitin thioesterase 1) (Ubiquitin-specific-processing protease 1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 XDH 3 0 XDH XDHA XDH_HUMAN 5.97333333333333 4.68 4.68 3 Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)] 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 LOX15 1 0 ALOX15 LOG15 LOX15_HUMAN 5.3 4.68 4.68 1 Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (12/15-LO) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Probable linoleate 9S-lipoxygenase 5 (EC 1.13.11.58) (Leaf lipoxygenase) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 ALDR 1 0 Akr1b1 Akr1b4 Aldr1 ALDR_RAT 5.18 4.68 4.68 1 Aldose reductase (AR) (EC 1.1.1.21) (20-alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (EC 1.1.1.149) (Aldehyde reductase), Aldose reductase (AR) (EC 1.1.1.21) (Aldehyde reductase), Aldose reductase (AR) (EC 1.1.1.21) (Aldehyde reductase) (Aldo-keto reductase family 1 member B1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 LOX5 1 0 ALOX5 LOG5 LOX5_HUMAN 5 4.68 4.68 1 Arachidonate 5-lipoxygenase (5-LO) (5-lipoxygenase) (EC 1.13.11.34) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 AKT1 1 0 AKT1 PKB RAC AKT1_HUMAN 5.65854134728041 4.68 4.68 1 RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (AKT1 kinase) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha) (Thymoma viral proto-oncogene), RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha), RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (RAC-PK-alpha) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 SGK1 1 0 SGK1 SGK SGK1_HUMAN 4.84193184507759 4.68 4.68 1 Serine/threonine-protein kinase Sgk1 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CYSP 1 0 CYSP_TRYCR 4.9 4.68 4.68 1 Cruzipain (EC 3.4.22.51) (Cruzaine) (Major cysteine proteinase), Trophozoite cysteine proteinase (TCP) (EC 3.4.22.-) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 ABCG2 2 0 ABCG2 ABCP BCRP BCRP1 MXR ABCG2_HUMAN 5.37 4.68 4.68 2 ATP-binding cassette sub-family G member 2 (Breast cancer resistance protein 1 homolog) (Urate exporter) (CD antigen CD338), ATP-binding cassette sub-family G member 2 (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 TNKS2 2 0 TNKS2 PARP5B TANK2 TNKL TNKS2_HUMAN 5.535 4.68 4.68 2 Tankyrase-2 (TANK2) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 6) (ARTD6) (Poly [ADP-ribose] polymerase 5B) (TNKS-2) (TRF1-interacting ankyrin-related ADP-ribose polymerase 2) (Tankyrase II) (Tankyrase-like protein) (Tankyrase-related protein), Tankyrase-2 (TANK2) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 6) (ARTD6) (TNKS-2) (TRF1-interacting ankyrin-related ADP-ribose polymerase 2) (Tankyrase II) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 ATAD5 2 0 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.58639103825321 4.68 4.68 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CSK 1 0 CSK CSK_HUMAN 5.52476288915489 4.68 4.68 1 Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase), Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase) (Protein-tyrosine kinase CYL) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 POLI 1 0 POLI RAD30B POLI_HUMAN 4.89999841719865 4.68 4.68 1 DNA polymerase iota (EC 2.7.7.7) (Eta2) (RAD30 homolog B), DNA polymerase iota (EC 2.7.7.7) (Rad30 homolog B) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 END4 1 0 nfo b2159 JW2146 END4_ECOLI 5.25 4.68 4.68 1 Endonuclease 4 (EC 3.1.21.2) (Endodeoxyribonuclease IV) (Endonuclease IV) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CSK2B 3 0 CSNK2B CK2N G5A CSK2B_HUMAN 6.1 4.68 4.68 3 Casein kinase II subunit beta (CK II beta) (Phosvitin), Casein kinase II subunit beta (CK II beta) (Phosvitin) (Protein G5a) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CSK22 3 0 CSNK2A2 CK2A2 CSK22_HUMAN 6.1 4.68 4.68 3 Casein kinase II subunit alpha' (CK II alpha') (EC 2.7.11.1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 FGR 1 0 FGR SRC2 FGR_HUMAN 4.96523789374079 4.68 4.68 1 Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog) (Proto-oncogene c-Fgr) (p55-Fgr) (p58-Fgr) (p58c-Fgr), Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Proto-oncogene c-Fgr) (p55-Fgr) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 MP2K1 1 0 MAP2K1 MEK1 PRKMK1 MP2K1_HUMAN 6.69019608002851 4.68 4.68 1 Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1), Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (MKK1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CP1B1 2 0 CYP1B1 CP1B1_HUMAN 7.395 4.68 4.68 2 Cytochrome P450 1B1 (EC 1.14.14.1) (CYPIB1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 TSHR 2 0 TSHR LGR3 TSHR_HUMAN 5.4 4.68 4.68 2 Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 PIM1 3 0 PIM1 PIM1_HUMAN 5.40910388177262 4.68 4.68 3 Serine/threonine-protein kinase pim-1 (EC 2.7.11.1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 DAPK1 1 0 DAPK1 DAPK DAPK1_HUMAN 4.51 4.68 4.68 1 Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 NPC1 1 0 NPC1 NPC1_HUMAN 5.24 4.68 4.68 1 Niemann-Pick C1 protein 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 M4K5 1 0 MAP4K5 M4K5_HUMAN 6.38021124171161 4.68 4.68 1 Mitogen-activated protein kinase kinase kinase kinase 5 (EC 2.7.11.1) (Kinase homologous to SPS1/STE20) (KHS) (MAPK/ERK kinase kinase kinase 5) (MEK kinase kinase 5) (MEKKK 5) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 LYN 1 0 LYN JTK8 LYN_HUMAN 5.86530142610254 4.68 4.68 1 Tyrosine-protein kinase Lyn (EC 2.7.10.2) (Lck/Yes-related novel protein tyrosine kinase) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn), Tyrosine-protein kinase Lyn (EC 2.7.10.2) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 485738 PMP22 1 0 PMP22 GAS3 PMP22_HUMAN 4.62 4.675 4.67500000000002 1 RIBAVIRIN ACUTE MYELOID LEUKEMIA, BREAST CARCINOMA, CANCER, CHRONIC HEPATITIS C INFECTION, HEPATITIS B INFECTION, HEPATITIS C INFECTION, HIV INFECTION, INFECTION, NEOPLASM, VIRAL DISEASE Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor, Inosine-5'-monophosphate dehydrogenase 1 inhibitor, RNA inhibitor INHIBITOR 4 Peripheral myelin protein 22 (PMP-22) (Growth arrest-specific protein 3) (GAS-3), Peripheral myelin protein 22 (PMP-22) (Protein CD25) (SR13 myelin protein) (Schwann cell membrane glycoprotein) (SAG) 0 4.675 actual drug [drugName] NC(=O)c1ncn(n1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O 485738 SMN 2 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.675 4.675 4.67500000000002 2 RIBAVIRIN ACUTE MYELOID LEUKEMIA, BREAST CARCINOMA, CANCER, CHRONIC HEPATITIS C INFECTION, HEPATITIS B INFECTION, HEPATITIS C INFECTION, HIV INFECTION, INFECTION, NEOPLASM, VIRAL DISEASE Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor, Inosine-5'-monophosphate dehydrogenase 1 inhibitor, RNA inhibitor INHIBITOR 4 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.675 actual drug [drugName] NC(=O)c1ncn(n1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O 485738 GEMI 1 0 GMNN GEMI_HUMAN 6.73612732313478 4.675 4.67500000000001 1 RIBAVIRIN ACUTE MYELOID LEUKEMIA, BREAST CARCINOMA, CANCER, CHRONIC HEPATITIS C INFECTION, HEPATITIS B INFECTION, HEPATITIS C INFECTION, HIV INFECTION, INFECTION, NEOPLASM, VIRAL DISEASE Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor, Inosine-5'-monophosphate dehydrogenase 1 inhibitor, RNA inhibitor INHIBITOR 4 Geminin 0 4.675 actual drug [drugName] NC(=O)c1ncn(n1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O 485738 AL1A1 1 0 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.6 4.675 4.67500000000002 1 RIBAVIRIN ACUTE MYELOID LEUKEMIA, BREAST CARCINOMA, CANCER, CHRONIC HEPATITIS C INFECTION, HEPATITIS B INFECTION, HEPATITIS C INFECTION, HIV INFECTION, INFECTION, NEOPLASM, VIRAL DISEASE Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor, Inosine-5'-monophosphate dehydrogenase 1 inhibitor, RNA inhibitor INHIBITOR 4 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 0 4.675 actual drug [drugName] NC(=O)c1ncn(n1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O 485738 GSK3B 1 0 GSK3B GSK3B_HUMAN 4.69831839958977 4.675 4.67500000000002 1 RIBAVIRIN ACUTE MYELOID LEUKEMIA, BREAST CARCINOMA, CANCER, CHRONIC HEPATITIS C INFECTION, HEPATITIS B INFECTION, HEPATITIS C INFECTION, HIV INFECTION, INFECTION, NEOPLASM, VIRAL DISEASE Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor, Inosine-5'-monophosphate dehydrogenase 1 inhibitor, RNA inhibitor INHIBITOR 4 Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Factor A) (FA) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1), Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1) 0 4.675 actual drug [drugName] NC(=O)c1ncn(n1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O 485738 NF2L2 2 0 NFE2L2 NRF2 NF2L2_HUMAN 4.9612138990678 4.675 4.67500000000001 2 RIBAVIRIN ACUTE MYELOID LEUKEMIA, BREAST CARCINOMA, CANCER, CHRONIC HEPATITIS C INFECTION, HEPATITIS B INFECTION, HEPATITIS C INFECTION, HIV INFECTION, INFECTION, NEOPLASM, VIRAL DISEASE Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor, Inosine-5'-monophosphate dehydrogenase 1 inhibitor, RNA inhibitor INHIBITOR 4 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 0 4.675 actual drug [drugName] NC(=O)c1ncn(n1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O 485738 SO1B3 1 0 SLCO1B3 LST2 OATP1B3 OATP8 SLC21A8 SO1B3_HUMAN 5.84071036509216 4.675 4.67500000000001 1 RIBAVIRIN ACUTE MYELOID LEUKEMIA, BREAST CARCINOMA, CANCER, CHRONIC HEPATITIS C INFECTION, HEPATITIS B INFECTION, HEPATITIS C INFECTION, HIV INFECTION, INFECTION, NEOPLASM, VIRAL DISEASE Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor, Inosine-5'-monophosphate dehydrogenase 1 inhibitor, RNA inhibitor INHIBITOR 4 Solute carrier organic anion transporter family member 1B3 (Liver-specific organic anion transporter 2) (LST-2) (Organic anion transporter 8) (Organic anion-transporting polypeptide 8) (OATP-8) (Solute carrier family 21 member 8) 0 4.675 actual drug [drugName] NC(=O)c1ncn(n1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O 485738 RORG 1 0 RORC NR1F3 RORG RZRG RORG_HUMAN 4.72506665764136 4.675 4.67500000000002 1 RIBAVIRIN ACUTE MYELOID LEUKEMIA, BREAST CARCINOMA, CANCER, CHRONIC HEPATITIS C INFECTION, HEPATITIS B INFECTION, HEPATITIS C INFECTION, HIV INFECTION, INFECTION, NEOPLASM, VIRAL DISEASE Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor, Inosine-5'-monophosphate dehydrogenase 1 inhibitor, RNA inhibitor INHIBITOR 4 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 0 4.675 actual drug [drugName] NC(=O)c1ncn(n1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O 485738 TPO 2 0 THPO MGDF TPO_HUMAN 4.9 4.675 4.67500000000002 2 RIBAVIRIN ACUTE MYELOID LEUKEMIA, BREAST CARCINOMA, CANCER, CHRONIC HEPATITIS C INFECTION, HEPATITIS B INFECTION, HEPATITIS C INFECTION, HIV INFECTION, INFECTION, NEOPLASM, VIRAL DISEASE Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor, Inosine-5'-monophosphate dehydrogenase 1 inhibitor, RNA inhibitor INHIBITOR 4 Thrombopoietin (C-mpl ligand) (ML) (Megakaryocyte colony-stimulating factor) (Megakaryocyte growth and development factor) (MGDF) (Myeloproliferative leukemia virus oncogene ligand) 0 4.675 actual drug [drugName] NC(=O)c1ncn(n1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O 485738 LMNA 1 0 LMNA LMN1 LMNA_HUMAN 8.4 4.675 4.67500000000001 1 RIBAVIRIN ACUTE MYELOID LEUKEMIA, BREAST CARCINOMA, CANCER, CHRONIC HEPATITIS C INFECTION, HEPATITIS B INFECTION, HEPATITIS C INFECTION, HIV INFECTION, INFECTION, NEOPLASM, VIRAL DISEASE Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor, Inosine-5'-monophosphate dehydrogenase 1 inhibitor, RNA inhibitor INHIBITOR 4 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 0 4.675 actual drug [drugName] NC(=O)c1ncn(n1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O 1756 VGFR1 0 2 FLT1 FLT FRT VEGFR1 VGFR1_HUMAN 5.7209784188282 5.3 5.3 2 Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Embryonic receptor kinase 2) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase receptor FLT), Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase FRT) (Tyrosine-protein kinase receptor FLT) (FLT) (Vascular permeability factor receptor) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KCC2D 0 1 CAMK2D CAMKD KCC2D_HUMAN 5.62973141792582 5.3 5.3 1 Calcium/calmodulin-dependent protein kinase type II subunit delta (CaM kinase II subunit delta) (CaMK-II subunit delta) (EC 2.7.11.17) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 SGK3 0 1 SGK3 CISK SGKL SGK3_HUMAN 5.95424250943933 5.3 5.3 1 Serine/threonine-protein kinase Sgk3 (EC 2.7.11.1) (Cytokine-independent survival kinase) (Serum/glucocorticoid-regulated kinase 3) (Serum/glucocorticoid-regulated kinase-like) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 TSSK2 0 2 TSSK2 DGSG SPOGA2 STK22B TSSK2_HUMAN 6.00479888288177 5.3 5.3 2 Testis-specific serine/threonine-protein kinase 2 (TSK-2) (TSK2) (TSSK-2) (Testis-specific kinase 2) (EC 2.7.11.1) (DiGeorge syndrome protein G) (DGS-G) (Serine/threonine-protein kinase 22B) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 PAK6 0 2 PAK6 PAK5 PAK6_HUMAN 5.85986974618548 5.3 5.3 2 Serine/threonine-protein kinase PAK 6 (EC 2.7.11.1) (PAK-5) (p21-activated kinase 6) (PAK-6) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 HIPK2 0 1 HIPK2 HIPK2_HUMAN 6.50965047954658 5.3 5.3 1 Homeodomain-interacting protein kinase 2 (hHIPk2) (EC 2.7.11.1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 DCLK2 0 2 DCLK2 DCAMKL2 DCDC3B DCK2 DCLK2_HUMAN 5.79315723188788 5.3 5.3 2 Serine/threonine-protein kinase DCLK2 (EC 2.7.11.1) (CaMK-like CREB regulatory kinase 2) (CL2) (CLICK-II) (CLICK2) (Doublecortin domain-containing protein 3B) (Doublecortin-like and CAM kinase-like 2) (Doublecortin-like kinase 2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 STK3 0 2 STK3 KRS1 MST2 STK3_HUMAN 6.07202751352768 5.3 5.3 2 Serine/threonine-protein kinase 3 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 2) (MST-2) (STE20-like kinase MST2) (Serine/threonine-protein kinase Krs-1) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit (MST2/N); Serine/threonine-protein kinase 3 20kDa subunit (MST2/C)], Serine/threonine-protein kinase 3 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 2) (MST-2) (STE20-like kinase MST2) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit (MST2/N); Serine/threonine-protein kinase 3 20kDa subunit (MST2/C)] 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 M3K7 0 2 MAP3K7 TAK1 M3K7_HUMAN 6.32948242133222 5.3 5.3 2 Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25) (Transforming growth factor-beta-activated kinase 1) (TGF-beta-activated kinase 1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 PLK1 0 2 PLK1 PLK PLK1_HUMAN 5.55342633632274 5.3 5.3 2 Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 EPHA2 0 1 EPHA2 ECK EPHA2_HUMAN 6.50965047954658 5.3 5.3 1 Ephrin type-A receptor 2 (EC 2.7.10.1) (Epithelial cell kinase) (Tyrosine-protein kinase receptor ECK) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 EF2K 0 1 EEF2K EF2K_HUMAN 5.78837041556533 5.3 5.3 1 Eukaryotic elongation factor 2 kinase (eEF-2 kinase) (eEF-2K) (EC 2.7.11.20) (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KAPCA 0 2 PRKACA PKACA KAPCA_HUMAN 5.6327458351425 5.3 5.3 2 cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 AURKB 0 2 AURKB AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5 AURKB_HUMAN 5.65134857751572 5.3 5.3 2 Aurora kinase B (EC 2.7.11.1) (Aurora 1) (Aurora- and IPL1-like midbody-associated protein 1) (AIM-1) (Aurora/IPL1-related kinase 2) (ARK-2) (Aurora-related kinase 2) (STK-1) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase 5) (Serine/threonine-protein kinase aurora-B), Aurora kinase B (EC 2.7.11.1) (Aurora 1) (Aurora- and IPL1-like midbody-associated protein 1) (Aurora/IPL1-related kinase 2) (ARK-2) (Aurora-related kinase 2) (STK-1) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase 5) (Serine/threonine-protein kinase aurora-B) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 TEC 0 2 TEC PSCTK4 TEC_HUMAN 5.67155143012972 5.3 5.3 2 Tyrosine-protein kinase Tec (EC 2.7.10.2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 6.1 5.3 5.3 1 Ras-related protein Rab-9A 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 TBK1 0 2 TBK1 NAK TBK1_HUMAN 5.6101647557634 5.3 5.3 2 Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (NF-kappa-B-activating kinase) (T2K) (TANK-binding kinase 1), Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (T2K) (TANK-binding kinase 1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KPCD 0 1 PRKCD KPCD_HUMAN 5.75332766665861 5.3 5.3 1 Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)], Protein kinase C delta type (EC 2.7.11.13) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)] 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 HASP 0 2 HASPIN GSG2 HASP_HUMAN 5.75710253565479 5.3 5.3 2 Serine/threonine-protein kinase haspin (EC 2.7.11.1) (Germ cell-specific gene 2 protein) (H-haspin) (Haploid germ cell-specific nuclear protein kinase) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 IRAK1 0 2 IRAK1 IRAK IRAK1_HUMAN 6.5953058989068 5.3 5.3 2 Interleukin-1 receptor-associated kinase 1 (IRAK-1) (EC 2.7.11.1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 BRSK2 0 1 BRSK2 C11orf7 PEN11B SADA STK29 HUSSY-12 BRSK2_HUMAN 6.50965047954658 5.3 5.3 1 Serine/threonine-protein kinase BRSK2 (EC 2.7.11.1) (Brain-selective kinase 2) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 2) (BR serine/threonine-protein kinase 2) (Serine/threonine-protein kinase 29) (Serine/threonine-protein kinase SAD-A) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 AAPK1 0 10 PRKAA1 AMPK1 AAPK1_HUMAN 5.92264694750582 5.3 5.3 10 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 AAKG1 0 10 PRKAG1 AAKG1_HUMAN 5.92264694750582 5.3 5.3 10 5'-AMP-activated protein kinase subunit gamma-1 (AMPK gamma1) (AMPK subunit gamma-1) (AMPKg) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 AAKB1 0 10 PRKAB1 AMPK AAKB1_HUMAN 5.92264694750582 5.3 5.3 10 5'-AMP-activated protein kinase subunit beta-1 (AMPK subunit beta-1) (AMPKb) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 TSSK1 0 1 TSSK1B SPOGA1 SPOGA4 STK22A STK22D TSSK1 FKSG81 TSSK1_HUMAN 6.50965047954658 5.3 5.3 1 Testis-specific serine/threonine-protein kinase 1 (TSK-1) (TSK1) (TSSK-1) (Testis-specific kinase 1) (EC 2.7.11.1) (Serine/threonine-protein kinase 22A) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 DDR2 0 1 DDR2 NTRKR3 TKT TYRO10 DDR2_HUMAN 5.95424250943933 5.3 5.3 1 Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Discoidin domain-containing receptor tyrosine kinase 2) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MARK1 0 2 MARK1 KIAA1477 MARK MARK1_HUMAN 5.83720090642264 5.3 5.3 2 Serine/threonine-protein kinase MARK1 (EC 2.7.11.1) (EC 2.7.11.26) (MAP/microtubule affinity-regulating kinase 1) (PAR1 homolog c) (Par-1c) (Par1c) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 NUAK1 0 2 NUAK1 ARK5 KIAA0537 OMPHK1 NUAK1_HUMAN 6.12783722178484 5.3 5.3 2 NUAK family SNF1-like kinase 1 (EC 2.7.11.1) (AMPK-related protein kinase 5) (ARK5) (Omphalocele kinase 1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 PAK3 0 2 PAK3 OPHN3 PAK3_HUMAN 5.4918220276171 5.3 5.3 2 Serine/threonine-protein kinase PAK 3 (EC 2.7.11.1) (Beta-PAK) (Oligophrenin-3) (p21-activated kinase 3) (PAK-3) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 1 4 NotRecorded 4.81968537526503 5.3 5.11716666666667 5 0.8 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KC1G1 0 2 CSNK1G1 KC1G1_HUMAN 5.97448040442573 5.3 5.3 2 Casein kinase I isoform gamma-1 (CKI-gamma 1) (EC 2.7.11.1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MELK 0 2 MELK KIAA0175 MELK_HUMAN 5.46746867712197 5.3 5.3 2 Maternal embryonic leucine zipper kinase (hMELK) (EC 2.7.11.1) (Protein kinase Eg3) (pEg3 kinase) (Protein kinase PK38) (hPK38) (Tyrosine-protein kinase MELK) (EC 2.7.10.2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 CHK1 0 2 CHEK1 CHK1 CHK1_HUMAN 6.12783722178484 5.3 5.3 2 Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Cell cycle checkpoint kinase) (Checkpoint kinase-1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 JAK3 0 4 JAK3 JAK3_HUMAN 6.15996374897717 5.3 5.3 4 Tyrosine-protein kinase JAK3 (EC 2.7.10.2) (Janus kinase 3) (JAK-3), Tyrosine-protein kinase JAK3 (EC 2.7.10.2) (Janus kinase 3) (JAK-3) (Leukocyte janus kinase) (L-JAK) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 PRKX 0 1 PRKX PKX1 PRKX_HUMAN 6.50965047954658 5.3 5.3 1 cAMP-dependent protein kinase catalytic subunit PRKX (PrKX) (Protein kinase X) (Protein kinase X-linked) (Serine/threonine-protein kinase PRKX) (EC 2.7.11.1) (Protein kinase PKX1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 ALK 0 2 ALK ALK_HUMAN 5.41731630316804 5.3 5.3 2 ALK tyrosine kinase receptor (EC 2.7.10.1) (Anaplastic lymphoma kinase) (CD antigen CD246) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 WNK3 0 2 WNK3 KIAA1566 PRKWNK3 WNK3_HUMAN 6.22045454103261 5.3 5.3 2 Serine/threonine-protein kinase WNK3 (EC 2.7.11.1) (Protein kinase lysine-deficient 3) (Protein kinase with no lysine 3) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 EPHA3 0 1 EPHA3 ETK ETK1 HEK TYRO4 EPHA3_HUMAN 6.06069784035361 5.3 5.3 1 Ephrin type-A receptor 3 (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (hEK4) (HEK) (Human embryo kinase) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) (Eph-like tyrosine kinase 1), Ephrin type-A receptor 3 (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (mEK4) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 ACK1 0 2 TNK2 ACK1 ACK1_HUMAN 5.47321928524387 5.3 5.3 2 Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Non-receptor protein tyrosine kinase Ack) (Tyrosine kinase non-receptor protein 2), Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Tyrosine kinase non-receptor protein 2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 AKT2 0 2 AKT2 AKT2_HUMAN 6.00512641505789 5.3 5.3 2 RAC-beta serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-2) (Protein kinase B beta) (PKB beta) (RAC-PK-beta) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 M4K2 0 2 MAP4K2 GCK RAB8IP M4K2_HUMAN 6.32221929473392 5.3 5.3 2 Mitogen-activated protein kinase kinase kinase kinase 2 (EC 2.7.11.1) (B lymphocyte serine/threonine-protein kinase) (Germinal center kinase) (GC kinase) (MAPK/ERK kinase kinase kinase 2) (MEK kinase kinase 2) (MEKKK 2) (Rab8-interacting protein) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 PGFRB 0 11 PDGFRB PDGFR PDGFR1, Pdgfrb Pdgfr Pdgfr1 PGFRB_HUMAN, PGFRB_MOUSE 5.70962240330083 5.3 5.3 11 Platelet-derived growth factor receptor beta (PDGF-R-beta) (PDGFR-beta) (EC 2.7.10.1) (Beta platelet-derived growth factor receptor) (Beta-type platelet-derived growth factor receptor) (CD140 antigen-like family member B) (Platelet-derived growth factor receptor 1) (PDGFR-1) (CD antigen CD140b) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MK03 0 2 MAPK3 ERK1 PRKM3 MK03_HUMAN 5.80697315793856 5.3 5.3 2 Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (MNK1) (Microtubule-associated protein 2 kinase) (p44-ERK1), Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (Microtubule-associated protein 2 kinase) (p44-ERK1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 NEK11 0 2 NEK11 NEK11_HUMAN 6.31651769404313 5.3 5.3 2 Serine/threonine-protein kinase Nek11 (EC 2.7.11.1) (Never in mitosis A-related kinase 11) (NimA-related protein kinase 11) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 M3K9 0 1 MAP3K9 MLK1 PRKE1 M3K9_HUMAN 6.06069784035361 5.3 5.3 1 Mitogen-activated protein kinase kinase kinase 9 (EC 2.7.11.25) (Mixed lineage kinase 1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 FLT3 0 4 FLT3 CD135 FLK2 STK1 FLT3_HUMAN 5.34767518340382 5.3 5.3 4 Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase 2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Tyrosine-protein kinase receptor flk-2) (CD antigen CD135), Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase-2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Stem cell tyrosine kinase 1) (STK-1) (CD antigen CD135) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 FRK 0 1 FRK PTK5 RAK FRK_HUMAN 5.86530142610254 5.3 5.3 1 Tyrosine-protein kinase FRK (EC 2.7.10.2) (FYN-related kinase) (Nuclear tyrosine protein kinase RAK) (Protein-tyrosine kinase 5) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 AKT3 0 2 AKT3 PKBG AKT3_HUMAN 5.88990920487556 5.3 5.3 2 RAC-gamma serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-3) (Protein kinase B gamma) (PKB gamma) (RAC-PK-gamma) (STK-2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 EPHA8 0 2 EPHA8 EEK HEK3 KIAA1459 EPHA8_HUMAN 6.59992327978754 5.3 5.3 2 Ephrin type-A receptor 8 (EC 2.7.10.1) (EPH- and ELK-related kinase) (EPH-like kinase 3) (EK3) (hEK3) (Tyrosine-protein kinase receptor EEK) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 BMX 0 1 BMX BMX_HUMAN 6.12338490853968 5.3 5.3 1 Cytoplasmic tyrosine-protein kinase BMX (EC 2.7.10.2) (Bone marrow tyrosine kinase gene in chromosome X protein homolog), Cytoplasmic tyrosine-protein kinase BMX (EC 2.7.10.2) (Bone marrow tyrosine kinase gene in chromosome X protein) (Epithelial and endothelial tyrosine kinase) (ETK) (NTK38) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 TAOK2 0 1 TAOK2 KIAA0881 MAP3K17 PSK PSK1 UNQ2971/PRO7431 TAOK2_HUMAN 6.00479888288177 5.3 5.3 1 Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Kinase from chicken homolog C) (hKFC-C) (Prostate-derived sterile 20-like kinase 1) (PSK-1) (PSK1) (Prostate-derived STE20-like kinase 1) (Thousand and one amino acid protein kinase 2), Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Thousand and one amino acid protein 2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 RAF1 0 2 RAF1 RAF RAF1_HUMAN 6.09913982527219 5.3 5.3 2 RAF proto-oncogene serine/threonine-protein kinase (EC 2.7.11.1) (Proto-oncogene c-RAF) (cRaf) (Raf-1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 ATAD5 0 5 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.75561951962184 5.3 5.285 5 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 FGFR4 0 1 FGFR4 JTK2 TKF FGFR4_HUMAN 6.12338490853968 5.3 5.3 1 Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (CD antigen CD334), Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (Protein-tyrosine kinase receptor MPK-11) (CD antigen CD334) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 HIPK1 0 1 HIPK1 KIAA0630 MYAK NBAK2 HIPK1_HUMAN 6.19497660321606 5.3 5.3 1 Homeodomain-interacting protein kinase 1 (EC 2.7.11.1) (Nuclear body-associated kinase 2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KS6B1 0 2 RPS6KB1 STK14A KS6B1_HUMAN 5.31841104879359 5.3 5.3 2 Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (S6K) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA), Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (Serine/threonine-protein kinase 14A) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 CLK3 0 2 CLK3 CLK3_HUMAN 6.53520366087006 5.3 5.3 2 Dual specificity protein kinase CLK3 (EC 2.7.12.1) (CDC-like kinase 3) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 RET 0 1 RET CDHF12 CDHR16 PTC RET51 RET_HUMAN 6.38021124171161 5.3 5.3 1 Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment], Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment] 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 P53 0 1 TP53 P53 P53_HUMAN 4.89999841719865 5.3 5.3 1 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MK08 0 1 MAPK8 JNK1 PRKM8 SAPK1 SAPK1C MK08_HUMAN 6.99563519459755 5.3 5.3 1 Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (JNK-46) (Stress-activated protein kinase 1c) (SAPK1c) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1), Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (SAPK gamma) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1) (p54 gamma), Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 GSK3B 0 1 GSK3B GSK3B_HUMAN 5.86530142610254 5.3 5.3 1 Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Factor A) (FA) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1), Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MK14 0 2 MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A MK14_HUMAN 5.70593450696951 5.3 5.3 2 Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (CRK1) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha), Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (Cytokine suppressive anti-inflammatory drug-binding protein) (CSAID-binding protein) (CSBP) (MAP kinase MXI2) (MAX-interacting protein 2) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha) (Stress-activated protein kinase 2a) (SAPK2a) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 AURKC 0 1 AURKC AIE2 AIK3 AIRK3 ARK3 STK13 AURKC_HUMAN 5.82557590031178 5.3 5.3 1 Aurora kinase C (EC 2.7.11.1) (Aurora 3) (Aurora/IPL1-related kinase 3) (ARK-3) (Aurora-related kinase 3) (Aurora/IPL1/Eg2 protein 2) (Serine/threonine-protein kinase 13) (Serine/threonine-protein kinase aurora-C) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 SRPK1 0 1 SRPK1 SRPK1_HUMAN 6.50965047954658 5.3 5.3 1 SRSF protein kinase 1 (EC 2.7.11.1) (SFRS protein kinase 1) (Serine/arginine-rich protein-specific kinase 1) (SR-protein-specific kinase 1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 HCK 0 3 HCK HCK_HUMAN 5.80338143490093 5.3 5.3 3 Tyrosine-protein kinase HCK (EC 2.7.10.2) (Hematopoietic cell kinase) (Hemopoietic cell kinase) (p59-HCK/p60-HCK) (p59Hck) (p61Hck) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 ULK2 0 1 ULK2 KIAA0623 ULK2_HUMAN 5.86530142610254 5.3 5.3 1 Serine/threonine-protein kinase ULK2 (EC 2.7.11.1) (Unc-51-like kinase 2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 FKB1A 0 4 FKBP1A FKBP1 FKBP12 FKB1A_HUMAN 5.5283029781462 5.3 5.3 4 Peptidyl-prolyl cis-trans isomerase FKBP1A (PPIase FKBP1A) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (Calstabin-1) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MTOR 0 5 MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 MTOR_HUMAN 5.64731936422489 5.3 5.3 5 Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1), Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KCC2G 0 1 CAMK2G CAMK CAMK-II CAMKG KCC2G_HUMAN 6.19497660321606 5.3 5.3 1 Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MK10 0 1 MAPK10 JNK3 JNK3A PRKM10 SAPK1B MK10_HUMAN 5.36797678529459 5.3 5.3 1 Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (MAP kinase p49 3F12) (Stress-activated protein kinase 1b) (SAPK1b) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3), Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (MAP kinase p49 3F12) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3), Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (SAPK-beta) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3) (p54-beta) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 WNK2 0 2 WNK2 KIAA1760 PRKWNK2 SDCCAG43 P/OKcl.13 WNK2_HUMAN 6.55951005156861 5.3 5.3 2 Serine/threonine-protein kinase WNK2 (EC 2.7.11.1) (Antigen NY-CO-43) (Protein kinase lysine-deficient 2) (Protein kinase with no lysine 2) (Serologically defined colon cancer antigen 43) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 DAPK1 0 2 DAPK1 DAPK DAPK1_HUMAN 5.96299963322807 5.3 5.3 2 Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 PGFRA 0 5 PDGFRA PDGFR2 RHEPDGFRA, Pdgfra PGFRA_HUMAN, PGFRA_MOUSE 5.69603574063301 5.3 5.3 5 Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (CD140a antigen) (Platelet-derived growth factor alpha receptor) (Platelet-derived growth factor receptor 2) (PDGFR-2) (CD antigen CD140a), Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (Platelet-derived growth factor alpha receptor) (CD antigen CD140a) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 TXK 0 2 TXK PTK4 RLK TXK_HUMAN 5.83720090642264 5.3 5.3 2 Tyrosine-protein kinase TXK (EC 2.7.10.2) (Protein-tyrosine kinase 4) (Resting lymphocyte kinase) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 SRC 0 2 SRC SRC1 SRC_HUMAN 6.34213218279768 5.3 5.3 2 Neuronal proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src), Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src), Tyrosine-protein kinase transforming protein Src (EC 2.7.10.2) (pp60v-src) (p60-Src) (v-Src) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 PIM1 0 2 PIM1 PIM1_HUMAN 6.11490489147627 5.3 5.3 2 Serine/threonine-protein kinase pim-1 (EC 2.7.11.1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KS6A1 0 4 RPS6KA1 MAPKAPK1A RSK1 KS6A1_HUMAN 6.03356200825908 5.3 5.3 4 Ribosomal protein S6 kinase alpha-1 (S6K-alpha-1) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 1) (p90-RSK 1) (p90RSK1) (p90S6K) (MAP kinase-activated protein kinase 1a) (MAPK-activated protein kinase 1a) (MAPKAP kinase 1a) (MAPKAPK-1a) (Ribosomal S6 kinase 1) (RSK-1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 EPHA7 0 2 EPHA7 EHK3 HEK11 EPHA7_HUMAN 6.55951005156861 5.3 5.3 2 Ephrin type-A receptor 7 (EC 2.7.10.1) (EPH homology kinase 3) (EHK-3) (EPH-like kinase 11) (EK11) (hEK11) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.08621262979452 5.3 5.3 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 GEMI 0 1 GMNN GEMI_HUMAN 5.88622371616297 5.3 5.3 1 Geminin 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 M3K5 0 2 MAP3K5 ASK1 MAPKKK5 MEKK5 M3K5_HUMAN 5.61915054643304 5.3 5.3 2 Mitogen-activated protein kinase kinase kinase 5 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 1) (ASK-1) (MAPK/ERK kinase kinase 5) (MEK kinase 5) (MEKK 5) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 PAK4 0 1 PAK4 KIAA1142 PAK4_HUMAN 5.86530142610254 5.3 5.3 1 Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 CLK2 0 1 CLK2 CLK2_HUMAN 6.69019608002851 5.3 5.3 1 Dual specificity protein kinase CLK2 (EC 2.7.12.1) (CDC-like kinase 2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 GRK7 0 1 GRK7 GPRK7 GRK7_HUMAN 6.19497660321606 5.3 5.3 1 Rhodopsin kinase (EC 2.7.11.14) (G protein-coupled receptor kinase 7) (G protein-coupled receptor kinase GRK7) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KGP1 0 2 PRKG1 PRKG1B PRKGR1A PRKGR1B KGP1_HUMAN 5.94180288710693 5.3 5.3 2 cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 ABL1 0 2 ABL1 ABL JTK7 ABL1_HUMAN 5.9431368703327 5.3 5.3 2 Tyrosine-protein kinase ABL1 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 1) (Abelson tyrosine-protein kinase 1) (Proto-oncogene c-Abl) (p150) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 CDK9 0 2 CDK9 CDC2L4 TAK CDK9_HUMAN 5.75332766665861 5.3 5.3 2 Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (C-2K) (Cell division cycle 2-like protein kinase 4) (Cell division protein kinase 9) (Serine/threonine-protein kinase PITALRE) (Tat-associated kinase complex catalytic subunit) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 CCNT1 0 2 CCNT1 CCNT1_HUMAN 5.75332766665861 5.3 5.3 2 Cyclin-T1 (CycT1) (Cyclin-T) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MRCKA 0 1 CDC42BPA KIAA0451 MRCKA_HUMAN 5.62973141792582 5.3 5.3 1 Serine/threonine-protein kinase MRCK alpha (EC 2.7.11.1) (CDC42-binding protein kinase alpha) (DMPK-like alpha) (Myotonic dystrophy kinase-related CDC42-binding kinase alpha) (MRCK alpha) (Myotonic dystrophy protein kinase-like alpha) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 CCND3 0 2 CCND3 CCND3_HUMAN 5.86530142610254 5.3 5.3 2 G1/S-specific cyclin-D3 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 CDK6 0 2 CDK6 CDKN6 CDK6_HUMAN 5.86530142610254 5.3 5.3 2 Cyclin-dependent kinase 6 (EC 2.7.11.22) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 INSRR 0 1 INSRR IRR INSRR_HUMAN 5.38886035082012 5.3 5.3 1 Insulin receptor-related protein (IRR) (EC 2.7.10.1) (IR-related receptor) [Cleaved into: Insulin receptor-related protein alpha chain; Insulin receptor-related protein beta chain] 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MP2K7 0 2 MAP2K7 JNKK2 MEK7 MKK7 PRKMK7 SKK4 MP2K7_HUMAN 5.81199362955443 5.3 5.3 2 Dual specificity mitogen-activated protein kinase kinase 7 (MAP kinase kinase 7) (MAPKK 7) (EC 2.7.12.2) (JNK-activating kinase 2) (MAPK/ERK kinase 7) (MEK 7) (Stress-activated protein kinase kinase 4) (SAPK kinase 4) (SAPKK-4) (SAPKK4) (c-Jun N-terminal kinase kinase 2) (JNK kinase 2) (JNKK 2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 RUNX1 0 2 RUNX1 AML1 CBFA2 RUNX1_HUMAN 4.8000008748032 5.3 5.3 2 Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 PEBB 0 2 CBFB PEBB_HUMAN 4.8000008748032 5.3 5.3 2 Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 PASK 0 1 PASK KIAA0135 PASK_HUMAN 6.19497660321606 5.3 5.3 1 PAS domain-containing serine/threonine-protein kinase (PAS-kinase) (PASKIN) (hPASK) (EC 2.7.11.1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MP2K6 0 1 MAP2K6 MEK6 MKK6 PRKMK6 SKK3 MP2K6_HUMAN 5.78837041556533 5.3 5.3 1 Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (MAPK/ERK kinase 6) (MEK 6) (Stress-activated protein kinase kinase 3) (SAPK kinase 3) (SAPKK-3) (SAPKK3) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MYLK 0 2 MYLK MLCK MLCK1 MYLK1 MYLK_HUMAN 5.95248706543325 5.3 5.3 2 Myosin light chain kinase, smooth muscle (MLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form], Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form] 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 NEK3 0 1 NEK3 NEK3_HUMAN 6.12338490853968 5.3 5.3 1 Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (HSPK 36) (Never in mitosis A-related kinase 3) (NimA-related protein kinase 3) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 IKKB 0 1 IKBKB IKKB IKKB_HUMAN 6.99563519459755 5.3 5.3 1 Inhibitor of nuclear factor kappa-B kinase subunit beta (I-kappa-B-kinase beta) (IKK-B) (IKK-beta) (IkBKB) (EC 2.7.11.10) (I-kappa-B kinase 2) (IKK2) (Nuclear factor NF-kappa-B inhibitor kinase beta) (NFKBIKB) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 IGF1R 0 1 IGF1R IGF1R_HUMAN 6.99563519459755 5.3 5.3 1 Insulin-like growth factor 1 receptor (EC 2.7.10.1) (Insulin-like growth factor I receptor) (IGF-I receptor) (CD antigen CD221) [Cleaved into: Insulin-like growth factor 1 receptor alpha chain; Insulin-like growth factor 1 receptor beta chain] 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MAPK5 0 1 MAPKAPK5 PRAK MAPK5_HUMAN 5.43195909596147 5.3 5.3 1 MAP kinase-activated protein kinase 5 (MAPK-activated protein kinase 5) (MAPKAP kinase 5) (MAPKAP-K5) (MAPKAPK-5) (MK-5) (MK5) (EC 2.7.11.1) (p38-regulated/activated protein kinase) (PRAK) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 RON 0 2 MST1R PTK8 RON RON_HUMAN 5.81805281845507 5.3 5.3 2 Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (CDw136) (Protein-tyrosine kinase 8) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain], Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (Stem cell-derived tyrosine kinase) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain] 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 FGR 0 1 FGR SRC2 FGR_HUMAN 6.00479888288177 5.3 5.3 1 Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog) (Proto-oncogene c-Fgr) (p55-Fgr) (p58-Fgr) (p58c-Fgr), Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Proto-oncogene c-Fgr) (p55-Fgr) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 VGFR2 0 3 KDR FLK1 VEGFR2 VGFR2_HUMAN 5.61536854563671 5.3 5.3 3 Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase NYK) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309), Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase insert domain receptor) (KDR) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309), Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1b) (FLK-1b) (Kinase insert domain receptor) (Kinase insert domain receptor-B) (Protein-tyrosine kinase receptor flk-1b) (Vascular endothelial growth factor receptor 2 homolog B) (VEGFR-2 homolog B) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 SIK1 0 1 SIK1 SIK SNF1LK SIK1_HUMAN 5.60205999132796 5.3 5.3 1 Serine/threonine-protein kinase SIK1 (EC 2.7.11.1) (Salt-inducible kinase 1) (SIK-1) (Serine/threonine-protein kinase SNF1-like kinase 1) (Serine/threonine-protein kinase SNF1LK) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 ULK3 0 1 ULK3 ULK3_HUMAN 6.38021124171161 5.3 5.3 1 Serine/threonine-protein kinase ULK3 (EC 2.7.11.1) (Unc-51-like kinase 3) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 NPC1 0 1 NPC1 NPC1_HUMAN 5.9 5.3 5.3 1 Niemann-Pick C1 protein 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 ROCK2 0 1 ROCK2 KIAA0619 ROCK2_HUMAN 6.19497660321606 5.3 5.3 1 Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2), Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (RhoA-binding kinase 2) (p150 ROK-alpha) (ROKalpha) (p164 ROCK-2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MERTK 0 1 MERTK MER MERTK_HUMAN 5.95424250943933 5.3 5.3 1 Tyrosine-protein kinase Mer (EC 2.7.10.1) (Proto-oncogene c-Mer) (Receptor tyrosine kinase MerTK) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 ZAP70 0 2 ZAP70 SRK ZAP70_HUMAN 6.53520366087006 5.3 5.3 2 Tyrosine-protein kinase ZAP-70 (EC 2.7.10.2) (70 kDa zeta-chain associated protein) (Syk-related tyrosine kinase) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 FGFR1 0 1 FGFR1 BFGFR CEK FGFBR FLG FLT2 HBGFR FGFR1_HUMAN 5.78837041556533 5.3 5.3 1 Fibroblast growth factor receptor 1 (FGFR-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (BFGFR) (bFGF-R-1) (Fms-like tyrosine kinase 2) (FLT-2) (N-sam) (Proto-oncogene c-Fgr) (CD antigen CD331), Fibroblast growth factor receptor 1 (FGFR-1) (bFGF-R-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (MFR) (Proto-oncogene c-Fgr) (CD antigen CD331) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 ABL2 0 1 ABL2 ABLL ARG ABL2_HUMAN 6.38021124171161 5.3 5.3 1 Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 STK33 0 1 STK33 STK33_HUMAN 6.69019608002851 5.3 5.3 1 Serine/threonine-protein kinase 33 (EC 2.7.11.1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KC1G2 0 2 CSNK1G2 CK1G2 KC1G2_HUMAN 5.34460508352343 5.3 5.3 2 Casein kinase I isoform gamma-2 (CKI-gamma 2) (EC 2.7.11.1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 STK24 0 2 STK24 MST3 STK3 STK24_HUMAN 5.47873724164519 5.3 5.3 2 Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)] 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 BLK 0 1 BLK BLK_HUMAN 6.27875360095283 5.3 5.3 1 Tyrosine-protein kinase Blk (EC 2.7.10.2) (B lymphocyte kinase) (p55-Blk) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 LCK 0 2 LCK LCK_HUMAN 6.25722468121418 5.3 5.3 2 Proto-oncogene tyrosine-protein kinase LCK (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (p56-LCK), Tyrosine-protein kinase Lck (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (Protein YT16) (Proto-oncogene Lck) (T cell-specific protein-tyrosine kinase) (p56-LCK) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 FYN 0 2 FYN FYN_HUMAN 5.62911849203352 5.3 5.3 2 Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene Syn) (Proto-oncogene c-Fyn) (Src-like kinase) (SLK) (p59-Fyn), Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene c-Fyn) (p59-Fyn) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 PHKG2 0 1 PHKG2 PHKG2_HUMAN 6.19497660321606 5.3 5.3 1 Phosphorylase b kinase gamma catalytic chain, liver/testis isoform (PHK-gamma-LT) (PHK-gamma-T) (EC 2.7.11.19) (PSK-C3) (Phosphorylase kinase subunit gamma-2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KCC1A 0 1 CAMK1 KCC1A_HUMAN 5.90799732148669 5.3 5.3 1 Calcium/calmodulin-dependent protein kinase type 1 (EC 2.7.11.17) (CaM kinase I) (CaM-KI) (CaM kinase I alpha) (CaMKI-alpha) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 STK10 0 2 STK10 LOK STK10_HUMAN 6.01569111501319 5.3 5.3 2 Serine/threonine-protein kinase 10 (EC 2.7.11.1) (Lymphocyte-oriented kinase) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 ERBB4 0 1 ERBB4 HER4 ERBB4_HUMAN 6.99563519459755 5.3 5.3 1 Receptor tyrosine-protein kinase erbB-4 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-4) (Tyrosine kinase-type cell surface receptor HER4) (p180erbB4) [Cleaved into: ERBB4 intracellular domain (4ICD) (E4ICD) (s80HER4)] 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KS6A6 0 2 RPS6KA6 RSK4 KS6A6_HUMAN 6.50965047954658 5.3 5.3 2 Ribosomal protein S6 kinase alpha-6 (S6K-alpha-6) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 6) (p90-RSK 6) (p90RSK6) (Ribosomal S6 kinase 4) (RSK-4) (pp90RSK4) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 PAK2 0 2 PAK2 PAK2_HUMAN 6.35231354138132 5.3 5.3 2 Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (PAK65) (S6/H4 kinase) (p21-activated kinase 2) (PAK-2) (p58) [Cleaved into: PAK-2p27 (p27); PAK-2p34 (p34) (C-t-PAK2)] 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MRCKB 0 2 CDC42BPB KIAA1124 MRCKB_HUMAN 5.96299963322807 5.3 5.3 2 Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MK09 0 1 MAPK9 JNK2 PRKM9 SAPK1A MK09_HUMAN 6.50965047954658 5.3 5.3 1 Mitogen-activated protein kinase 9 (MAP kinase 9) (MAPK 9) (EC 2.7.11.24) (JNK-55) (Stress-activated protein kinase 1a) (SAPK1a) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2), Mitogen-activated protein kinase 9 (MAP kinase 9) (MAPK 9) (EC 2.7.11.24) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 PTH1R 0 2 PTH1R PTHR PTHR1 PTH1R_HUMAN 5.39999691337226 5.3 5.45 2 Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH/PTHrP type I receptor) (PTH/PTHr receptor) (Parathyroid hormone 1 receptor) (PTH1 receptor) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 LYN 0 2 LYN JTK8 LYN_HUMAN 5.46568981323991 5.3 5.3 2 Tyrosine-protein kinase Lyn (EC 2.7.10.2) (Lck/Yes-related novel protein tyrosine kinase) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn), Tyrosine-protein kinase Lyn (EC 2.7.10.2) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MINK1 0 2 MINK1 B55 MAP4K6 MINK YSK2 ZC3 MINK1_HUMAN 5.92675897524824 5.3 5.3 2 Misshapen-like kinase 1 (EC 2.7.11.1) (GCK family kinase MiNK) (MAPK/ERK kinase kinase kinase 6) (MEK kinase kinase 6) (MEKKK 6) (Misshapen/NIK-related kinase) (Mitogen-activated protein kinase kinase kinase kinase 6) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 NLK 0 1 NLK LAK1 NLK_HUMAN 6.00479888288177 5.3 5.3 1 Serine/threonine-protein kinase NLK (EC 2.7.11.24) (Nemo-like kinase) (Protein LAK1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 EPHA1 0 1 EPHA1 EPH EPHT EPHT1 EPHA1_HUMAN 6.38021124171161 5.3 5.3 1 Ephrin type-A receptor 1 (hEpha1) (EC 2.7.10.1) (EPH tyrosine kinase) (EPH tyrosine kinase 1) (Erythropoietin-producing hepatoma receptor) (Tyrosine-protein kinase receptor EPH) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 AAKG2 0 7 PRKAG2 AAKG2_HUMAN 6.12338490853968 5.3 5.3 7 5'-AMP-activated protein kinase subunit gamma-2 (AMPK gamma2) (AMPK subunit gamma-2) (H91620p) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 AAKB2 0 7 PRKAB2 AAKB2_HUMAN 6.12338490853968 5.3 5.3 7 5'-AMP-activated protein kinase subunit beta-2 (AMPK subunit beta-2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 AAPK2 0 7 PRKAA2 AMPK AMPK2 AAPK2_HUMAN 6.12338490853968 5.3 5.3 7 5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 AAKG3 0 7 PRKAG3 AMPKG3 AAKG3_HUMAN 6.12338490853968 5.3 5.3 7 5'-AMP-activated protein kinase subunit gamma-3 (AMPK gamma3) (AMPK subunit gamma-3) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 TIE2 0 2 TEK TIE2 VMCM VMCM1 TIE2_HUMAN 6.2990967007576 5.3 5.3 2 Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (HYK) (STK1) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (mTIE2) (p140 TEK) (CD antigen CD202b), Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK) (CD antigen CD202b) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 VGFR3 0 2 FLT4 VEGFR3 VGFR3_HUMAN 4.84296016570244 5.3 5.3 2 Vascular endothelial growth factor receptor 3 (VEGFR-3) (EC 2.7.10.1) (Fms-like tyrosine kinase 4) (FLT-4) (Tyrosine-protein kinase receptor FLT4) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KC1G3 0 2 CSNK1G3 KC1G3_HUMAN 5.5504075317808 5.3 5.3 2 Casein kinase I isoform gamma-3 (CKI-gamma 3) (EC 2.7.11.1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 NTRK1 0 1 NTRK1 MTC TRK TRKA NTRK1_HUMAN 5.62973141792582 5.3 5.3 1 High affinity nerve growth factor receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 1) (Slow nerve growth factor receptor) (p140-TrkA) (Trk-A), High affinity nerve growth factor receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 1) (TRK1-transforming tyrosine kinase protein) (Tropomyosin-related kinase A) (Tyrosine kinase receptor) (Tyrosine kinase receptor A) (Trk-A) (gp140trk) (p140-TrkA) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KC1D 0 2 CSNK1D HCKID KC1D_HUMAN 5.45636303801534 5.3 5.3 2 Casein kinase I isoform delta (CKI-delta) (CKId) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26), Casein kinase I isoform delta (CKI-delta) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 ITK 0 1 ITK EMT LYK ITK_HUMAN 6.12338490853968 5.3 5.3 1 Tyrosine-protein kinase ITK/TSK (EC 2.7.10.2) (Interleukin-2-inducible T-cell kinase) (IL-2-inducible T-cell kinase) (Kinase EMT) (T-cell-specific kinase) (Tyrosine-protein kinase Lyk) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 NEK2 0 1 NEK2 NEK2A NLK1 NEK2_HUMAN 6.06069784035361 5.3 5.3 1 Serine/threonine-protein kinase Nek2 (EC 2.7.11.1) (HSPK 21) (Never in mitosis A-related kinase 2) (NimA-related protein kinase 2) (NimA-like protein kinase 1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 NTRK2 0 2 NTRK2 TRKB NTRK2_HUMAN 5.62357730744056 5.3 5.3 2 BDNF/NT-3 growth factors receptor (EC 2.7.10.1) (GP145-TrkB) (Trk-B) (Neurotrophic tyrosine kinase receptor type 2) (TrkB tyrosine kinase) (Tropomyosin-related kinase B), BDNF/NT-3 growth factors receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 2) (TrkB tyrosine kinase) (Trk-B) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 RIPK2 0 1 RIPK2 CARDIAK RICK RIP2 UNQ277/PRO314/PRO34092 RIPK2_HUMAN 5.65854134728041 5.3 5.3 1 Receptor-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (CARD-containing interleukin-1 beta-converting enzyme-associated kinase) (CARD-containing IL-1 beta ICE-kinase) (RIP-like-interacting CLARP kinase) (Receptor-interacting protein 2) (RIP-2) (Tyrosine-protein kinase RIPK2) (EC 2.7.10.2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 PIM3 0 1 PIM3 PIM3_HUMAN 6.38021124171161 5.3 5.3 1 Serine/threonine-protein kinase pim-3 (EC 2.7.11.1), Serine/threonine-protein kinase pim-3 (EC 2.7.11.1) (Kinase induced by depolarization) (Protein kinase Kid-1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 UFO 0 1 AXL UFO UFO_HUMAN 5.86530142610254 5.3 5.3 1 Tyrosine-protein kinase receptor UFO (EC 2.7.10.1) (AXL oncogene) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MET 0 1 MET MET_HUMAN 5.82557590031178 5.3 5.3 1 Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 AURKA 0 2 AURKA AIK AIRK1 ARK1 AURA AYK1 BTAK IAK1 STK15 STK6 AURKA_HUMAN 5.95248706543325 5.3 5.3 2 Aurora kinase A (EC 2.7.11.1) (Aurora 2) (Aurora family kinase 1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Ipl1- and aurora-related kinase 1) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase Ayk1) (Serine/threonine-protein kinase aurora-A), Aurora kinase A (EC 2.7.11.1) (Aurora 2) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (hARK1) (Breast tumor-amplified kinase) (Serine/threonine-protein kinase 15) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase aurora-A) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MUSK 0 1 MUSK MUSK_HUMAN 5.47712125471966 5.3 5.3 1 Muscle, skeletal receptor tyrosine-protein kinase (EC 2.7.10.1) (Muscle-specific tyrosine-protein kinase receptor) (MuSK) (Muscle-specific kinase receptor) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KS6A3 0 4 RPS6KA3 ISPK1 MAPKAPK1B RSK2 KS6A3_HUMAN 4.91195437047216 5.3 5.3 4 Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2), Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KIT 0 2 KIT SCFR KIT_HUMAN 5.57817360042996 5.3 5.3 2 Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Piebald trait protein) (PBT) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (p145 c-kit) (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) (CD antigen CD117), Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (CD antigen CD117) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 SRPK3 0 1 SRPK3 MSSK1 STK23 SRPK3_HUMAN 5.82557590031178 5.3 5.3 1 SRSF protein kinase 3 (EC 2.7.11.1) (Muscle-specific serine kinase 1) (MSSK-1) (Serine/arginine-rich protein-specific kinase 3) (SR-protein-specific kinase 3) (Serine/threonine-protein kinase 23) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 CHK2 0 2 CHEK2 CDS1 CHK2 RAD53 CHK2_HUMAN 5.81407831244633 5.3 5.3 2 Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 LUCI 0 1 LUCI_PHOPY 6.22098102808513 5.3 5.315 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 BTK 0 1 BTK AGMX1 ATK BPK BTK_HUMAN 6.19497660321606 5.3 5.3 1 Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase), Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase) (Kinase EMB) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KPCI 0 2 PRKCI DXS1179E KPCI_HUMAN 5.61915054643304 5.3 5.3 2 Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (PRKC-lambda/iota) (aPKC-lambda/iota) (nPKC-iota) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 GRK6 0 1 GRK6 GPRK6 GRK6_HUMAN 6.27875360095283 5.3 5.3 1 G protein-coupled receptor kinase 6 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK6) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.3 5.3 5.225 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 DMPK 0 1 DMPK DM1PK MDPK DMPK_HUMAN 6.50965047954658 5.3 5.3 1 Myotonin-protein kinase (MT-PK) (EC 2.7.11.1) (DM-kinase) (DMK) (DM1 protein kinase) (DMPK) (Myotonic dystrophy protein kinase) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 CDK7 0 2 CDK7 CAK CAK1 CDKN7 MO15 STK1 CDK7_HUMAN 6.50965047954658 5.3 5.3 2 Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (P39 Mo15) (CDK-activating kinase) (CR4 protein kinase) (CRK4) (Cell division protein kinase 7) (Protein-tyrosine kinase MPK-7) (TFIIH basal transcription factor complex kinase subunit), Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (p39 Mo15) (CDK-activating kinase 1) (Cell division protein kinase 7) (Serine/threonine-protein kinase 1) (TFIIH basal transcription factor complex kinase subunit) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 CCNH 0 2 CCNH CCNH_HUMAN 6.50965047954658 5.3 5.3 2 Cyclin-H (MO15-associated protein) (p34) (p37) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KCC2B 0 1 CAMK2B CAM2 CAMK2 CAMKB KCC2B_HUMAN 6.06069784035361 5.3 5.3 1 Calcium/calmodulin-dependent protein kinase type II subunit beta (CaM kinase II subunit beta) (CaMK-II subunit beta) (EC 2.7.11.17) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 CDK2 0 3 CDK2 CDKN2 CDK2_HUMAN 5.65854134728041 5.3 5.3 3 Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2) (p33 protein kinase) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 CCNA1 0 3 CCNA1 CCNA1_HUMAN 5.65854134728041 5.3 5.3 3 Cyclin-A1 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 CCNA2 0 3 CCNA2 CCN1 CCNA CCNA2_HUMAN 5.65854134728041 5.3 5.3 3 Cyclin-A2 (Cyclin-A) (Cyclin A) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 STK11 0 1 STK11 LKB1 PJS STK11_HUMAN 6.99563519459755 5.3 5.3 1 Serine/threonine-protein kinase STK11 (EC 2.7.11.1) (Liver kinase B1) (LKB1) (hLKB1) (Renal carcinoma antigen NY-REN-19) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MAPK3 0 1 MAPKAPK3 MAPK3_HUMAN 6.12338490853968 5.3 5.3 1 MAP kinase-activated protein kinase 3 (MAPK-activated protein kinase 3) (MAPKAP kinase 3) (MAPKAP-K3) (MAPKAPK-3) (MK-3) (EC 2.7.11.1) (Chromosome 3p kinase) (3pK) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 SGK2 0 1 SGK2 SGK2_HUMAN 6.99563519459755 5.3 5.3 1 Serine/threonine-protein kinase Sgk2 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 DYRK2 0 1 DYRK2 DYRK2_HUMAN 5.75332766665861 5.3 5.3 1 Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 CD5R1 0 4 CDK5R1 CDK5R NCK5A CD5R1_HUMAN 6.15918075587787 5.3 5.3 4 Cyclin-dependent kinase 5 activator 1 (CDK5 activator 1) (Cyclin-dependent kinase 5 regulatory subunit 1) (TPKII regulatory subunit) [Cleaved into: Cyclin-dependent kinase 5 activator 1, p35 (p35); Cyclin-dependent kinase 5 activator 1, p25 (p25) (Tau protein kinase II 23 kDa subunit) (p23)] 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 CDK5 0 4 CDK5 CDKN5 CDK5_HUMAN 6.15918075587787 5.3 5.3 4 Cyclin-dependent-like kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 FES 0 1 FES FPS FES_HUMAN 6.12338490853968 5.3 5.3 1 Tyrosine-protein kinase Fes/Fps (EC 2.7.10.2) (Feline sarcoma/Fujinami avian sarcoma oncogene homolog) (Proto-oncogene c-Fes) (Proto-oncogene c-Fps) (p93c-fes) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MP2K1 0 1 MAP2K1 MEK1 PRKMK1 MP2K1_HUMAN 5.95424250943933 5.3 5.3 1 Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1), Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (MKK1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KS6A4 0 2 RPS6KA4 MSK2 KS6A4_HUMAN 6.06069784035361 5.3 5.3 2 Ribosomal protein S6 kinase alpha-4 (S6K-alpha-4) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 4) (Nuclear mitogen- and stress-activated protein kinase 2) (Ribosomal protein kinase B) (RSKB) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MAPK2 0 1 MAPKAPK2 MAPK2_HUMAN 6.12338490853968 5.3 5.3 1 MAP kinase-activated protein kinase 2 (MAPK-activated protein kinase 2) (MAPKAP kinase 2) (MAPKAP-K2) (MAPKAPK-2) (MK-2) (MK2) (EC 2.7.11.1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 PAK5 0 1 PAK5 KIAA1264 PAK7 PAK5_HUMAN 6.06069784035361 5.3 5.3 1 Serine/threonine-protein kinase PAK 5 (EC 2.7.11.1) (p21-activated kinase 5) (PAK-5) (p21-activated kinase 7) (PAK-7) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 DAPK2 0 1 DAPK2 DAPK2_HUMAN 6.99563519459755 5.3 5.3 1 Death-associated protein kinase 2 (DAP kinase 2) (EC 2.7.11.1) (DAP-kinase-related protein 1) (DRP-1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 5.7999981345934 5.3 5.315 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 CDK3 0 6 CDK3 CDKN3 CDK3_HUMAN 6.16722687557547 5.3 5.3 6 Cyclin-dependent kinase 3 (EC 2.7.11.22) (Cell division protein kinase 3) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 CCNE1 0 6 CCNE1 CCNE CCNE1_HUMAN 6.16722687557547 5.3 5.3 6 G1/S-specific cyclin-E1 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 CCNE2 0 6 CCNE2 CCNE2_HUMAN 6.16722687557547 5.3 5.3 6 G1/S-specific cyclin-E2 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 TGFR1 0 1 TGFBR1 ALK5 SKR4 TGFR1_HUMAN 6.00479888288177 5.3 5.3 1 TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (Activin A receptor type II-like protein kinase of 53kD) (Activin receptor-like kinase 5) (ALK-5) (ALK5) (Serine/threonine-protein kinase receptor R4) (SKR4) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I), TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (ESK2) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KPCL 0 1 PRKCH PKCL PRKCL KPCL_HUMAN 5.72015930340596 5.3 5.3 1 Protein kinase C eta type (EC 2.7.11.13) (PKC-L) (nPKC-eta) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 TLK2 0 1 TLK2 TLK2_HUMAN 6.99563519459755 5.3 5.3 1 Serine/threonine-protein kinase tousled-like 2 (EC 2.7.11.1) (HsHPK) (PKU-alpha) (Tousled-like kinase 2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 PLK3 0 2 PLK3 CNK FNK PRK PLK3_HUMAN 5.9431368703327 5.3 5.3 2 Serine/threonine-protein kinase PLK3 (EC 2.7.11.21) (Cytokine-inducible serine/threonine-protein kinase) (FGF-inducible kinase) (Polo-like kinase 3) (PLK-3) (Proliferation-related kinase) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 BRSK1 0 1 BRSK1 KIAA1811 SAD1 SADB BRSK1_HUMAN 5.82557590031178 5.3 5.3 1 Serine/threonine-protein kinase BRSK1 (EC 2.7.11.1) (Brain-selective kinase 1) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 1) (BR serine/threonine-protein kinase 1) (Serine/threonine-protein kinase SAD-B) (Synapses of Amphids Defective homolog 1) (SAD1 homolog) (hSAD1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 IRAK4 0 1 IRAK4 IRAK4_HUMAN 6.19497660321606 5.3 5.3 1 Interleukin-1 receptor-associated kinase 4 (IRAK-4) (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-64) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 FGFR3 0 2 FGFR3 JTK4 FGFR3_HUMAN 6.01604063380572 5.3 5.3 2 Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (CD antigen CD333), Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (Heparin-binding growth factor receptor) (CD antigen CD333) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 ST17A 0 2 STK17A DRAK1 ST17A_HUMAN 5.82336519312371 5.3 5.3 2 Serine/threonine-protein kinase 17A (EC 2.7.11.1) (DAP kinase-related apoptosis-inducing protein kinase 1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 FAK1 0 1 PTK2 FAK FAK1 FAK1_HUMAN 6.06069784035361 5.3 5.3 1 Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein phosphatase 1 regulatory subunit 71) (PPP1R71) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK), Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK), Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (p41/p43FRNK) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 LIMK1 0 1 LIMK1 LIMK LIMK1_HUMAN 6.12338490853968 5.3 5.3 1 LIM domain kinase 1 (LIMK-1) (EC 2.7.11.1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 GLHA 0 1 CGA GLHA_HUMAN 5.65000410073714 5.3 5.3 1 Glycoprotein hormones alpha chain (Anterior pituitary glycoprotein hormones common subunit alpha) (Choriogonadotropin alpha chain) (Chorionic gonadotrophin subunit alpha) (CG-alpha) (Follicle-stimulating hormone alpha chain) (FSH-alpha) (Follitropin alpha chain) (Luteinizing hormone alpha chain) (LSH-alpha) (Lutropin alpha chain) (Thyroid-stimulating hormone alpha chain) (TSH-alpha) (Thyrotropin alpha chain) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 VRK2 0 1 VRK2 VRK2_HUMAN 6.38021124171161 5.3 5.3 1 Serine/threonine-protein kinase VRK2 (EC 2.7.11.1) (Vaccinia-related kinase 2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 2516 0 21 NotRecorded 4.68843290135177 7.35 7.35 21 1 7.35 actual molregno [molregno] COc1ccc(NS(=O)(=O)c2ccc(N)cc2)nn1 2516 SO1B3 0 1 SLCO1B3 LST2 OATP1B3 OATP8 SLC21A8 SO1B3_HUMAN 6.38800156128963 7.35 6.0125 1 Solute carrier organic anion transporter family member 1B3 (Liver-specific organic anion transporter 2) (LST-2) (Organic anion transporter 8) (Organic anion-transporting polypeptide 8) (OATP-8) (Solute carrier family 21 member 8) 1 7.35 actual molregno [molregno] COc1ccc(NS(=O)(=O)c2ccc(N)cc2)nn1 2516 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 8.46 7.35 7.35 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 7.35 actual molregno [molregno] COc1ccc(NS(=O)(=O)c2ccc(N)cc2)nn1 2516 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 7.35 7.35 7.35 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 7.35 actual molregno [molregno] COc1ccc(NS(=O)(=O)c2ccc(N)cc2)nn1 2249 P53 0 1 TP53 P53 P53_HUMAN 4.6 4.85 4.85000000000001 1 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 TXK 0 2 TXK PTK4 RLK TXK_HUMAN 6.04252913805155 4.85 4.85000000000001 2 Tyrosine-protein kinase TXK (EC 2.7.10.2) (Protein-tyrosine kinase 4) (Resting lymphocyte kinase) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 TAOK3 0 2 TAOK3 DPK JIK KDS MAP3K18 TAOK3_HUMAN 5.21667116507053 4.85 4.85000000000001 2 Serine/threonine-protein kinase TAO3 (EC 2.7.11.1) (Cutaneous T-cell lymphoma-associated antigen HD-CL-09) (CTCL-associated antigen HD-CL-09) (Dendritic cell-derived protein kinase) (JNK/SAPK-inhibitory kinase) (Jun kinase-inhibitory kinase) (Kinase from chicken homolog A) (hKFC-A) (Thousand and one amino acid protein 3) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 0 23 NotRecorded, Protein kinase Pfmrk 5.35113641791829 4.85 4.85000000000001 23 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MK03 0 1 MAPK3 ERK1 PRKM3 MK03_HUMAN 6.19497660321606 4.85 4.85000000000001 1 Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (MNK1) (Microtubule-associated protein 2 kinase) (p44-ERK1), Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (Microtubule-associated protein 2 kinase) (p44-ERK1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 FKB1A 0 4 FKBP1A FKBP1 FKBP12 FKB1A_HUMAN 5.77696529855017 4.85 4.85000000000001 4 Peptidyl-prolyl cis-trans isomerase FKBP1A (PPIase FKBP1A) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (Calstabin-1) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MTOR 0 6 MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 MTOR_HUMAN 5.83716618347045 4.85 4.85000000000001 6 Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1), Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 FAK1 0 1 PTK2 FAK FAK1 FAK1_HUMAN 4.76886117461341 4.85 4.85000000000001 1 Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein phosphatase 1 regulatory subunit 71) (PPP1R71) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK), Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK), Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (p41/p43FRNK) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MP2K6 0 2 MAP2K6 MEK6 MKK6 PRKMK6 SKK3 MP2K6_HUMAN 5.81199362955443 4.85 4.85000000000001 2 Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (MAPK/ERK kinase 6) (MEK 6) (Stress-activated protein kinase kinase 3) (SAPK kinase 3) (SAPKK-3) (SAPKK3) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 RUNX1 0 6 RUNX1 AML1 CBFA2 RUNX1_HUMAN 4.71666610908814 4.85 4.85000000000001 6 Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 PEBB 0 6 CBFB PEBB_HUMAN 4.71666610908814 4.85 4.85000000000001 6 Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MK14 0 1 MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A MK14_HUMAN 5.86530142610254 4.85 4.85000000000001 1 Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (CRK1) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha), Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (Cytokine suppressive anti-inflammatory drug-binding protein) (CSAID-binding protein) (CSBP) (MAP kinase MXI2) (MAX-interacting protein 2) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha) (Stress-activated protein kinase 2a) (SAPK2a) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CHK2 0 2 CHEK2 CDS1 CHK2 RAD53 CHK2_HUMAN 4.65730140142663 4.85 4.85000000000001 2 Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 EPHA1 0 2 EPHA1 EPH EPHT EPHT1 EPHA1_HUMAN 5.52380738778312 4.85 4.85000000000001 2 Ephrin type-A receptor 1 (hEpha1) (EC 2.7.10.1) (EPH tyrosine kinase) (EPH tyrosine kinase 1) (Erythropoietin-producing hepatoma receptor) (Tyrosine-protein kinase receptor EPH) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CCND1 0 2 CCND1 BCL1 PRAD1 CCND1_HUMAN 6 4.85 4.85000000000001 2 G1/S-specific cyclin-D1 (B-cell lymphoma 1 protein) (BCL-1) (BCL-1 oncogene) (PRAD1 oncogene) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CDK4 0 2 CDK4 CDK4_HUMAN 6 4.85 4.85000000000001 2 Cyclin-dependent kinase 4 (EC 2.7.11.22) (CRK3) (Cell division protein kinase 4) (PSK-J3), Cyclin-dependent kinase 4 (EC 2.7.11.22) (Cell division protein kinase 4) (PSK-J3) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MET 0 2 MET MET_HUMAN 5.91518739159678 4.85 4.85000000000001 2 Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 JAK2 0 2 JAK2 JAK2_HUMAN 5.95424250943933 4.85 4.85000000000001 2 Tyrosine-protein kinase JAK2 (EC 2.7.10.2) (Janus kinase 2) (JAK-2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 PRKX 0 1 PRKX PKX1 PRKX_HUMAN 4.78739190711856 4.85 4.85000000000001 1 cAMP-dependent protein kinase catalytic subunit PRKX (PrKX) (Protein kinase X) (Protein kinase X-linked) (Serine/threonine-protein kinase PRKX) (EC 2.7.11.1) (Protein kinase PKX1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CD5R1 0 8 CDK5R1 CDK5R NCK5A CD5R1_HUMAN 5.08054263877572 4.85 4.85000000000001 8 Cyclin-dependent kinase 5 activator 1 (CDK5 activator 1) (Cyclin-dependent kinase 5 regulatory subunit 1) (TPKII regulatory subunit) [Cleaved into: Cyclin-dependent kinase 5 activator 1, p35 (p35); Cyclin-dependent kinase 5 activator 1, p25 (p25) (Tau protein kinase II 23 kDa subunit) (p23)] 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CDK5 0 8 CDK5 CDKN5 CDK5_HUMAN 5.08054263877572 4.85 4.85000000000001 8 Cyclin-dependent-like kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 TAOK1 0 2 TAOK1 KIAA1361 MAP3K16 MARKK TAOK1_HUMAN 5.78091424560582 4.85 4.85000000000001 2 Serine/threonine-protein kinase TAO1 (EC 2.7.11.1) (Kinase from chicken homolog B) (hKFC-B) (MARK Kinase) (MARKK) (Prostate-derived sterile 20-like kinase 2) (PSK-2) (PSK2) (Prostate-derived STE20-like kinase 2) (Thousand and one amino acid protein kinase 1) (TAOK1) (hTAOK1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 YES 0 1 YES1 YES YES_HUMAN 4.69243913717706 4.85 4.85000000000001 1 Tyrosine-protein kinase Yes (EC 2.7.10.2) (Proto-oncogene c-Yes) (p61-Yes) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MELK 0 2 MELK KIAA0175 MELK_HUMAN 4.5081779723829 4.85 4.85000000000001 2 Maternal embryonic leucine zipper kinase (hMELK) (EC 2.7.11.1) (Protein kinase Eg3) (pEg3 kinase) (Protein kinase PK38) (hPK38) (Tyrosine-protein kinase MELK) (EC 2.7.10.2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 TBK1 0 2 TBK1 NAK TBK1_HUMAN 5.02619403472985 4.85 4.85000000000001 2 Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (NF-kappa-B-activating kinase) (T2K) (TANK-binding kinase 1), Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (T2K) (TANK-binding kinase 1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MK11 0 2 MAPK11 PRKM11 SAPK2 SAPK2B MK11_HUMAN 6.22045454103261 4.85 4.85000000000001 2 Mitogen-activated protein kinase 11 (MAP kinase 11) (MAPK 11) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 beta) (MAP kinase p38 beta) (p38B), Mitogen-activated protein kinase 11 (MAP kinase 11) (MAPK 11) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 beta) (MAP kinase p38 beta) (p38b) (Stress-activated protein kinase 2b) (SAPK2b) (p38-2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CDK7 0 4 CDK7 CAK CAK1 CDKN7 MO15 STK1 CDK7_HUMAN 4.56112304401158 4.85 4.85000000000001 4 Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (P39 Mo15) (CDK-activating kinase) (CR4 protein kinase) (CRK4) (Cell division protein kinase 7) (Protein-tyrosine kinase MPK-7) (TFIIH basal transcription factor complex kinase subunit), Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (p39 Mo15) (CDK-activating kinase 1) (Cell division protein kinase 7) (Serine/threonine-protein kinase 1) (TFIIH basal transcription factor complex kinase subunit) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CCNH 0 4 CCNH CCNH_HUMAN 4.56112304401158 4.85 4.85000000000001 4 Cyclin-H (MO15-associated protein) (p34) (p37) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 M3K7 0 1 MAP3K7 TAK1 M3K7_HUMAN 5.2498774732166 4.85 4.85000000000001 1 Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25) (Transforming growth factor-beta-activated kinase 1) (TGF-beta-activated kinase 1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 PAK3 0 2 PAK3 OPHN3 PAK3_HUMAN 5.32334082330819 4.85 4.85000000000001 2 Serine/threonine-protein kinase PAK 3 (EC 2.7.11.1) (Beta-PAK) (Oligophrenin-3) (p21-activated kinase 3) (PAK-3) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KAPCA 0 8 PRKACA PKACA KAPCA_HUMAN 5.01278813061184 4.85 4.85000000000001 8 cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 TAU 0 6 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.78333333333333 4.85 4.85000000000001 6 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KPCG 0 37 PRKCG PKCG KPCG_HUMAN 5.30469543287983 4.85 4.85000000000001 37 Protein kinase C gamma type (PKC-gamma) (EC 2.7.11.13) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KPCA 0 39 PRKCA PKCA PRKACA KPCA_HUMAN 5.40085406495206 4.85 4.85000000000001 39 Protein kinase C alpha type (PKC-A) (PKC-alpha) (EC 2.7.11.13) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KPCL 0 37 PRKCH PKCL PRKCL KPCL_HUMAN 5.34444776562891 4.85 4.85000000000001 37 Protein kinase C eta type (EC 2.7.11.13) (PKC-L) (nPKC-eta) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KPCD1 0 34 PRKD1 PKD PKD1 PRKCM KPCD1_HUMAN 5.45948808840165 4.85 4.85000000000001 34 Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KPCI 0 36 PRKCI DXS1179E KPCI_HUMAN 5.461307826829 4.85 4.85000000000001 36 Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (PRKC-lambda/iota) (aPKC-lambda/iota) (nPKC-iota) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KPCB 0 37 PRKCB PKCB PRKCB1 KPCB_HUMAN 5.26146378396025 4.85 4.85000000000001 37 Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KPCD 0 36 PRKCD KPCD_HUMAN 5.54457792571445 4.85 4.85000000000001 36 Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)], Protein kinase C delta type (EC 2.7.11.13) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)] 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KPCD3 0 33 PRKD3 EPK2 PRKCN KPCD3_HUMAN 5.47712125471966 4.85 4.85000000000001 33 Serine/threonine-protein kinase D3 (EC 2.7.11.13) (Protein kinase C nu type) (Protein kinase EPK2) (nPKC-nu) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KPCE 0 37 PRKCE PKCE KPCE_HUMAN 5.5187871270733 4.85 4.85000000000001 37 Protein kinase C epsilon type (EC 2.7.11.13) (nPKC-epsilon) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KPCT 0 37 PRKCQ PRKCT KPCT_HUMAN 5.3353977224758 4.85 4.85000000000001 37 Protein kinase C theta type (EC 2.7.11.13) (nPKC-theta) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KPCZ 0 36 PRKCZ PKC2 KPCZ_HUMAN 5.43541712687311 4.85 4.85000000000001 36 Protein kinase C zeta type (EC 2.7.11.13) (nPKC-zeta) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 BRSK2 0 2 BRSK2 C11orf7 PEN11B SADA STK29 HUSSY-12 BRSK2_HUMAN 4.91959421447593 4.85 4.85000000000001 2 Serine/threonine-protein kinase BRSK2 (EC 2.7.11.1) (Brain-selective kinase 2) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 2) (BR serine/threonine-protein kinase 2) (Serine/threonine-protein kinase 29) (Serine/threonine-protein kinase SAD-A) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 TIE2 0 1 TEK TIE2 VMCM VMCM1 TIE2_HUMAN 5.17609125905568 4.85 4.85000000000001 1 Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (HYK) (STK1) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (mTIE2) (p140 TEK) (CD antigen CD202b), Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK) (CD antigen CD202b) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CCNB3 0 16 CCNB3 CYCB3 CCNB3_HUMAN 5.16525749891599 4.85 4.85000000000001 16 G2/mitotic-specific cyclin-B3 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CDK1 0 16 CDK1 CDC2 CDC28A CDKN1 P34CDC2 CDK1_HUMAN 5.16525749891599 4.85 4.85000000000001 16 Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (Cell division control protein 28) (Cell division protein kinase 1), Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CCNB1 0 16 CCNB1 CCNB CCNB1_HUMAN 5.16525749891599 4.85 4.85000000000001 16 G2/mitotic-specific cyclin-B1 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CCNB2 0 16 CCNB2 CCNB2_HUMAN 5.16525749891599 4.85 4.85000000000001 16 G2/mitotic-specific cyclin-B2 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 AKT1 0 1 AKT1 PKB RAC AKT1_HUMAN 5.52476288915489 4.85 4.85000000000001 1 RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (AKT1 kinase) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha) (Thymoma viral proto-oncogene), RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha), RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (RAC-PK-alpha) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MK01 0 5 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 6.30075541371934 4.85 4.85000000000001 5 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 AURKA 0 1 AURKA AIK AIRK1 ARK1 AURA AYK1 BTAK IAK1 STK15 STK6 AURKA_HUMAN 5.60205999132796 4.85 4.85000000000001 1 Aurora kinase A (EC 2.7.11.1) (Aurora 2) (Aurora family kinase 1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Ipl1- and aurora-related kinase 1) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase Ayk1) (Serine/threonine-protein kinase aurora-A), Aurora kinase A (EC 2.7.11.1) (Aurora 2) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (hARK1) (Breast tumor-amplified kinase) (Serine/threonine-protein kinase 15) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase aurora-A) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KPCD2 0 2 PRKD2 PKD2 HSPC187 KPCD2_HUMAN 6.0840959134135 4.85 4.85000000000001 2 Serine/threonine-protein kinase D2 (EC 2.7.11.13) (nPKC-D2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 PAK6 0 2 PAK6 PAK5 PAK6_HUMAN 5.91421276141055 4.85 4.85000000000001 2 Serine/threonine-protein kinase PAK 6 (EC 2.7.11.1) (PAK-5) (p21-activated kinase 6) (PAK-6) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MK12 0 1 MAPK12 ERK6 SAPK3 MK12_HUMAN 5.90799732148669 4.85 4.85000000000001 1 Mitogen-activated protein kinase 12 (MAP kinase 12) (MAPK 12) (EC 2.7.11.24) (Extracellular signal-regulated kinase 6) (ERK-6) (Mitogen-activated protein kinase p38 gamma) (MAP kinase p38 gamma) (Stress-activated protein kinase 3) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MK08 0 2 MAPK8 JNK1 PRKM8 SAPK1 SAPK1C MK08_HUMAN 6.34749748145514 4.85 4.85000000000001 2 Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (JNK-46) (Stress-activated protein kinase 1c) (SAPK1c) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1), Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (SAPK gamma) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1) (p54 gamma), Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 LEF 0 2 lef pXO1-107 BXA0172 GBAA_pXO1_0172 LEF_BACAN 6.11 4.85 4.85000000000001 2 Lethal factor (LF) (EC 3.4.24.83) (Anthrax lethal toxin endopeptidase component) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 LIMK1 0 1 LIMK1 LIMK LIMK1_HUMAN 5.43195909596147 4.85 4.85000000000001 1 LIM domain kinase 1 (LIMK-1) (EC 2.7.11.1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KC1G3 0 2 CSNK1G3 KC1G3_HUMAN 5.61915054643304 4.85 4.85000000000001 2 Casein kinase I isoform gamma-3 (CKI-gamma 3) (EC 2.7.11.1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 AURKC 0 1 AURKC AIE2 AIK3 AIRK3 ARK3 STK13 AURKC_HUMAN 5.41017446508905 4.85 4.85000000000001 1 Aurora kinase C (EC 2.7.11.1) (Aurora 3) (Aurora/IPL1-related kinase 3) (ARK-3) (Aurora-related kinase 3) (Aurora/IPL1/Eg2 protein 2) (Serine/threonine-protein kinase 13) (Serine/threonine-protein kinase aurora-C) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 ROCK1 0 2 ROCK1 ROCK1_HUMAN 5.79831324624224 4.85 4.85000000000001 2 Rho-associated protein kinase 1 (EC 2.7.11.1) (Liver regeneration-related protein LRRG199) (Rho-associated, coiled-coil-containing protein kinase 1) (Rho-associated, coiled-coil-containing protein kinase I) (ROCK-I) (p150 RhoA-binding kinase ROK beta) (p160 ROCK-1) (p160ROCK), Rho-associated protein kinase 1 (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-35) (Rho-associated, coiled-coil-containing protein kinase 1) (Rho-associated, coiled-coil-containing protein kinase I) (ROCK-I) (p160 ROCK-1) (p160ROCK) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 SRPK1 0 1 SRPK1 SRPK1_HUMAN 5.23113882538659 4.85 4.85000000000001 1 SRSF protein kinase 1 (EC 2.7.11.1) (SFRS protein kinase 1) (Serine/arginine-rich protein-specific kinase 1) (SR-protein-specific kinase 1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MAPK5 0 1 MAPKAPK5 PRAK MAPK5_HUMAN 6.69019608002851 4.85 4.85000000000001 1 MAP kinase-activated protein kinase 5 (MAPK-activated protein kinase 5) (MAPKAP kinase 5) (MAPKAP-K5) (MAPKAPK-5) (MK-5) (MK5) (EC 2.7.11.1) (p38-regulated/activated protein kinase) (PRAK) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CLK3 0 2 CLK3 CLK3_HUMAN 4.85632861097154 4.85 4.85000000000001 2 Dual specificity protein kinase CLK3 (EC 2.7.12.1) (CDC-like kinase 3) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 ULK3 0 1 ULK3 ULK3_HUMAN 5.19426522798427 4.85 4.85000000000001 1 Serine/threonine-protein kinase ULK3 (EC 2.7.11.1) (Unc-51-like kinase 3) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 TSSK1 0 2 TSSK1B SPOGA1 SPOGA4 STK22A STK22D TSSK1 FKSG81 TSSK1_HUMAN 5.27861579508937 4.85 4.85000000000001 2 Testis-specific serine/threonine-protein kinase 1 (TSK-1) (TSK1) (TSSK-1) (Testis-specific kinase 1) (EC 2.7.11.1) (Serine/threonine-protein kinase 22A) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 PDK1 0 1 PDK1 PDHK1 PDK1_HUMAN 5.75332766665861 4.85 4.85000000000001 1 [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (PDK p48) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1), [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 ERBB4 0 1 ERBB4 HER4 ERBB4_HUMAN 5.78837041556533 4.85 4.85000000000001 1 Receptor tyrosine-protein kinase erbB-4 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-4) (Tyrosine kinase-type cell surface receptor HER4) (p180erbB4) [Cleaved into: ERBB4 intracellular domain (4ICD) (E4ICD) (s80HER4)] 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 NEK6 0 1 NEK6 NEK6_HUMAN 6.38021124171161 4.85 4.85000000000001 1 Serine/threonine-protein kinase Nek6 (EC 2.7.11.1) (Never in mitosis A-related kinase 6) (NimA-related protein kinase 6) (Protein kinase SID6-1512) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CHK1 0 4 CHEK1 CHK1 CHK1_HUMAN 4.93329731881374 4.85 4.85000000000001 4 Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Cell cycle checkpoint kinase) (Checkpoint kinase-1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 RIPK2 0 2 RIPK2 CARDIAK RICK RIP2 UNQ277/PRO314/PRO34092 RIPK2_HUMAN 5.73950269929711 4.85 4.85000000000001 2 Receptor-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (CARD-containing interleukin-1 beta-converting enzyme-associated kinase) (CARD-containing IL-1 beta ICE-kinase) (RIP-like-interacting CLARP kinase) (Receptor-interacting protein 2) (RIP-2) (Tyrosine-protein kinase RIPK2) (EC 2.7.10.2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 STK33 0 2 STK33 STK33_HUMAN 5.03740272299367 4.85 4.85000000000001 2 Serine/threonine-protein kinase 33 (EC 2.7.11.1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 GSK3B 0 6 GSK3B GSK3B_HUMAN 5.23829119498071 4.85 4.85000000000001 6 Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Factor A) (FA) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1), Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MAPK2 0 2 MAPKAPK2 MAPK2_HUMAN 5.6931008027004 4.85 4.85000000000001 2 MAP kinase-activated protein kinase 2 (MAPK-activated protein kinase 2) (MAPKAP kinase 2) (MAPKAP-K2) (MAPKAPK-2) (MK-2) (MK2) (EC 2.7.11.1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 FGFR2 0 2 FGFR2 BEK KGFR KSAM FGFR2_HUMAN 5.2788702816398 4.85 4.85000000000001 2 Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (K-sam) (KGFR) (Keratinocyte growth factor receptor) (CD antigen CD332), Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (Keratinocyte growth factor receptor) (KGFR) (CD antigen CD332) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 PASK 0 2 PASK KIAA0135 PASK_HUMAN 4.89785851223987 4.85 4.85000000000001 2 PAS domain-containing serine/threonine-protein kinase (PAS-kinase) (PASKIN) (hPASK) (EC 2.7.11.1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 TAOK2 0 1 TAOK2 KIAA0881 MAP3K17 PSK PSK1 UNQ2971/PRO7431 TAOK2_HUMAN 4.98262590393058 4.85 4.85000000000001 1 Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Kinase from chicken homolog C) (hKFC-C) (Prostate-derived sterile 20-like kinase 1) (PSK-1) (PSK1) (Prostate-derived STE20-like kinase 1) (Thousand and one amino acid protein kinase 2), Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Thousand and one amino acid protein 2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 HIPK1 0 2 HIPK1 KIAA0630 MYAK NBAK2 HIPK1_HUMAN 5.5032102605522 4.85 4.85000000000001 2 Homeodomain-interacting protein kinase 1 (EC 2.7.11.1) (Nuclear body-associated kinase 2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 GLCM 0 1 GBA GC GLUC GLCM_HUMAN 4.70000050388302 4.85 4.85000000000001 1 Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase), Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (D-glucosyl-N-acylsphingosine glucohydrolase) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KCNH2 0 1 KCNH2 ERG ERG1 HERG KCNH2_HUMAN 6 4.85 4.85000000000001 1 Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (DERG) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (c-ERG) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (RERG) (ra-erg) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (gp-erg) (Voltage-gated potassium channel subunit Kv11.1) (Fragment) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 SIR2 0 4 SIRT2 SIR2L SIR2L2 SIR2_HUMAN 5.09652281476392 4.85 4.85000000000001 4 NAD-dependent histone deacetylase SIR2 (EC 3.5.1.-) (Regulatory protein SIR2) (Silent information regulator 2), NAD-dependent protein deacetylase sirtuin-2 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2), NAD-dependent protein deacetylase sirtuin-2 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2) (mSIR2L2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 FRK 0 1 FRK PTK5 RAK FRK_HUMAN 5.72015930340596 4.85 4.85000000000001 1 Tyrosine-protein kinase FRK (EC 2.7.10.2) (FYN-related kinase) (Nuclear tyrosine protein kinase RAK) (Protein-tyrosine kinase 5) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 GRK7 0 2 GRK7 GPRK7 GRK7_HUMAN 4.50839689731268 4.85 4.85000000000001 2 Rhodopsin kinase (EC 2.7.11.14) (G protein-coupled receptor kinase 7) (G protein-coupled receptor kinase GRK7) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 BRSK1 0 2 BRSK1 KIAA1811 SAD1 SADB BRSK1_HUMAN 4.83277803442535 4.85 4.85000000000001 2 Serine/threonine-protein kinase BRSK1 (EC 2.7.11.1) (Brain-selective kinase 1) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 1) (BR serine/threonine-protein kinase 1) (Serine/threonine-protein kinase SAD-B) (Synapses of Amphids Defective homolog 1) (SAD1 homolog) (hSAD1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 EPHB1 0 2 EPHB1 ELK EPHT2 HEK6 NET EPHB1_HUMAN 5.76913969831701 4.85 4.85000000000001 2 Ephrin type-B receptor 1 (EC 2.7.10.1) (ELK) (EPH tyrosine kinase 2) (EPH-like kinase 6) (EK6) (hEK6) (Neuronally-expressed EPH-related tyrosine kinase) (NET) (Tyrosine-protein kinase receptor EPH-2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KIT 0 1 KIT SCFR KIT_HUMAN 6.06069784035361 4.85 4.85000000000001 1 Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Piebald trait protein) (PBT) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (p145 c-kit) (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) (CD antigen CD117), Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (CD antigen CD117) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CCNE2 0 15 CCNE2 CCNE2_HUMAN 5.35770914610672 4.85 4.85000000000001 15 G1/S-specific cyclin-E2 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CDK2 0 12 CDK2 CDKN2 CDK2_HUMAN 5.25454926859314 4.85 4.85000000000001 12 Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2) (p33 protein kinase) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CCNE1 0 15 CCNE1 CCNE CCNE1_HUMAN 5.35770914610672 4.85 4.85000000000001 15 G1/S-specific cyclin-E1 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 HIPK2 0 2 HIPK2 HIPK2_HUMAN 4.88603980017323 4.85 4.85000000000001 2 Homeodomain-interacting protein kinase 2 (hHIPk2) (EC 2.7.11.1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 ALK 0 2 ALK ALK_HUMAN 6.09988774304892 4.85 4.85000000000001 2 ALK tyrosine kinase receptor (EC 2.7.10.1) (Anaplastic lymphoma kinase) (CD antigen CD246) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 EPHA7 0 1 EPHA7 EHK3 HEK11 EPHA7_HUMAN 5.82557590031178 4.85 4.85000000000001 1 Ephrin type-A receptor 7 (EC 2.7.10.1) (EPH homology kinase 3) (EHK-3) (EPH-like kinase 11) (EK11) (hEK11) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 TYRO3 0 2 TYRO3 BYK DTK RSE SKY TIF TYRO3_HUMAN 5.9404067961404 4.85 4.85000000000001 2 Tyrosine-protein kinase receptor TYRO3 (EC 2.7.10.1) (Etk2/tyro3) (TK19-2) (Tyrosine-protein kinase DTK) (Tyrosine-protein kinase RSE) (Tyrosine-protein kinase TIF), Tyrosine-protein kinase receptor TYRO3 (EC 2.7.10.1) (Tyrosine-protein kinase BYK) (Tyrosine-protein kinase DTK) (Tyrosine-protein kinase RSE) (Tyrosine-protein kinase SKY) (Tyrosine-protein kinase TIF) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 PIM1 0 7 PIM1 PIM1_HUMAN 5.26645387528147 4.85 4.85000000000001 7 Serine/threonine-protein kinase pim-1 (EC 2.7.11.1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CP2C9 0 2 CYP2C9 CYP2C10 CP2C9_HUMAN 4.8 4.85 4.85000000000001 2 Cytochrome P450 2C9 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (EC 1.14.99.38) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 DAPK2 0 2 DAPK2 DAPK2_HUMAN 5.05130680113306 4.85 4.85000000000001 2 Death-associated protein kinase 2 (DAP kinase 2) (EC 2.7.11.1) (DAP-kinase-related protein 1) (DRP-1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CSF1R 0 2 CSF1R FMS CSF1R_HUMAN 4.8160116073527 4.85 4.85000000000001 2 Macrophage colony-stimulating factor 1 receptor (CSF-1 receptor) (CSF-1-R) (CSF-1R) (M-CSF-R) (EC 2.7.10.1) (Proto-oncogene c-Fms) (CD antigen CD115) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 NLK 0 1 NLK LAK1 NLK_HUMAN 5.86530142610254 4.85 4.85000000000001 1 Serine/threonine-protein kinase NLK (EC 2.7.11.24) (Nemo-like kinase) (Protein LAK1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 GRK5 0 2 GRK5 GPRK5 GRK5_HUMAN 4.59473317255125 4.85 4.85000000000001 2 G protein-coupled receptor kinase 5 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK5) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 M3K5 0 1 MAP3K5 ASK1 MAPKKK5 MEKK5 M3K5_HUMAN 6.38021124171161 4.85 4.85000000000001 1 Mitogen-activated protein kinase kinase kinase 5 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 1) (ASK-1) (MAPK/ERK kinase kinase 5) (MEK kinase 5) (MEKK 5) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KMT2A 0 4 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.6 4.85 4.85000000000001 4 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MEN1 0 4 MEN1 SCG2 MEN1_HUMAN 4.6 4.85 4.85000000000001 4 Menin 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 DAPK1 0 1 DAPK1 DAPK DAPK1_HUMAN 5.47712125471966 4.85 4.85000000000001 1 Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 PGFRB 0 1 PDGFRB PDGFR PDGFR1 PGFRB_HUMAN 5.26884531229258 4.85 4.85000000000001 1 Platelet-derived growth factor receptor beta (PDGF-R-beta) (PDGFR-beta) (EC 2.7.10.1) (Beta platelet-derived growth factor receptor) (Beta-type platelet-derived growth factor receptor) (CD140 antigen-like family member B) (Platelet-derived growth factor receptor 1) (PDGFR-1) (CD antigen CD140b) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 SIK1 0 2 SIK1 SIK SNF1LK SIK1_HUMAN 4.74043151466672 4.85 4.85000000000001 2 Serine/threonine-protein kinase SIK1 (EC 2.7.11.1) (Salt-inducible kinase 1) (SIK-1) (Serine/threonine-protein kinase SNF1-like kinase 1) (Serine/threonine-protein kinase SNF1LK) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 FGR 0 2 FGR SRC2 FGR_HUMAN 5.73368070871526 4.85 4.85000000000001 2 Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog) (Proto-oncogene c-Fgr) (p55-Fgr) (p58-Fgr) (p58c-Fgr), Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Proto-oncogene c-Fgr) (p55-Fgr) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 JAK3 0 4 JAK3 JAK3_HUMAN 5.30321973429673 4.85 4.85000000000001 4 Tyrosine-protein kinase JAK3 (EC 2.7.10.2) (Janus kinase 3) (JAK-3), Tyrosine-protein kinase JAK3 (EC 2.7.10.2) (Janus kinase 3) (JAK-3) (Leukocyte janus kinase) (L-JAK) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KC1G1 0 1 CSNK1G1 KC1G1_HUMAN 6.50965047954658 4.85 4.85000000000001 1 Casein kinase I isoform gamma-1 (CKI-gamma 1) (EC 2.7.11.1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 EHMT2 0 2 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 4.79999955049828 4.85 4.85000000000001 2 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 PHKG2 0 2 PHKG2 PHKG2_HUMAN 5.54822012574456 4.85 4.85000000000001 2 Phosphorylase b kinase gamma catalytic chain, liver/testis isoform (PHK-gamma-LT) (PHK-gamma-T) (EC 2.7.11.19) (PSK-C3) (Phosphorylase kinase subunit gamma-2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 PAK2 0 1 PAK2 PAK2_HUMAN 6.50965047954658 4.85 4.85000000000001 1 Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (PAK65) (S6/H4 kinase) (p21-activated kinase 2) (PAK-2) (p58) [Cleaved into: PAK-2p27 (p27); PAK-2p34 (p34) (C-t-PAK2)] 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 UFO 0 2 AXL UFO UFO_HUMAN 5.08685577865516 4.85 4.85000000000001 2 Tyrosine-protein kinase receptor UFO (EC 2.7.10.1) (AXL oncogene) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KCC4 0 2 CAMK4 CAMK CAMK-GR CAMKIV KCC4_HUMAN 5.38907562519182 4.85 4.85000000000001 2 Calcium/calmodulin-dependent protein kinase type IV (CaMK IV) (EC 2.7.11.17) (CaM kinase-GR) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MRCKB 0 2 CDC42BPB KIAA1124 MRCKB_HUMAN 5.55133117094858 4.85 4.85000000000001 2 Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 RGS4 0 1 RGS4 RGS4_HUMAN 8.22184874961636 4.85 4.85000000000001 1 Regulator of G-protein signaling 4 (RGP4) (RGS4) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 BMX 0 2 BMX BMX_HUMAN 5.30796926603083 4.85 4.85000000000001 2 Cytoplasmic tyrosine-protein kinase BMX (EC 2.7.10.2) (Bone marrow tyrosine kinase gene in chromosome X protein homolog), Cytoplasmic tyrosine-protein kinase BMX (EC 2.7.10.2) (Bone marrow tyrosine kinase gene in chromosome X protein) (Epithelial and endothelial tyrosine kinase) (ETK) (NTK38) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KCC1D 0 2 CAMK1D CAMKID KCC1D_HUMAN 4.63844815797363 4.85 4.85000000000001 2 Calcium/calmodulin-dependent protein kinase type 1D (EC 2.7.11.17) (CaM kinase I delta) (CaM kinase ID) (CaM-KI delta) (CaMKI delta) (CaMKID) (CaMKI-like protein kinase) (CKLiK) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 FGFR4 0 1 FGFR4 JTK2 TKF FGFR4_HUMAN 5.36797678529459 4.85 4.85000000000001 1 Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (CD antigen CD334), Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (Protein-tyrosine kinase receptor MPK-11) (CD antigen CD334) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 SRPK2 0 2 SRPK2 SRPK2_HUMAN 5.9063012400607 4.85 4.85000000000001 2 SRSF protein kinase 2 (EC 2.7.11.1) (SFRS protein kinase 2) (Serine/arginine-rich protein-specific kinase 2) (SR-protein-specific kinase 2) [Cleaved into: SRSF protein kinase 2 N-terminal; SRSF protein kinase 2 C-terminal] 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 PAK5 0 2 PAK5 KIAA1264 PAK7 PAK5_HUMAN 5.69503215762871 4.85 4.85000000000001 2 Serine/threonine-protein kinase PAK 5 (EC 2.7.11.1) (p21-activated kinase 5) (PAK-5) (p21-activated kinase 7) (PAK-7) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 TGFR1 0 2 TGFBR1 ALK5 SKR4 TGFR1_HUMAN 5.69682961685094 4.85 4.85000000000001 2 TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (Activin A receptor type II-like protein kinase of 53kD) (Activin receptor-like kinase 5) (ALK-5) (ALK5) (Serine/threonine-protein kinase receptor R4) (SKR4) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I), TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (ESK2) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 STK3 0 2 STK3 KRS1 MST2 STK3_HUMAN 4.87166496248184 4.85 4.85000000000001 2 Serine/threonine-protein kinase 3 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 2) (MST-2) (STE20-like kinase MST2) (Serine/threonine-protein kinase Krs-1) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit (MST2/N); Serine/threonine-protein kinase 3 20kDa subunit (MST2/C)], Serine/threonine-protein kinase 3 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 2) (MST-2) (STE20-like kinase MST2) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit (MST2/N); Serine/threonine-protein kinase 3 20kDa subunit (MST2/C)] 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 BLK 0 2 BLK BLK_HUMAN 4.7216347059904 4.85 4.85000000000001 2 Tyrosine-protein kinase Blk (EC 2.7.10.2) (B lymphocyte kinase) (p55-Blk) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MINK1 0 2 MINK1 B55 MAP4K6 MINK YSK2 ZC3 MINK1_HUMAN 5.33399064587045 4.85 4.85000000000001 2 Misshapen-like kinase 1 (EC 2.7.11.1) (GCK family kinase MiNK) (MAPK/ERK kinase kinase kinase 6) (MEK kinase kinase 6) (MEKKK 6) (Misshapen/NIK-related kinase) (Mitogen-activated protein kinase kinase kinase kinase 6) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 BTK 0 2 BTK AGMX1 ATK BPK BTK_HUMAN 5.65908589328787 4.85 4.85000000000001 2 Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase), Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase) (Kinase EMB) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KCC1A 0 2 CAMK1 KCC1A_HUMAN 5.44531161270863 4.85 4.85000000000001 2 Calcium/calmodulin-dependent protein kinase type 1 (EC 2.7.11.17) (CaM kinase I) (CaM-KI) (CaM kinase I alpha) (CaMKI-alpha) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 NEK3 0 2 NEK3 NEK3_HUMAN 6.32221929473392 4.85 4.85000000000001 2 Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (HSPK 36) (Never in mitosis A-related kinase 3) (NimA-related protein kinase 3) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MERTK 0 2 MERTK MER MERTK_HUMAN 4.6340469687845 4.85 4.85000000000001 2 Tyrosine-protein kinase Mer (EC 2.7.10.1) (Proto-oncogene c-Mer) (Receptor tyrosine kinase MerTK) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 M3K9 0 2 MAP3K9 MLK1 PRKE1 M3K9_HUMAN 4.65730140142663 4.85 4.85000000000001 2 Mitogen-activated protein kinase kinase kinase 9 (EC 2.7.11.25) (Mixed lineage kinase 1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 DAPK3 0 2 DAPK3 ZIPK DAPK3_HUMAN 4.97188139029443 4.85 4.85000000000001 2 Death-associated protein kinase 3 (DAP kinase 3) (EC 2.7.11.1) (DAP-like kinase) (Dlk) (MYPT1 kinase) (Zipper-interacting protein kinase) (ZIP-kinase) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MK09 0 1 MAPK9 JNK2 PRKM9 SAPK1A MK09_HUMAN 6.69019608002851 4.85 4.85000000000001 1 Mitogen-activated protein kinase 9 (MAP kinase 9) (MAPK 9) (EC 2.7.11.24) (JNK-55) (Stress-activated protein kinase 1a) (SAPK1a) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2), Mitogen-activated protein kinase 9 (MAP kinase 9) (MAPK 9) (EC 2.7.11.24) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 PDPK1 0 2 PDPK1 PDK1 PDPK1_HUMAN 4.73890557936399 4.85 4.85000000000001 2 3-phosphoinositide-dependent protein kinase 1 (hPDK1) (EC 2.7.11.1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 SRC 0 2 SRC SRC1 SRC_HUMAN 5.96864747411662 4.85 4.85000000000001 2 Neuronal proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src), Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src), Tyrosine-protein kinase transforming protein Src (EC 2.7.10.2) (pp60v-src) (p60-Src) (v-Src) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 INSRR 0 1 INSRR IRR INSRR_HUMAN 5.47712125471966 4.85 4.85000000000001 1 Insulin receptor-related protein (IRR) (EC 2.7.10.1) (IR-related receptor) [Cleaved into: Insulin receptor-related protein alpha chain; Insulin receptor-related protein beta chain] 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 WNK3 0 1 WNK3 KIAA1566 PRKWNK3 WNK3_HUMAN 6.50965047954658 4.85 4.85000000000001 1 Serine/threonine-protein kinase WNK3 (EC 2.7.11.1) (Protein kinase lysine-deficient 3) (Protein kinase with no lysine 3) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 M4K2 0 2 MAP4K2 GCK RAB8IP M4K2_HUMAN 4.9637246664257 4.85 4.85000000000001 2 Mitogen-activated protein kinase kinase kinase kinase 2 (EC 2.7.11.1) (B lymphocyte serine/threonine-protein kinase) (Germinal center kinase) (GC kinase) (MAPK/ERK kinase kinase kinase 2) (MEK kinase kinase 2) (MEKKK 2) (Rab8-interacting protein) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 SGK3 0 1 SGK3 CISK SGKL SGK3_HUMAN 5.26884531229258 4.85 4.85000000000001 1 Serine/threonine-protein kinase Sgk3 (EC 2.7.11.1) (Cytokine-independent survival kinase) (Serum/glucocorticoid-regulated kinase 3) (Serum/glucocorticoid-regulated kinase-like) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KCC2B 0 2 CAMK2B CAM2 CAMK2 CAMKB KCC2B_HUMAN 4.78629873905309 4.85 4.85000000000001 2 Calcium/calmodulin-dependent protein kinase type II subunit beta (CaM kinase II subunit beta) (CaMK-II subunit beta) (EC 2.7.11.17) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KAPCG 0 6 PRKACG KAPCG_HUMAN 5.08804562952784 4.85 4.85000000000001 6 cAMP-dependent protein kinase catalytic subunit gamma (PKA C-gamma) (EC 2.7.11.11) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KAPCB 0 6 PRKACB KAPCB_HUMAN 5.08804562952784 4.85 4.85000000000001 6 cAMP-dependent protein kinase catalytic subunit beta (PKA C-beta) (EC 2.7.11.11) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 HIPK3 0 2 HIPK3 DYRK6 FIST3 PKY HIPK3_HUMAN 5.2783652940096 4.85 4.85000000000001 2 Homeodomain-interacting protein kinase 3 (EC 2.7.11.1) (Androgen receptor-interacting nuclear protein kinase) (ANPK) (Fas-interacting serine/threonine-protein kinase) (FIST) (Homolog of protein kinase YAK1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 RON 0 1 MST1R PTK8 RON RON_HUMAN 5.82557590031178 4.85 4.85000000000001 1 Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (CDw136) (Protein-tyrosine kinase 8) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain], Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (Stem cell-derived tyrosine kinase) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain] 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 ST17A 0 1 STK17A DRAK1 ST17A_HUMAN 4.93036407185861 4.85 4.85000000000001 1 Serine/threonine-protein kinase 17A (EC 2.7.11.1) (DAP kinase-related apoptosis-inducing protein kinase 1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 ITK 0 1 ITK EMT LYK ITK_HUMAN 6.99563519459755 4.85 4.85000000000001 1 Tyrosine-protein kinase ITK/TSK (EC 2.7.10.2) (Interleukin-2-inducible T-cell kinase) (IL-2-inducible T-cell kinase) (Kinase EMT) (T-cell-specific kinase) (Tyrosine-protein kinase Lyk) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MP2K7 0 2 MAP2K7 JNKK2 MEK7 MKK7 PRKMK7 SKK4 MP2K7_HUMAN 5.97780951913406 4.85 4.85000000000001 2 Dual specificity mitogen-activated protein kinase kinase 7 (MAP kinase kinase 7) (MAPKK 7) (EC 2.7.12.2) (JNK-activating kinase 2) (MAPK/ERK kinase 7) (MEK 7) (Stress-activated protein kinase kinase 4) (SAPK kinase 4) (SAPKK-4) (SAPKK4) (c-Jun N-terminal kinase kinase 2) (JNK kinase 2) (JNKK 2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MARK1 0 2 MARK1 KIAA1477 MARK MARK1_HUMAN 4.89586202878646 4.85 4.85000000000001 2 Serine/threonine-protein kinase MARK1 (EC 2.7.11.1) (EC 2.7.11.26) (MAP/microtubule affinity-regulating kinase 1) (PAR1 homolog c) (Par-1c) (Par1c) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 ABL2 0 2 ABL2 ABLL ARG ABL2_HUMAN 5.72742243000426 4.85 4.85000000000001 2 Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 IRAK4 0 1 IRAK4 IRAK4_HUMAN 5.05217801166507 4.85 4.85000000000001 1 Interleukin-1 receptor-associated kinase 4 (IRAK-4) (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-64) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.85 4.85 4.85000000000001 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CDK3 0 6 CDK3 CDKN3 CDK3_HUMAN 5.2788702816398 4.85 4.85000000000001 6 Cyclin-dependent kinase 3 (EC 2.7.11.22) (Cell division protein kinase 3) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 NEK11 0 2 NEK11 NEK11_HUMAN 5.28412131000573 4.85 4.85000000000001 2 Serine/threonine-protein kinase Nek11 (EC 2.7.11.1) (Never in mitosis A-related kinase 11) (NimA-related protein kinase 11) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MKNK2 0 2 MKNK2 GPRK7 MNK2 MKNK2_HUMAN 5.57907350739944 4.85 4.85000000000001 2 MAP kinase-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 2) (MAPK signal-integrating kinase 2) (Mnk2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 EPHA2 0 1 EPHA2 ECK EPHA2_HUMAN 5.32735893438633 4.85 4.85000000000001 1 Ephrin type-A receptor 2 (EC 2.7.10.1) (Epithelial cell kinase) (Tyrosine-protein kinase receptor ECK) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 DCLK2 0 2 DCLK2 DCAMKL2 DCDC3B DCK2 DCLK2_HUMAN 6.12275633390708 4.85 4.85000000000001 2 Serine/threonine-protein kinase DCLK2 (EC 2.7.11.1) (CaMK-like CREB regulatory kinase 2) (CL2) (CLICK-II) (CLICK2) (Doublecortin domain-containing protein 3B) (Doublecortin-like and CAM kinase-like 2) (Doublecortin-like kinase 2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 PTK6 0 1 PTK6 BRK PTK6_HUMAN 5.90799732148669 4.85 4.85000000000001 1 Protein-tyrosine kinase 6 (EC 2.7.10.2) (Breast tumor kinase) (Tyrosine-protein kinase BRK) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 NEK2 0 1 NEK2 NEK2A NLK1 NEK2_HUMAN 6.19497660321606 4.85 4.85000000000001 1 Serine/threonine-protein kinase Nek2 (EC 2.7.11.1) (HSPK 21) (Never in mitosis A-related kinase 2) (NimA-related protein kinase 2) (NimA-like protein kinase 1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 RECQ1 0 1 RECQL RECQ1 RECQL1 RECQ1_HUMAN 4.55 4.85 4.85000000000001 1 ATP-dependent DNA helicase Q1 (EC 3.6.4.12) (DNA helicase, RecQ-like type 1) (RecQ1) (DNA-dependent ATPase Q1) (RecQ protein-like 1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 ROCK2 0 2 ROCK2 KIAA0619, Rock2 ROCK2_HUMAN, ROCK2_RAT 5.90977196777093 4.85 4.85000000000001 2 Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2), Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (RhoA-binding kinase 2) (p150 ROK-alpha) (ROKalpha) (p164 ROCK-2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 TEC 0 1 TEC PSCTK4 TEC_HUMAN 5.26884531229258 4.85 4.85000000000001 1 Tyrosine-protein kinase Tec (EC 2.7.10.2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 DDR2 0 1 DDR2 NTRKR3 TKT TYRO10 DDR2_HUMAN 5.65854134728041 4.85 4.85000000000001 1 Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Discoidin domain-containing receptor tyrosine kinase 2) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 IKKB 0 1 IKBKB IKKB IKKB_HUMAN 5.65854134728041 4.85 4.85000000000001 1 Inhibitor of nuclear factor kappa-B kinase subunit beta (I-kappa-B-kinase beta) (IKK-B) (IKK-beta) (IkBKB) (EC 2.7.11.10) (I-kappa-B kinase 2) (IKK2) (Nuclear factor NF-kappa-B inhibitor kinase beta) (NFKBIKB) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 AKT2 0 1 AKT2 AKT2_HUMAN 5.17609125905568 4.85 4.85000000000001 1 RAC-beta serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-2) (Protein kinase B beta) (PKB beta) (RAC-PK-beta) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 NTRK1 0 2 NTRK1 MTC TRK TRKA NTRK1_HUMAN 4.5698309967145 4.85 4.85000000000001 2 High affinity nerve growth factor receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 1) (Slow nerve growth factor receptor) (p140-TrkA) (Trk-A), High affinity nerve growth factor receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 1) (TRK1-transforming tyrosine kinase protein) (Tropomyosin-related kinase A) (Tyrosine kinase receptor) (Tyrosine kinase receptor A) (Trk-A) (gp140trk) (p140-TrkA) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 EGFR 0 1 EGFR ERBB ERBB1 HER1 EGFR_HUMAN 6.69019608002851 4.85 4.85000000000001 1 Epidermal growth factor receptor (EC 2.7.10.1), Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 PLK2 0 1 PLK2 SNK PLK2_HUMAN 5.86530142610254 4.85 4.85000000000001 1 Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (hPlk2) (Serine/threonine-protein kinase SNK) (hSNK) (Serum-inducible kinase) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 PAK4 0 1 PAK4 KIAA1142 PAK4_HUMAN 5.47712125471966 4.85 4.85000000000001 1 Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 ROS1 0 1 ROS1 MCF3 ROS ROS1_HUMAN 6.50965047954658 4.85 4.85000000000001 1 Proto-oncogene tyrosine-protein kinase ROS (EC 2.7.10.1) (Proto-oncogene c-Ros) (Proto-oncogene c-Ros-1) (Receptor tyrosine kinase c-ros oncogene 1) (c-Ros receptor tyrosine kinase) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CSK22 0 1 CSNK2A2 CK2A2 CSK22_HUMAN 6.27875360095283 4.85 4.85000000000001 1 Casein kinase II subunit alpha' (CK II alpha') (EC 2.7.11.1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 FGFR3 0 2 FGFR3 JTK4 FGFR3_HUMAN 5.40305812619797 4.85 4.85000000000001 2 Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (CD antigen CD333), Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (Heparin-binding growth factor receptor) (CD antigen CD333) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 ULK2 0 1 ULK2 KIAA0623 ULK2_HUMAN 5.86530142610254 4.85 4.85000000000001 1 Serine/threonine-protein kinase ULK2 (EC 2.7.11.1) (Unc-51-like kinase 2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MARK2 0 2 MARK2 EMK1 MARK2_HUMAN 4.87894447047734 4.85 4.85000000000001 2 Serine/threonine-protein kinase MARK2 (EC 2.7.11.1) (EC 2.7.11.26) (ELKL motif kinase 1) (EMK-1) (MAP/microtubule affinity-regulating kinase 2) (PAR1 homolog) (PAR1 homolog b) (Par-1b) (Par1b) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 IKKA 0 1 CHUK IKKA TCF16 IKKA_HUMAN 5.14017870316504 4.85 4.85000000000001 1 Inhibitor of nuclear factor kappa-B kinase subunit alpha (I-kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA), Inhibitor of nuclear factor kappa-B kinase subunit alpha (I-kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) (Transcription factor 16) (TCF-16) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 SGK1 0 4 SGK1 SGK SGK1_HUMAN 4.95319825237927 4.85 4.85000000000001 4 Serine/threonine-protein kinase Sgk1 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 FAK2 0 1 PTK2B FAK2 PYK2 RAFTK FAK2_HUMAN 4.85982129683496 4.85 4.85000000000001 1 Protein-tyrosine kinase 2-beta (EC 2.7.10.2) (Calcium-dependent tyrosine kinase) (CADTK) (Calcium-regulated non-receptor proline-rich tyrosine kinase) (Cell adhesion kinase beta) (CAK-beta) (CAKB) (Focal adhesion kinase 2) (FADK 2) (Proline-rich tyrosine kinase 2), Protein-tyrosine kinase 2-beta (EC 2.7.10.2) (Calcium-dependent tyrosine kinase) (CADTK) (Calcium-regulated non-receptor proline-rich tyrosine kinase) (Cell adhesion kinase beta) (CAK-beta) (CAKB) (Focal adhesion kinase 2) (FADK 2) (Proline-rich tyrosine kinase 2) (Related adhesion focal tyrosine kinase) (RAFTK) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 EPHA3 0 1 EPHA3 ETK ETK1 HEK TYRO4 EPHA3_HUMAN 5.65854134728041 4.85 4.85000000000001 1 Ephrin type-A receptor 3 (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (hEK4) (HEK) (Human embryo kinase) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) (Eph-like tyrosine kinase 1), Ephrin type-A receptor 3 (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (mEK4) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CCNA1 0 3 CCNA1 CCNA1_HUMAN 4.78739190711856 4.85 4.85000000000001 3 Cyclin-A1 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CCNA2 0 3 CCNA2 CCN1 CCNA CCNA2_HUMAN 4.78739190711856 4.85 4.85000000000001 3 Cyclin-A2 (Cyclin-A) (Cyclin A) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CCND3 0 2 CCND3 CCND3_HUMAN 5.05217801166507 4.85 4.85000000000001 2 G1/S-specific cyclin-D3 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CDK6 0 2 CDK6 CDKN6 CDK6_HUMAN 5.05217801166507 4.85 4.85000000000001 2 Cyclin-dependent kinase 6 (EC 2.7.11.22) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 LYN 0 2 LYN JTK8 LYN_HUMAN 5.01286793734412 4.85 4.85000000000001 2 Tyrosine-protein kinase Lyn (EC 2.7.10.2) (Lck/Yes-related novel protein tyrosine kinase) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn), Tyrosine-protein kinase Lyn (EC 2.7.10.2) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 HCK 0 3 HCK HCK_HUMAN 5.41468453443584 4.85 4.85000000000001 3 Tyrosine-protein kinase HCK (EC 2.7.10.2) (Hematopoietic cell kinase) (Hemopoietic cell kinase) (p59-HCK/p60-HCK) (p59Hck) (p61Hck) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MRCKA 0 1 CDC42BPA KIAA0451 MRCKA_HUMAN 5.50060235056919 4.85 4.85000000000001 1 Serine/threonine-protein kinase MRCK alpha (EC 2.7.11.1) (CDC42-binding protein kinase alpha) (DMPK-like alpha) (Myotonic dystrophy kinase-related CDC42-binding kinase alpha) (MRCK alpha) (Myotonic dystrophy protein kinase-like alpha) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 LCK 0 4 LCK LCK_HUMAN 5.31266247768274 4.85 4.85000000000001 4 Proto-oncogene tyrosine-protein kinase LCK (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (p56-LCK), Tyrosine-protein kinase Lck (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (Protein YT16) (Proto-oncogene Lck) (T cell-specific protein-tyrosine kinase) (p56-LCK) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 RET 0 2 RET CDHF12 CDHR16 PTC RET51 RET_HUMAN 5.76431553708471 4.85 4.85000000000001 2 Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment], Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment] 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CP1A2 0 1 CYP1A2 CP1A2_HUMAN 5.1 4.85 4.85000000000001 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 INSR 0 1 INSR INSR_HUMAN 5.41017446508905 4.85 4.85000000000001 1 Insulin receptor (IR) (EC 2.7.10.1) (CD antigen CD220) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 HASP 0 2 HASPIN GSG2 HASP_HUMAN 4.50614608690228 4.85 4.85000000000001 2 Serine/threonine-protein kinase haspin (EC 2.7.11.1) (Germ cell-specific gene 2 protein) (H-haspin) (Haploid germ cell-specific nuclear protein kinase) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 GRK6 0 2 GRK6 GPRK6 GRK6_HUMAN 5.24910848296273 4.85 4.85000000000001 2 G protein-coupled receptor kinase 6 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK6) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 IGF1R 0 2 IGF1R IGF1R_HUMAN 6.68792321815458 4.85 4.85000000000001 2 Insulin-like growth factor 1 receptor (EC 2.7.10.1) (Insulin-like growth factor I receptor) (IGF-I receptor) (CD antigen CD221) [Cleaved into: Insulin-like growth factor 1 receptor alpha chain; Insulin-like growth factor 1 receptor beta chain] 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 PGFRA 0 1 PDGFRA PDGFR2 RHEPDGFRA PGFRA_HUMAN 5.54967192186827 4.85 4.85000000000001 1 Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (CD140a antigen) (Platelet-derived growth factor alpha receptor) (Platelet-derived growth factor receptor 2) (PDGFR-2) (CD antigen CD140a), Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (Platelet-derived growth factor alpha receptor) (CD antigen CD140a) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KSYK 0 1 SYK KSYK_HUMAN 5.1224064000929 4.85 4.85000000000001 1 Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72-Syk), Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72Syk) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 DMPK 0 2 DMPK DM1PK MDPK DMPK_HUMAN 4.58769567418868 4.85 4.85000000000001 2 Myotonin-protein kinase (MT-PK) (EC 2.7.11.1) (DM-kinase) (DMK) (DM1 protein kinase) (DMPK) (Myotonic dystrophy protein kinase) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 ACK1 0 1 TNK2 ACK1 ACK1_HUMAN 4.9128498242811 4.85 4.85000000000001 1 Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Non-receptor protein tyrosine kinase Ack) (Tyrosine kinase non-receptor protein 2), Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Tyrosine kinase non-receptor protein 2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 DYRK2 0 1 DYRK2 DYRK2_HUMAN 6.50965047954658 4.85 4.85000000000001 1 Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 FER 0 1 FER TYK3 FER_HUMAN 5.62973141792582 4.85 4.85000000000001 1 Tyrosine-protein kinase Fer (EC 2.7.10.2) (Feline encephalitis virus-related kinase FER) (Fujinami poultry sarcoma/Feline sarcoma-related protein Fer) (Proto-oncogene c-Fer) (Tyrosine kinase 3) (p94-Fer) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 TSSK2 0 1 TSSK2 DGSG SPOGA2 STK22B TSSK2_HUMAN 6.19497660321606 4.85 4.85000000000001 1 Testis-specific serine/threonine-protein kinase 2 (TSK-2) (TSK2) (TSSK-2) (Testis-specific kinase 2) (EC 2.7.11.1) (DiGeorge syndrome protein G) (DGS-G) (Serine/threonine-protein kinase 22B) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 SRPK3 0 1 SRPK3 MSSK1 STK23 SRPK3_HUMAN 5.0871501757189 4.85 4.85000000000001 1 SRSF protein kinase 3 (EC 2.7.11.1) (Muscle-specific serine kinase 1) (MSSK-1) (Serine/arginine-rich protein-specific kinase 3) (SR-protein-specific kinase 3) (Serine/threonine-protein kinase 23) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 PLK1 0 1 PLK1 PLK PLK1_HUMAN 5.72015930340596 4.85 4.85000000000001 1 Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 EPHA4 0 1 EPHA4 HEK8 SEK TYRO1 EPHA4_HUMAN 5.65854134728041 4.85 4.85000000000001 1 Ephrin type-A receptor 4 (EC 2.7.10.1) (EPH-like kinase 8) (EK8) (hEK8) (Tyrosine-protein kinase TYRO1) (Tyrosine-protein kinase receptor SEK), Ephrin type-A receptor 4 (EC 2.7.10.1) (Tyrosine-protein kinase receptor MPK-3) (Tyrosine-protein kinase receptor SEK-1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 VGFR2 0 2 KDR FLK1 VEGFR2 VGFR2_HUMAN 4.70294740620947 4.85 4.85000000000001 2 Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase NYK) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309), Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase insert domain receptor) (KDR) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309), Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1b) (FLK-1b) (Kinase insert domain receptor) (Kinase insert domain receptor-B) (Protein-tyrosine kinase receptor flk-1b) (Vascular endothelial growth factor receptor 2 homolog B) (VEGFR-2 homolog B) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 VRK2 0 1 VRK2 VRK2_HUMAN 5.50060235056919 4.85 4.85000000000001 1 Serine/threonine-protein kinase VRK2 (EC 2.7.11.1) (Vaccinia-related kinase 2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 IRAK1 0 1 IRAK1 IRAK IRAK1_HUMAN 5.90799732148669 4.85 4.85000000000001 1 Interleukin-1 receptor-associated kinase 1 (IRAK-1) (EC 2.7.11.1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 ACV1B 0 1 ACVR1B ACVRLK4 ALK4 ACV1B_HUMAN 5.50060235056919 4.85 4.85000000000001 1 Activin receptor type-1B (EC 2.7.11.30) (Activin receptor type IB) (ACTR-IB) (Activin receptor-like kinase 4) (ALK-4) (Serine/threonine-protein kinase receptor R2) (SKR2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KC1D 0 2 CSNK1D HCKID KC1D_HUMAN 5.76482515299792 4.85 4.85000000000001 2 Casein kinase I isoform delta (CKI-delta) (CKId) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26), Casein kinase I isoform delta (CKI-delta) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 WNK2 0 1 WNK2 KIAA1760 PRKWNK2 SDCCAG43 P/OKcl.13 WNK2_HUMAN 5.78837041556533 4.85 4.85000000000001 1 Serine/threonine-protein kinase WNK2 (EC 2.7.11.1) (Antigen NY-CO-43) (Protein kinase lysine-deficient 2) (Protein kinase with no lysine 2) (Serologically defined colon cancer antigen 43) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MP2K1 0 1 MAP2K1 MEK1 PRKMK1 MP2K1_HUMAN 5.03476210625921 4.85 4.85000000000001 1 Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1), Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (MKK1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MUSK 0 1 MUSK MUSK_HUMAN 5.45425837176016 4.85 4.85000000000001 1 Muscle, skeletal receptor tyrosine-protein kinase (EC 2.7.10.1) (Muscle-specific tyrosine-protein kinase receptor) (MuSK) (Muscle-specific kinase receptor) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 FYN 0 1 FYN FYN_HUMAN 5.36797678529459 4.85 4.85000000000001 1 Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene Syn) (Proto-oncogene c-Fyn) (Src-like kinase) (SLK) (p59-Fyn), Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene c-Fyn) (p59-Fyn) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2658 ALDR 2 0 AKR1B1 ALDR1, Akr1b1 Akr1b4 Aldr1 ALDR_HUMAN, ALDR_RAT 4.525 4.6 4.60000000000001 2 Aldose reductase (AR) (EC 1.1.1.21) (20-alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (EC 1.1.1.149) (Aldehyde reductase), Aldose reductase (AR) (EC 1.1.1.21) (Aldehyde reductase), Aldose reductase (AR) (EC 1.1.1.21) (Aldehyde reductase) (Aldo-keto reductase family 1 member B1) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 NR1H4 2 0 NR1H4 BAR FXR HRR1 RIP14 NR1H4_HUMAN 4.59999938302362 4.6 4.60000000000001 2 Bile acid receptor (Farnesoid X-activated receptor) (Farnesol receptor HRR-1) (Nuclear receptor subfamily 1 group H member 4) (Retinoid X receptor-interacting protein 14) (RXR-interacting protein 14) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 PPARG 2 0 PPARG NR1C3 PPARG_HUMAN 4.65000010122271 4.6 4.60000000000001 2 Peroxisome proliferator-activated receptor gamma (PPAR-gamma) (Nuclear receptor subfamily 1 group C member 3) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 ESR2 41 0 ESR2 ESTRB NR3A2, Esr2 Erbeta Nr3a2 ESR2_HUMAN, ESR2_RAT 6.86619516395008 4.6 4.60000000000001 41 Estrogen receptor beta (ER-beta) (Nuclear receptor subfamily 3 group A member 2) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 ESR1 44 0 ESR1 ESR NR3A1, Esr1 Esr Estr Nr3a1 ESR1_HUMAN, ESR1_RAT 5.68867713562138 4.6 4.60000000000001 44 Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1), Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1) (Fragment) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 LOX15 3 0 ALOX15, ALOX15 LOG15 LOX15_HUMAN, LOX15_RABIT 4.74666666666667 4.6 4.60000000000001 3 Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (12/15-LO) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Probable linoleate 9S-lipoxygenase 5 (EC 1.13.11.58) (Leaf lipoxygenase) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 AA2AR 4 0 ADORA2A ADORA2, Adora2a AA2AR_HUMAN, AA2AR_RAT 4.6625 4.6 4.60000000000001 4 Adenosine receptor A2a 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 TAU 6 0 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.30833333333333 4.6 4.60000000000001 6 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 PGDH 5 0 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.67 4.6 4.60000000000001 5 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 TOP2A 6 0 TOP2A TOP2 TOP2A_HUMAN 4.98566302414106 4.6 4.60000000000001 6 DNA topoisomerase 2-alpha (EC 5.99.1.3) (DNA topoisomerase II, alpha isozyme) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 AHR 2 0 AHR BHLHE76 AHR_HUMAN 4.87499883113825 4.6 4.60000000000001 2 Aryl hydrocarbon receptor (Ah receptor) (AhR), Aryl hydrocarbon receptor (Ah receptor) (AhR) (Class E basic helix-loop-helix protein 76) (bHLHe76) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 THB 1 0 THRB ERBA2 NR1A2 THR1 THB_HUMAN 8.49485002168009 4.6 4.60000000000001 1 Thyroid hormone receptor beta (Nuclear receptor subfamily 1 group A member 2) (c-erbA-2) (c-erbA-beta) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 EGFR 11 0 EGFR ERBB ERBB1 HER1 EGFR_HUMAN 5.04165151864931 4.6 4.60000000000001 11 Epidermal growth factor receptor (EC 2.7.10.1), Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 SC6A3 2 0 SLC6A3 DAT1 SC6A3_HUMAN 4.82 4.6 4.60000000000001 2 Sodium-dependent dopamine transporter (DA transporter) (DAT) (Solute carrier family 6 member 3) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 RXRA 4 0 RXRA NR2B1 RXRA_HUMAN 4.65000040771605 4.6 4.60000000000001 4 Retinoic acid receptor RXR-alpha (Nuclear receptor subfamily 2 group B member 1) (Retinoid X receptor alpha) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 LEF 2 0 lef pXO1-107 BXA0172 GBAA_pXO1_0172 LEF_BACAN 4.7 4.6 4.60000000000001 2 Lethal factor (LF) (EC 3.4.24.83) (Anthrax lethal toxin endopeptidase component) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 Q7ZJM1 3 0 pol Q7ZJM1_9HIV1 5.11931333622401 4.6 4.60000000000001 3 Integrase (Fragment) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 NPC1 2 0 NPC1 NPC1_HUMAN 5.295 4.6 4.60000000000001 2 Niemann-Pick C1 protein 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 FEN1 1 0 FEN1 RAD2 FEN1_HUMAN 5.27381905802915 4.6 4.60000000000001 1 Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (DNase IV) (Flap structure-specific endonuclease 1) (Maturation factor 1) (MF1) (hFEN-1) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 ATX2 1 0 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 4.8000008748032 4.6 4.60000000000001 1 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 PPARD 6 0 PPARD NR1C2 PPARB PPARD_HUMAN 4.59625607589676 4.6 4.60000000000001 6 Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 MRP1 1 0 ABCC1 MRP MRP1 MRP1_HUMAN 6.24349737657882 4.6 4.60000000000001 1 Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 SMN 3 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.6 4.6 4.60000000000001 3 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 LUCI 2 0 LUCI_PHOPY 4.85658477164208 4.6 4.60000000000001 2 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 AOFA 11 0 MAOA AOFA_HUMAN 5.59959490812582 4.6 4.60000000000001 11 Amine oxidase [flavin-containing] A (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 DNMT1 1 0 DNMT1 AIM CXXC9 DNMT DNMT1_HUMAN 4.52 4.6 4.60000000000001 1 DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (EC 2.1.1.37) (CXXC-type zinc finger protein 9) (DNA methyltransferase HsaI) (DNA MTase HsaI) (M.HsaI) (MCMT), DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (Met-1) (EC 2.1.1.37) (DNA methyltransferase MmuI) (DNA MTase MmuI) (M.MmuI) (MCMT) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 HIF1A 2 0 HIF1A BHLHE78 MOP1 PASD8 HIF1A_HUMAN 5.3 4.6 4.60000000000001 2 Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein), Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 BRCA1 1 0 BRCA1 RNF53 BRCA1_HUMAN 5 4.6 4.60000000000001 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 P53 4 0 TP53 P53 P53_HUMAN 5.17499941351801 4.6 4.60000000000001 4 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 SO1B3 3 0 SLCO1B3 LST2 OATP1B3 OATP8 SLC21A8 SO1B3_HUMAN 5.24893907329278 4.6 4.60000000000001 3 Solute carrier organic anion transporter family member 1B3 (Liver-specific organic anion transporter 2) (LST-2) (Organic anion transporter 8) (Organic anion-transporting polypeptide 8) (OATP-8) (Solute carrier family 21 member 8) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 AA1R 4 0 ADORA1, Adora1 AA1R_HUMAN, AA1R_RAT 5.06 4.6 4.60000000000001 4 Adenosine receptor A1 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 BLM 2 0 BLM RECQ2 RECQL3 BLM_HUMAN 9.69897000433602 4.6 4.60000000000001 2 Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 GLP1R 2 0 GLP1R GLP1R_HUMAN 5.19999875880851 4.6 4.60000000000001 2 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 ALDH2 4 0 ALDH2 ALDM ALDH2_HUMAN 5.31620648321977 4.6 4.60000000000001 4 Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDH1), Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDHI) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 NF2L2 7 0 NFE2L2 NRF2 NF2L2_HUMAN 5.0839659963869 4.6 4.60000000000001 7 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 ABL2 2 0 ABL2 ABLL ARG ABL2_HUMAN 5 4.6 4.60000000000001 2 Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 ABL1 3 0 ABL1 ABL JTK7 ABL1_HUMAN 5 4.6 4.60000000000001 3 Tyrosine-protein kinase ABL1 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 1) (Abelson tyrosine-protein kinase 1) (Proto-oncogene c-Abl) (p150) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 MDR1 1 0 ABCB1 MDR1 PGY1 MDR1_HUMAN 4.58 4.6 4.60000000000001 1 Multidrug resistance protein 1 (EC 3.6.3.44) (ATP-binding cassette sub-family B member 1) (P-glycoprotein 1) (CD antigen CD243) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 GRP78 2 0 HSPA5 GRP78 GRP78_HUMAN 5.33300493205124 4.6 4.60000000000001 2 78 kDa glucose-regulated protein (GRP-78) (Endoplasmic reticulum lumenal Ca(2+)-binding protein grp78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP), 78 kDa glucose-regulated protein (GRP-78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 PMP22 3 0 PMP22 GAS3, Pmp22 Cd25 Pmp-22 PMP22_HUMAN, PMP22_RAT 4.88750648730812 4.6 4.60000000000001 3 Peripheral myelin protein 22 (PMP-22) (Growth arrest-specific protein 3) (GAS-3), Peripheral myelin protein 22 (PMP-22) (Protein CD25) (SR13 myelin protein) (Schwann cell membrane glycoprotein) (SAG) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 RAB9A 2 0 RAB9A RAB9 RAB9A_HUMAN 5.15 4.6 4.60000000000001 2 Ras-related protein Rab-9A 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 AOFB 10 0 MAOB AOFB_HUMAN 5.5995543989384 4.6 4.60000000000001 10 Amine oxidase [flavin-containing] B (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 FABI 1 0 fabI envM b1288 JW1281 FABI_ECOLI 5 4.6 4.60000000000001 1 Enoyl-[acyl-carrier-protein] reductase [NADH] FabI (ENR) (EC 1.3.1.9) (NADH-dependent enoyl-ACP reductase) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 SO1B1 4 0 SLCO1B1 LST1 OATP1B1 OATP2 OATPC SLC21A6 SO1B1_HUMAN 5.60564564812153 4.6 4.60000000000001 4 Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 GLCM 4 0 GBA GC GLUC GLCM_HUMAN 4.77500032913753 4.6 4.60000000000001 4 Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase), Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (D-glucosyl-N-acylsphingosine glucohydrolase) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 DHB1 2 0 HSD17B1 E17KSR EDH17B1 EDH17B2 EDHB17 SDR28C1 DHB1_HUMAN 4.9856854145011 4.6 4.60000000000001 2 Estradiol 17-beta-dehydrogenase 1 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 1) (17-beta-HSD 1), Estradiol 17-beta-dehydrogenase 1 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 1) (17-beta-HSD 1) (20 alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (E2DH) (Placental 17-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 28C member 1) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 GLSK 1 0 GLS GLS1 KIAA0838 GLSK_HUMAN 4.89999841719865 4.6 4.60000000000001 1 Glutaminase kidney isoform, mitochondrial (GLS) (EC 3.5.1.2) (K-glutaminase) (L-glutamine amidohydrolase) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 TPO 2 0 THPO MGDF TPO_HUMAN 5.8 4.6 4.60000000000001 2 Thrombopoietin (C-mpl ligand) (ML) (Megakaryocyte colony-stimulating factor) (Megakaryocyte growth and development factor) (MGDF) (Myeloproliferative leukemia virus oncogene ligand) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 CAC1C 4 0 CACNA1C CACH2 CACN2 CACNL1A1 CCHL1A1, Cacna1c Cach2 Cacn2 Cacnl1a1 Cchl1a1 CAC1C_CAVPO, CAC1C_RAT 4.715 4.6 4.60000000000001 4 Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (MELC-CC) (Mouse brain class C) (MBC) (Voltage-gated calcium channel subunit alpha Cav1.2), Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Rat brain class C) (RBC) (Voltage-gated calcium channel subunit alpha Cav1.2), Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Smooth muscle calcium channel blocker receptor) (CACB-receptor) (Voltage-gated calcium channel subunit alpha Cav1.2), Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Voltage-gated calcium channel subunit alpha Cav1.2), Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Voltage-gated calcium channel subunit alpha Cav1.2) (Fragment) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 ATAD5 4 0 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.873890252643 4.6 4.60000000000001 4 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 DHB2 2 0 HSD17B2 EDH17B2 SDR9C2 DHB2_HUMAN 4.52503603889225 4.6 4.60000000000001 2 Estradiol 17-beta-dehydrogenase 2 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 2) (17-beta-HSD 2) (20 alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (E2DH) (Microsomal 17-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 9C member 2) (Testosterone 17-beta-dehydrogenase) (EC 1.1.1.239), Estradiol 17-beta-dehydrogenase 2 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 2) (17-beta-HSD 2) (Testosterone 17-beta-dehydrogenase) (EC 1.1.1.239) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 TRXR1 1 0 Txnrd1 Trxr1 TRXR1_RAT 5.95000714307986 4.6 4.60000000000001 1 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 LMNA 3 0 LMNA LMN1 LMNA_HUMAN 4.85 4.6 4.60000000000001 3 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 ERR2 1 0 ESRRB ERRB2 ESRL2 NR3B2 ERR2_HUMAN 6.4 4.6 4.60000000000001 1 Steroid hormone receptor ERR2 (ERR beta-2) (Estrogen receptor-like 2) (Estrogen-related receptor beta) (ERR-beta) (Nuclear receptor subfamily 3 group B member 2) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 NR1H2 1 0 NR1H2 LXRB NER UNR NR1H2_HUMAN 4.66 4.6 4.60000000000001 1 Oxysterols receptor LXR-beta (Liver X receptor beta) (Nuclear receptor NER) (Nuclear receptor subfamily 1 group H member 2) (Ubiquitously-expressed nuclear receptor), Oxysterols receptor LXR-beta (Liver X receptor beta) (Nuclear receptor subfamily 1 group H member 2) (Retinoid X receptor-interacting protein No.15) (Ubiquitously-expressed nuclear receptor) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 NANH 1 0 nanH NANH_CLOPF 4.92 4.6 4.60000000000001 1 Sialidase (EC 3.2.1.18) (N-acylneuraminate glycohydrolase) (Neuraminidase) (NANase) (STNA), Sialidase (EC 3.2.1.18) (Neuraminidase), Sialidase (EC 3.2.1.18) (Neuraminidase) (NANase) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 THAS 1 0 TBXAS1 CYP5 CYP5A1 THAS_HUMAN 5.11 4.6 4.60000000000001 1 Thromboxane-A synthase (TXA synthase) (TXS) (EC 5.3.99.5) (Cytochrome P450 5A1) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 NR1H3 1 0 NR1H3 LXRA NR1H3_HUMAN 4.51 4.6 4.60000000000001 1 Oxysterols receptor LXR-alpha (Liver X receptor alpha) (Nuclear receptor subfamily 1 group H member 3) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 MGA 3 0 MGAM MGA MGAML MGA_HUMAN 5.18 4.6 4.60000000000001 3 Maltase-glucoamylase, intestinal [Includes: Maltase (EC 3.2.1.20) (Alpha-glucosidase); Glucoamylase (EC 3.2.1.3) (Glucan 1,4-alpha-glucosidase)] 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 VDR 1 0 VDR NR1I1 VDR_HUMAN 5.14999741390754 4.6 4.60000000000001 1 Vitamin D3 receptor (VDR) (1,25-dihydroxyvitamin D3 receptor) (Nuclear receptor subfamily 1 group I member 1) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 SO2B1 1 0 SLCO2B1 KIAA0880 OATP2B1 OATPB SLC21A9 SO2B1_HUMAN 5.32536474187563 4.6 4.60000000000001 1 Solute carrier organic anion transporter family member 2B1 (Organic anion transporter B) (OATP-B) (Organic anion transporter polypeptide-related protein 2) (OATP-RP2) (OATPRP2) (Solute carrier family 21 member 9), Solute carrier organic anion transporter family member 2B1 (Organic anion transporter moatp1) (Solute carrier family 21 member 9) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 RORG 1 0 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.8 4.6 4.60000000000001 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 DCOR 1 0 ODC1 DCOR_HUMAN 4.59 4.6 4.60000000000001 1 Ornithine decarboxylase (ODC) (EC 4.1.1.17) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 AOXA 1 0 AOX1 AO AOXA_HUMAN 6.47 4.6 4.60000000000001 1 Aldehyde oxidase (EC 1.2.3.1) (Aldehyde oxidase 1) (Azaheterocycle hydroxylase) (EC 1.17.3.-), Aldehyde oxidase 1 (EC 1.2.3.1) (Azaheterocycle hydroxylase 1) (EC 1.17.3.-), Aldehyde oxidase 1 (EC 1.2.3.1) (Azaheterocycle hydroxylase 1) (EC 1.17.3.-) (Retinal oxidase), Aldehyde oxidase 1 (EC 1.2.3.1) (Azaheterocycle hydroxylase 1) (EC 1.17.3.-) (Retinal oxidase) (Retinoic acid synthase) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 AMY1 1 0 AMY1A AMY1; AMY1B AMY1; AMY1C AMY1 AMY1_HUMAN 4.52519190378157 4.6 4.60000000000001 1 Alpha-amylase 1 (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase 1) (Salivary alpha-amylase), Alpha-amylase type A isozyme (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase) (HvAMY1) (Low pI alpha-amylase) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 ERR1 1 0 ESRRA ERR1 ESRL1 NR3B1 ERR1_HUMAN 8 4.6 4.60000000000001 1 Steroid hormone receptor ERR1 (Estrogen receptor-like 1) (Estrogen-related receptor alpha) (ERR-alpha) (Nuclear receptor subfamily 3 group B member 1) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 TYDP1 1 0 TDP1 TYDP1_HUMAN 5.05 4.6 4.60000000000001 1 Tyrosyl-DNA phosphodiesterase 1 (Tyr-DNA phosphodiesterase 1) (EC 3.1.4.-) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 5HT2A 2 0 HTR2A HTR2 5HT2A_HUMAN 5.25 4.6 4.60000000000001 2 5-hydroxytryptamine receptor 2A (5-HT-2) (5-HT-2A) (5-HT2A) (Serotonin receptor 2A), 5-hydroxytryptamine receptor 2A (5-HT-2) (5-HT-2A) (5-hydroxytryptamine receptor) (Serotonin receptor 2A), 5-hydroxytryptamine receptor 2A (5-HT-2) (5-HT-2A) (Serotonin receptor 2A) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 YES 1 0 YES1 YES YES_HUMAN 4.51219018981841 4.6 4.60000000000001 1 Tyrosine-protein kinase Yes (EC 2.7.10.2) (Proto-oncogene c-Yes) (p61-Yes) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 QOR 1 0 Cryz QOR_MOUSE 4.64016451766011 4.6 4.60000000000001 1 Quinone oxidoreductase (EC 1.6.5.5) (NADPH:quinone reductase) (Zeta-crystallin) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 PIM1 2 0 PIM1 PIM1_HUMAN 5.32885283155635 4.6 4.60000000000001 2 Serine/threonine-protein kinase pim-1 (EC 2.7.11.1) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 Q965D7 1 0 fabZ Q965D7_PLAFA 5.15 4.6 4.62000000000001 1 Beta-hydroxyacyl-ACP dehydratase (Fatty acid synthesis protein) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 5HT2C 2 0 HTR2C HTR1C 5HT2C_HUMAN 4.97 4.6 4.60000000000001 2 5-hydroxytryptamine receptor 2C (5-HT-2C) (5-HT2C) (5-HTR2C) (5-hydroxytryptamine receptor 1C) (5-HT-1C) (5-HT1C) (Serotonin receptor 2C), 5-hydroxytryptamine receptor 2C (5-HT-2C) (5-HT2C) (5-HTR2C) (Serotonin receptor 2C) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2994 SMAD3 0 1 SMAD3 MADH3 SMAD3_HUMAN 5.25000102344165 5.35 5.35000000000002 1 GEMFIBROZIL ALZHEIMERS DISEASE, ANEMIA, CANCER, CARDIOVASCULAR DISEASE, CORONARY HEART DISEASE, NICOTINE DEPENDENCE, SMOKING CESSATION, TYPE II DIABETES MELLITUS Peroxisome proliferator-activated receptor alpha agonist AGONIST 4 Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) 1 5.35 actual drug [drugName] Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 2994 SO1B1 0 6 SLCO1B1 LST1 OATP1B1 OATP2 OATPC SLC21A6 SO1B1_HUMAN 4.82133233735511 5.35 5.35000000000002 6 GEMFIBROZIL ALZHEIMERS DISEASE, ANEMIA, CANCER, CARDIOVASCULAR DISEASE, CORONARY HEART DISEASE, NICOTINE DEPENDENCE, SMOKING CESSATION, TYPE II DIABETES MELLITUS Peroxisome proliferator-activated receptor alpha agonist AGONIST 4 Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6) 1 5.35 actual drug [drugName] Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 2994 FABPL 0 3 Fabp1 FABPL_RAT 5.01751825519221 5.35 5.35000000000002 3 GEMFIBROZIL ALZHEIMERS DISEASE, ANEMIA, CANCER, CARDIOVASCULAR DISEASE, CORONARY HEART DISEASE, NICOTINE DEPENDENCE, SMOKING CESSATION, TYPE II DIABETES MELLITUS Peroxisome proliferator-activated receptor alpha agonist AGONIST 4 Fatty acid-binding protein, liver (Fatty acid-binding protein 1) (Liver basic FABP) (LB-FABP) (Liver bile acid-binding protein) (L-BABP) (Liver-type fatty acid-binding protein) (L-FABP), Fatty acid-binding protein, liver (Fatty acid-binding protein 1) (Liver-type fatty acid-binding protein) (L-FABP), Fatty acid-binding protein, liver (Fatty acid-binding protein 1) (Liver-type fatty acid-binding protein) (L-FABP) (Squalene- and sterol-carrier protein) (SCP) (Z-protein) (p14) 1 5.35 actual drug [drugName] Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 2994 RUNX1 0 2 RUNX1 AML1 CBFA2 RUNX1_HUMAN 4.89999841719865 5.35 5.35000000000002 2 GEMFIBROZIL ALZHEIMERS DISEASE, ANEMIA, CANCER, CARDIOVASCULAR DISEASE, CORONARY HEART DISEASE, NICOTINE DEPENDENCE, SMOKING CESSATION, TYPE II DIABETES MELLITUS Peroxisome proliferator-activated receptor alpha agonist AGONIST 4 Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit) 1 5.35 actual drug [drugName] Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 2994 PEBB 0 2 CBFB PEBB_HUMAN 4.89999841719865 5.35 5.35000000000002 2 GEMFIBROZIL ALZHEIMERS DISEASE, ANEMIA, CANCER, CARDIOVASCULAR DISEASE, CORONARY HEART DISEASE, NICOTINE DEPENDENCE, SMOKING CESSATION, TYPE II DIABETES MELLITUS Peroxisome proliferator-activated receptor alpha agonist AGONIST 4 Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit) 1 5.35 actual drug [drugName] Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 2994 CP2C8 0 2 CYP2C8 CP2C8_HUMAN 4.705 5.35 5.35000000000002 2 GEMFIBROZIL ALZHEIMERS DISEASE, ANEMIA, CANCER, CARDIOVASCULAR DISEASE, CORONARY HEART DISEASE, NICOTINE DEPENDENCE, SMOKING CESSATION, TYPE II DIABETES MELLITUS Peroxisome proliferator-activated receptor alpha agonist AGONIST 4 Cytochrome P450 2C8 (EC 1.14.14.1) (CYPIIC8) (Cytochrome P450 IIC2) (Cytochrome P450 MP-12) (Cytochrome P450 MP-20) (Cytochrome P450 form 1) (S-mephenytoin 4-hydroxylase) 1 5.35 actual drug [drugName] Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 2994 GEMI 0 1 GMNN GEMI_HUMAN 6.2500319164906 5.35 5.35000000000002 1 GEMFIBROZIL ALZHEIMERS DISEASE, ANEMIA, CANCER, CARDIOVASCULAR DISEASE, CORONARY HEART DISEASE, NICOTINE DEPENDENCE, SMOKING CESSATION, TYPE II DIABETES MELLITUS Peroxisome proliferator-activated receptor alpha agonist AGONIST 4 Geminin 1 5.35 actual drug [drugName] Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 2994 SO1B3 0 3 SLCO1B3 LST2 OATP1B3 OATP8 SLC21A8 SO1B3_HUMAN 4.9226956500826 5.35 5.35000000000002 3 GEMFIBROZIL ALZHEIMERS DISEASE, ANEMIA, CANCER, CARDIOVASCULAR DISEASE, CORONARY HEART DISEASE, NICOTINE DEPENDENCE, SMOKING CESSATION, TYPE II DIABETES MELLITUS Peroxisome proliferator-activated receptor alpha agonist AGONIST 4 Solute carrier organic anion transporter family member 1B3 (Liver-specific organic anion transporter 2) (LST-2) (Organic anion transporter 8) (Organic anion-transporting polypeptide 8) (OATP-8) (Solute carrier family 21 member 8) 1 5.35 actual drug [drugName] Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 2994 PPARG 0 4 PPARG NR1C3 PPARG_HUMAN 4.70286668124885 5.35 5.35000000000002 4 GEMFIBROZIL ALZHEIMERS DISEASE, ANEMIA, CANCER, CARDIOVASCULAR DISEASE, CORONARY HEART DISEASE, NICOTINE DEPENDENCE, SMOKING CESSATION, TYPE II DIABETES MELLITUS Peroxisome proliferator-activated receptor alpha agonist AGONIST 4 Peroxisome proliferator-activated receptor gamma (PPAR-gamma) (Nuclear receptor subfamily 1 group C member 3) 1 5.35 actual drug [drugName] Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 2994 TSHR 0 4 TSHR LGR3 TSHR_HUMAN 4.8 5.35 5.35000000000002 4 GEMFIBROZIL ALZHEIMERS DISEASE, ANEMIA, CANCER, CARDIOVASCULAR DISEASE, CORONARY HEART DISEASE, NICOTINE DEPENDENCE, SMOKING CESSATION, TYPE II DIABETES MELLITUS Peroxisome proliferator-activated receptor alpha agonist AGONIST 4 Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R) 1 5.35 actual drug [drugName] Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 2994 KAT2A 0 2 KAT2A GCN5 GCN5L2 HGCN5 KAT2A_HUMAN 4.8000008748032 5.35 5.35000000000002 2 GEMFIBROZIL ALZHEIMERS DISEASE, ANEMIA, CANCER, CARDIOVASCULAR DISEASE, CORONARY HEART DISEASE, NICOTINE DEPENDENCE, SMOKING CESSATION, TYPE II DIABETES MELLITUS Peroxisome proliferator-activated receptor alpha agonist AGONIST 4 Histone acetyltransferase KAT2A (EC 2.3.1.48) (General control of amino acid synthesis protein 5-like 2) (Histone acetyltransferase GCN5) (HsGCN5) (Lysine acetyltransferase 2A) (STAF97) 1 5.35 actual drug [drugName] Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 2994 LUCI 0 1 LUCI_PHOPY 4.62098289875995 5.35 5.35000000000002 1 GEMFIBROZIL ALZHEIMERS DISEASE, ANEMIA, CANCER, CARDIOVASCULAR DISEASE, CORONARY HEART DISEASE, NICOTINE DEPENDENCE, SMOKING CESSATION, TYPE II DIABETES MELLITUS Peroxisome proliferator-activated receptor alpha agonist AGONIST 4 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.35 actual drug [drugName] Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 2994 PFKA 0 1 pfk PFKA_TRYBB 4.67098267640138 5.35 5.35000000000002 1 GEMFIBROZIL ALZHEIMERS DISEASE, ANEMIA, CANCER, CARDIOVASCULAR DISEASE, CORONARY HEART DISEASE, NICOTINE DEPENDENCE, SMOKING CESSATION, TYPE II DIABETES MELLITUS Peroxisome proliferator-activated receptor alpha agonist AGONIST 4 ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase) 1 5.35 actual drug [drugName] Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 2994 RORG 0 1 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.7 5.35 5.35000000000002 1 GEMFIBROZIL ALZHEIMERS DISEASE, ANEMIA, CANCER, CARDIOVASCULAR DISEASE, CORONARY HEART DISEASE, NICOTINE DEPENDENCE, SMOKING CESSATION, TYPE II DIABETES MELLITUS Peroxisome proliferator-activated receptor alpha agonist AGONIST 4 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 5.35 actual drug [drugName] Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 2994 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.35 5.35 5.35000000000002 1 GEMFIBROZIL ALZHEIMERS DISEASE, ANEMIA, CANCER, CARDIOVASCULAR DISEASE, CORONARY HEART DISEASE, NICOTINE DEPENDENCE, SMOKING CESSATION, TYPE II DIABETES MELLITUS Peroxisome proliferator-activated receptor alpha agonist AGONIST 4 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.35 actual drug [drugName] Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 2994 TADBP 0 1 TARDBP TDP43 TADBP_HUMAN 4.59999938302362 5.35 5.35000000000002 1 GEMFIBROZIL ALZHEIMERS DISEASE, ANEMIA, CANCER, CARDIOVASCULAR DISEASE, CORONARY HEART DISEASE, NICOTINE DEPENDENCE, SMOKING CESSATION, TYPE II DIABETES MELLITUS Peroxisome proliferator-activated receptor alpha agonist AGONIST 4 TAR DNA-binding protein 43 (TDP-43) 1 5.35 actual drug [drugName] Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 2994 TTHY 0 2 TTR PALB TTHY_HUMAN 5.37236374744835 5.35 5.35000000000002 2 GEMFIBROZIL ALZHEIMERS DISEASE, ANEMIA, CANCER, CARDIOVASCULAR DISEASE, CORONARY HEART DISEASE, NICOTINE DEPENDENCE, SMOKING CESSATION, TYPE II DIABETES MELLITUS Peroxisome proliferator-activated receptor alpha agonist AGONIST 4 Transthyretin (ATTR) (Prealbumin) (TBPA), Transthyretin (Prealbumin) (TBPA) 1 5.35 actual drug [drugName] Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 2994 JUN 0 1 JUN JUN_HUMAN 5 5.35 5.35000000000002 1 GEMFIBROZIL ALZHEIMERS DISEASE, ANEMIA, CANCER, CARDIOVASCULAR DISEASE, CORONARY HEART DISEASE, NICOTINE DEPENDENCE, SMOKING CESSATION, TYPE II DIABETES MELLITUS Peroxisome proliferator-activated receptor alpha agonist AGONIST 4 Transcription factor AP-1 (AH119) (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (Jun A), Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog), Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (p39), Transcription factor AP-1 (Proto-oncogene c-Jun) 1 5.35 actual drug [drugName] Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 3281 RORG 1 0 RORC NR1F3 RORG RZRG RORG_HUMAN 5.92507390287604 4.7 4.7 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 CP2D6 2 0 CYP2D6 CYP2DL1 CP2D6_HUMAN 4.8 4.7 4.7 2 Cytochrome P450 2D6 (EC 1.14.14.1) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 SMN 4 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.7 4.7 4.7 4 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 ANDR 9 0 AR DHTR NR3C4 ANDR_HUMAN 4.70675579754694 4.7 4.70069444444445 9 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 KDM4E 4 0 KDM4E KDM4DL KDM4E_HUMAN 4.55 4.7 4.7 4 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 LMNA 1 0 LMNA LMN1 LMNA_HUMAN 8.3 4.7 4.7 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 HCD2 5 0 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.5 4.7 4.7 5 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 RAB9A 1 0 RAB9A RAB9 RAB9A_HUMAN 5 4.7 4.7 1 Ras-related protein Rab-9A 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 BLM 2 0 BLM RECQ2 RECQL3 BLM_HUMAN 6.3 4.7 4.70833333333333 2 Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 CP1A2 1 0 CYP1A2 CP1A2_HUMAN 4.8 4.7 4.7 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 NF2L2 6 0 NFE2L2 NRF2 NF2L2_HUMAN 4.92199748277815 4.7 4.71541666666667 6 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 CP2CJ 2 0 CYP2C19 CP2CJ_HUMAN 5 4.7 4.7 2 Cytochrome P450 2C19 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Mephenytoin 4-hydroxylase) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 CAH7 1 0 CA7 CAH7_HUMAN 8.38 4.7 4.64375 1 Carbonic anhydrase 7 (EC 4.2.1.1) (Carbonate dehydratase VII) (Carbonic anhydrase VII) (CA-VII) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 AHR 2 0 AHR BHLHE76 AHR_HUMAN 4.99999952349262 4.7 4.7 2 Aryl hydrocarbon receptor (Ah receptor) (AhR), Aryl hydrocarbon receptor (Ah receptor) (AhR) (Class E basic helix-loop-helix protein 76) (bHLHe76) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 ESR1 18 0 ESR1 ESR NR3A1 ESR1_HUMAN, ESR1_SHEEP 4.69763829036217 4.7 4.70104166666667 18 Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1), Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1) (Fragment) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 ATAD5 2 0 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.86139082578284 4.7 4.7 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 RGS4 1 0 RGS4 RGS4_HUMAN 6.02424661096371 4.7 4.7925 1 Regulator of G-protein signaling 4 (RGP4) (RGS4) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 TAU 2 0 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.775 4.7 4.7 2 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 APEX1 2 0 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 5.50002974382599 4.7 4.7 2 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 DHB2 1 0 HSD17B2 EDH17B2 SDR9C2 DHB2_HUMAN 5.14553249978526 4.7 4.7 1 Estradiol 17-beta-dehydrogenase 2 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 2) (17-beta-HSD 2) (20 alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (E2DH) (Microsomal 17-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 9C member 2) (Testosterone 17-beta-dehydrogenase) (EC 1.1.1.239), Estradiol 17-beta-dehydrogenase 2 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 2) (17-beta-HSD 2) (Testosterone 17-beta-dehydrogenase) (EC 1.1.1.239) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 ESR2 10 0 ESR2 ESTRB NR3A2, ESR2 NR3A2 ESR2_HUMAN, ESR2_SHEEP 5.403 4.7 4.7025 10 Estrogen receptor beta (ER-beta) (Nuclear receptor subfamily 3 group A member 2) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 PFKA 1 0 pfk PFKA_TRYBB 6.12096149476276 4.7 4.635 1 ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 NFKB1 4 0 NFKB1 NFKB1_HUMAN 5.35 4.7 4.7 4 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 ALDH2 3 0 ALDH2 ALDM ALDH2_HUMAN 5.18475279058672 4.7 4.7 3 Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDH1), Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDHI) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 CAC1C 2 0 Cacna1c Cach2 Cacn2 Cacnl1a1 Cchl1a1 CAC1C_RAT 4.92 4.7 4.7 2 Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (MELC-CC) (Mouse brain class C) (MBC) (Voltage-gated calcium channel subunit alpha Cav1.2), Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Rat brain class C) (RBC) (Voltage-gated calcium channel subunit alpha Cav1.2), Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Smooth muscle calcium channel blocker receptor) (CACB-receptor) (Voltage-gated calcium channel subunit alpha Cav1.2), Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Voltage-gated calcium channel subunit alpha Cav1.2), Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Voltage-gated calcium channel subunit alpha Cav1.2) (Fragment) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 CAH12 1 0 CA12 CAH12_HUMAN 7.25 4.7 4.7 1 Carbonic anhydrase 12 (EC 4.2.1.1) (Carbonate dehydratase XII) (Carbonic anhydrase XII) (CA-XII) (Tumor antigen HOM-RCC-3.1.3) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 PGDH 4 0 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.6 4.7 4.7 4 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 P53 3 0 TP53 P53 P53_HUMAN 4.96666666666667 4.7 4.7 3 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 TRXR1 3 0 Txnrd1 Trxr1 TRXR1_RAT 4.95715590510302 4.7 4.7 3 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 LUCI 1 0 LUCI_PHOPY 5 4.7 4.7 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 GRP78 2 0 HSPA5 GRP78 GRP78_HUMAN 5.75800529924034 4.7 4.7925 2 78 kDa glucose-regulated protein (GRP-78) (Endoplasmic reticulum lumenal Ca(2+)-binding protein grp78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP), 78 kDa glucose-regulated protein (GRP-78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 NRAM 1 0 NA NRAM_I34A1 4.54400224714056 4.7 4.7 1 Neuraminidase (EC 3.2.1.18) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 AOFA 10 0 MAOA AOFA_HUMAN 4.69853961855066 4.7 4.7 10 Amine oxidase [flavin-containing] A (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 AOFB 10 0 MAOB AOFB_HUMAN 4.69853961855066 4.7 4.7 10 Amine oxidase [flavin-containing] B (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 GEMI 1 0 GMNN GEMI_HUMAN 6.38626385873813 4.7 4.7 1 Geminin 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 ATX2 1 0 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 5.14999741390754 4.7 4.7 1 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 TPO 2 0 THPO MGDF TPO_HUMAN 5.6 4.7 4.67916666666667 2 Thrombopoietin (C-mpl ligand) (ML) (Megakaryocyte colony-stimulating factor) (Megakaryocyte growth and development factor) (MGDF) (Myeloproliferative leukemia virus oncogene ligand) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 DHB1 1 0 HSD17B1 E17KSR EDH17B1 EDH17B2 EDHB17 SDR28C1 DHB1_HUMAN 4.73115468770742 4.7 4.7 1 Estradiol 17-beta-dehydrogenase 1 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 1) (17-beta-HSD 1), Estradiol 17-beta-dehydrogenase 1 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 1) (17-beta-HSD 1) (20 alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (E2DH) (Placental 17-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 28C member 1) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 UD11 5 0 UGT1A1 GNT1 UGT1 UD11_HUMAN 4.81216375079048 4.7 4.7 5 UDP-glucuronosyltransferase 1-1 (UDPGT 1-1) (UGT1*1) (UGT1-01) (UGT1.1) (EC 2.4.1.17) (Bilirubin-specific UDPGT isozyme 1) (hUG-BR1) (UDP-glucuronosyltransferase 1-A) (UGT-1A) (UGT1A) (UDP-glucuronosyltransferase 1A1) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 SO2B1 1 0 SLCO2B1 KIAA0880 OATP2B1 OATPB SLC21A9 SO2B1_HUMAN 4.67264106561367 4.7 4.7 1 Solute carrier organic anion transporter family member 2B1 (Organic anion transporter B) (OATP-B) (Organic anion transporter polypeptide-related protein 2) (OATP-RP2) (OATPRP2) (Solute carrier family 21 member 9), Solute carrier organic anion transporter family member 2B1 (Organic anion transporter moatp1) (Solute carrier family 21 member 9) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 NPC1 1 0 NPC1 NPC1_HUMAN 5.04 4.7 4.7 1 Niemann-Pick C1 protein 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 THB 1 0 THRB ERBA2 NR1A2 THR1 THB_HUMAN 4.65000022087346 4.7 4.7 1 Thyroid hormone receptor beta (Nuclear receptor subfamily 1 group A member 2) (c-erbA-2) (c-erbA-beta) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 CP2C9 2 0 CYP2C9 CYP2C10 CP2C9_HUMAN 5.2 4.7 4.7 2 Cytochrome P450 2C9 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (EC 1.14.99.38) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 CAH2 1 0 CA2 CAH2_HUMAN 5 4.7 4.7 1 Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II), Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 SO1B1 1 0 SLCO1B1 LST1 OATP1B1 OATP2 OATPC SLC21A6 SO1B1_HUMAN 4.73115468770742 4.7 4.7 1 Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 CAH1 1 0 CA1 CAH1_HUMAN 5 4.7 4.7 1 Carbonic anhydrase 1 (EC 4.2.1.1) (Carbonate dehydratase I) (Carbonic anhydrase B) (CAB) (Carbonic anhydrase I) (CA-I) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 CAH4 1 0 CA4 CAH4_HUMAN 6.14 4.7 4.7 1 Carbonic anhydrase 4 (EC 4.2.1.1) (Carbonate dehydratase IV) (Carbonic anhydrase IV) (CA-IV) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 Q965D7 1 0 fabZ Q965D7_PLAFA 4.52 4.7 4.7 1 Beta-hydroxyacyl-ACP dehydratase (Fatty acid synthesis protein) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 PPARD 1 0 PPARD NR1C2 PPARB PPARD_HUMAN 4.84999924507786 4.7 4.7 1 Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 43740 SMN 0 2 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.85 4.85 4.85 2 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 LPXC 0 1 lpxC asmB envA b0096 JW0094 LPXC_ECOLI 5 4.85 4.85 1 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 UDP-3-O-acyl-N-acetylglucosamine deacetylase (UDP-3-O-acyl-GlcNAc deacetylase) (EC 3.5.1.108) (Protein EnvA) (UDP-3-O-[R-3-hydroxymyristoyl]-N-acetylglucosamine deacetylase), UDP-3-O-acyl-N-acetylglucosamine deacetylase (UDP-3-O-acyl-GlcNAc deacetylase) (EC 3.5.1.108) (UDP-3-O-[R-3-hydroxymyristoyl]-N-acetylglucosamine deacetylase) 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 NMDE1 0 7 Grin2a NMDE1_RAT 5.64 4.85 4.85 7 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 Glutamate receptor ionotropic, NMDA 2A (GluN2A) (Glutamate [NMDA] receptor subunit epsilon-1) (N-methyl D-aspartate receptor subtype 2A) (NMDAR2A) (NR2A), Glutamate receptor ionotropic, NMDA 2A (GluN2A) (Glutamate [NMDA] receptor subunit epsilon-1) (N-methyl D-aspartate receptor subtype 2A) (NMDAR2A) (NR2A) (hNR2A) 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 NMDE4 0 7 Grin2d GluN2D NMDE4_RAT 5.64 4.85 4.85 7 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 Glutamate receptor ionotropic, NMDA 2D (GluN2D) (EB11) (Glutamate [NMDA] receptor subunit epsilon-4) (N-methyl D-aspartate receptor subtype 2D) (NMDAR2D) (NR2D), Glutamate receptor ionotropic, NMDA 2D (GluN2D) (Glutamate [NMDA] receptor subunit epsilon-4) (N-methyl D-aspartate receptor subtype 2D) (NMDAR2D) (NR2D) 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 NMDZ1 0 8 Grin1 Nmdar1 NMDZ1_RAT 5.57625 4.85 4.85 8 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 Glutamate receptor ionotropic, NMDA 1 (GluN1) (Glutamate [NMDA] receptor subunit zeta-1) (N-methyl-D-aspartate receptor subunit NR1) (NMD-R1), Glutamate receptor ionotropic, NMDA 1 (GluN1) (N-methyl-D-aspartate receptor subunit NR1) (NMD-R1) 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 NMD3A 0 7 Grin3a NMD3A_RAT 5.64 4.85 4.85 7 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 Glutamate receptor ionotropic, NMDA 3A (GluN3A) (Glutamate receptor chi-1) (N-methyl-D-aspartate receptor) (N-methyl-D-aspartate receptor subtype 3A) (NMDAR3A) (NR3A) (NMDAR-L) (NMDAR-L1), Glutamate receptor ionotropic, NMDA 3A (GluN3A) (N-methyl-D-aspartate receptor subtype 3A) (NMDAR3A) (NR3A) (NMDAR-L) 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 NMD3B 0 7 Grin3b NMD3B_RAT 5.64 4.85 4.85 7 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 Glutamate receptor ionotropic, NMDA 3B (GluN3B) (N-methyl-D-aspartate receptor subtype 3B) (NMDAR3B) (NR3B) 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 NMDE3 0 8 Grin2c NMDE3_RAT 5.5275 4.85 4.85 8 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 Glutamate receptor ionotropic, NMDA 2C (GluN2C) (Glutamate [NMDA] receptor subunit epsilon-3) (N-methyl D-aspartate receptor subtype 2C) (NMDAR2C) (NR2C) 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 NMDE2 0 7 Grin2b NMDE2_RAT 5.64 4.85 4.85 7 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 Glutamate receptor ionotropic, NMDA 2B (GluN2B) (Glutamate [NMDA] receptor subunit epsilon-2) (N-methyl D-aspartate receptor subtype 2B) (NMDAR2B) (NR2B), Glutamate receptor ionotropic, NMDA 2B (GluN2B) (Glutamate [NMDA] receptor subunit epsilon-2) (N-methyl D-aspartate receptor subtype 2B) (NMDAR2B) (NR2B) (N-methyl-D-aspartate receptor subunit 3) (NR3) (hNR3) 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 RGS4 0 1 RGS4 RGS4_HUMAN 6.27384353382724 4.85 4.85 1 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 Regulator of G-protein signaling 4 (RGP4) (RGS4) 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 DDLB 0 3 ddlB ddl b0092 JW0090 DDLB_ECOLI 5 4.85 4.85 3 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 D-alanine--D-alanine ligase B (EC 6.3.2.4) (D-Ala-D-Ala ligase B) (D-alanylalanine synthetase B) 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 5.2 4.85 4.85 1 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 HIF1A 0 2 HIF1A BHLHE78 MOP1 PASD8 HIF1A_HUMAN 5.8 4.85 4.85 2 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein), Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 KMT2A 0 4 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.85 4.85 4.85 4 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 MEN1 0 4 MEN1 SCG2 MEN1_HUMAN 4.85 4.85 4.85 4 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 Menin 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 EHMT2 0 3 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 4.59999998775496 4.85 4.85 3 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 TSHR 0 8 TSHR LGR3 TSHR_HUMAN 5.4 4.85 4.85 8 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R) 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 PPARD 0 2 PPARD NR1C2 PPARB PPARD_HUMAN 4.67509864867999 4.85 4.85 2 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 CBX1 0 1 CBX1 CBX CBX1_HUMAN 5.07382224601261 4.85 4.85 1 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 Chromobox protein homolog 1 (HP1Hsbeta) (Heterochromatin protein 1 homolog beta) (HP1 beta) (Heterochromatin protein p25) (M31) (Modifier 1 protein) (p25beta) 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 MK01 0 1 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 5.3 4.85 4.85 1 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 543263 0 72 NotRecorded 5.14491555654766 5.05 5.12842085561247 72 1 5.05 actual molregno [molregno] Cl.NNc1nncc2ccccc12 543263 KDM4E 0 2 KDM4E KDM4DL KDM4E_HUMAN 4.575 5.05 5.295 2 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 5.05 actual molregno [molregno] Cl.NNc1nncc2ccccc12 543263 TAU 0 3 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.18333333333333 5.05 5.14625 3 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5.05 actual molregno [molregno] Cl.NNc1nncc2ccccc12 543263 O97447 0 2 ald O97447_GIAIN 4.95 5.05 5.34166666666667 2 Putative fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) 1 5.05 actual molregno [molregno] Cl.NNc1nncc2ccccc12 543263 APEX1 0 1 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 6.64994590642097 5.05 5.26145833333333 1 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 1 5.05 actual molregno [molregno] Cl.NNc1nncc2ccccc12 543263 RORG 0 2 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.925 5.05 5.18708333333333 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 5.05 actual molregno [molregno] Cl.NNc1nncc2ccccc12 543263 SMN 0 2 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.05 5.05 5.35625 2 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.05 actual molregno [molregno] Cl.NNc1nncc2ccccc12 543263 SO1B1 0 1 SLCO1B1 LST1 OATP1B1 OATP2 OATPC SLC21A6 SO1B1_HUMAN 5.8546696880553 5.05 5.24322916666667 1 Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6) 1 5.05 actual molregno [molregno] Cl.NNc1nncc2ccccc12 543263 KCNH2 0 1 KCNH2 ERG ERG1 HERG KCNH2_HUMAN 4.74999985591871 5.05 5.05 1 Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (DERG) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (c-ERG) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (RERG) (ra-erg) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (gp-erg) (Voltage-gated potassium channel subunit Kv11.1) (Fragment) 1 5.05 actual molregno [molregno] Cl.NNc1nncc2ccccc12 543263 P53 0 2 TP53 P53 P53_HUMAN 5.05 5.05 5.15208333333333 2 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 5.05 actual molregno [molregno] Cl.NNc1nncc2ccccc12 543263 NF2L2 0 2 NFE2L2 NRF2 NF2L2_HUMAN 5.10003828433404 5.05 5.07916666666667 2 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.05 actual molregno [molregno] Cl.NNc1nncc2ccccc12 543263 ANDR 0 3 AR DHTR NR3C4 ANDR_HUMAN 4.90617136738789 5.05 5.10833333333333 3 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 1 5.05 actual molregno [molregno] Cl.NNc1nncc2ccccc12 543263 CHLE 0 3 BCHE CHLE_HORSE 5.34 5.05 5.150625 3 Cholinesterase (EC 3.1.1.8) (Acylcholine acylhydrolase) (Butyrylcholine esterase) (Choline esterase II) (EQ-BCHE) (Pseudocholinesterase), Cholinesterase (EC 3.1.1.8) (Acylcholine acylhydrolase) (Butyrylcholine esterase) (Choline esterase II) (Pseudocholinesterase) 1 5.05 actual molregno [molregno] Cl.NNc1nncc2ccccc12 543263 ACES 0 2 ache ACES_ELEEL 5.075 5.05 5.071875 2 Acetylcholinesterase (AChE) (EC 3.1.1.7), Acetylcholinesterase (AChE) (EC 3.1.1.7) [Cleaved into: Acetylcholinesterase 16 kDa subunit; Acetylcholinesterase 55 kDa subunit] 1 5.05 actual molregno [molregno] Cl.NNc1nncc2ccccc12 3665 PGDH 0 3 HPGD PGDH1 SDR36C1 PGDH_HUMAN 5.05 4.9 4.90000000000001 3 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 Q7ZJM1 0 5 pol Q7ZJM1_9HIV1 5.618 4.9 4.9 5 Integrase (Fragment) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 NEP 0 1 Mme NEP_RAT 4.7501225267834 4.9 4.90000000000001 1 Neprilysin (EC 3.4.24.11) (Atriopeptidase) (Common acute lymphocytic leukemia antigen) (CALLA) (Enkephalinase) (Neutral endopeptidase 24.11) (NEP) (Neutral endopeptidase) (Skin fibroblast elastase) (SFE) (CD antigen CD10), Neprilysin (EC 3.4.24.11) (Atriopeptidase) (Enkephalinase) (Neutral endopeptidase 24.11) (NEP) (Neutral endopeptidase) (Skin fibroblast elastase) (SFE) (CD antigen CD10), Neprilysin (EC 3.4.24.11) (Atriopeptidase) (Enkephalinase) (Neutral endopeptidase 24.11) (NEP) (Neutral endopeptidase) (Skin fibroblast elastase) (SFE) (CD antigen CD10) (Fragment) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 BLM 0 2 BLM RECQ2 RECQL3 BLM_HUMAN 5 4.9 4.90000000000001 2 Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 TAU 0 9 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.8 4.9 4.90000000000001 9 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 TNFA 0 1 Tnf Tnfa Tnfsf2 TNFA_MOUSE 5.39520763311787 4.9 4.90000000000001 1 Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form] 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 LOX12 0 3 ALOX12 12LO LOG12 LOX12_HUMAN 5.77333333333333 4.9 4.9 3 Arachidonate 12-lipoxygenase, 12S-type (12S-LOX) (12S-lipoxygenase) (EC 1.13.11.31) (Lipoxin synthase 12-LO) (EC 3.3.2.-) (Platelet-type lipoxygenase 12), Arachidonate 12-lipoxygenase, 12S-type (12S-LOX) (12S-lipoxygenase) (EC 1.13.11.31) (Lipoxin synthase 12-LO) (EC 3.3.2.-) (Platelet-type lipoxygenase 12) (P-12LO) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 O97447 0 3 ald O97447_GIAIN 5.13333333333333 4.9 4.90500000000001 3 Putative fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 AMPN 0 1 ANPEP AMPN_PIG 5.1224064000929 4.9 4.90000000000001 1 Aminopeptidase N (AP-N) (bAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (CD antigen CD13), Aminopeptidase N (AP-N) (hAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (Myeloid plasma membrane glycoprotein CD13) (gp150) (CD antigen CD13), Aminopeptidase N (AP-N) (mAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Membrane protein p161) (Microsomal aminopeptidase) (CD antigen CD13), Aminopeptidase N (AP-N) (pAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (gp130) (CD antigen CD13), Aminopeptidase N (AP-N) (rAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Kidney Zn peptidase) (KZP) (Microsomal aminopeptidase) (CD antigen CD13), Aminopeptidase N (EC 3.4.11.2) (Alpha-aminoacylpeptide hydrolase) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 POLH 0 2 POLH RAD30 RAD30A XPV POLH_HUMAN 5.16048986040405 4.9 4.90000000000001 2 DNA polymerase eta (EC 2.7.7.7) (RAD30 homolog A) (Xeroderma pigmentosum variant type protein) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 BRCA1 0 2 BRCA1 RNF53 BRCA1_HUMAN 5.07499838464549 4.9 4.90000000000001 2 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 APEX1 0 5 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 5.76476904778231 4.9 4.9 5 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 HCD2 0 3 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 5.56666666666667 4.9 4.9 3 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 LGUL 0 1 GLO1 LGUL_HUMAN 4.96 4.9 4.90000000000001 1 Lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Glyoxalase I) (Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 RORG 0 4 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.75 4.9 4.90000000000001 4 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.90000000000001 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 GBRA2 0 16 GABRA2 GBRA2_HUMAN 5.25 4.9 4.9 16 Gamma-aminobutyric acid receptor subunit alpha-2 (GABA(A) receptor subunit alpha-2) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 GBRA6 0 16 GABRA6 GBRA6_HUMAN 5.25 4.9 4.9 16 Gamma-aminobutyric acid receptor subunit alpha-6 (GABA(A) receptor subunit alpha-6) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 GBRB1 0 16 GABRB1 GBRB1_HUMAN 5.25 4.9 4.9 16 Gamma-aminobutyric acid receptor subunit beta-1 (GABA(A) receptor subunit beta-1) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 GBRG2 0 16 GABRG2 GBRG2_HUMAN 5.25 4.9 4.9 16 Gamma-aminobutyric acid receptor subunit gamma-2 (GABA(A) receptor subunit gamma-2) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 GBRB2 0 16 GABRB2 GBRB2_HUMAN 5.25 4.9 4.9 16 Gamma-aminobutyric acid receptor subunit beta-2 (GABA(A) receptor subunit beta-2) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 GBRP 0 16 GABRP GBRP_HUMAN 5.25 4.9 4.9 16 Gamma-aminobutyric acid receptor subunit pi (GABA(A) receptor subunit pi) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 GBRA3 0 16 GABRA3 GBRA3_HUMAN 5.25 4.9 4.9 16 Gamma-aminobutyric acid receptor subunit alpha-3 (GABA(A) receptor subunit alpha-3) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 GBRG1 0 16 GABRG1 GBRG1_HUMAN 5.25 4.9 4.9 16 Gamma-aminobutyric acid receptor subunit gamma-1 (GABA(A) receptor subunit gamma-1) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 GBRE 0 16 GABRE GBRE_HUMAN 5.25 4.9 4.9 16 Gamma-aminobutyric acid receptor subunit epsilon (GABA(A) receptor subunit epsilon) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 GBRG3 0 16 GABRG3 GBRG3_HUMAN 5.25 4.9 4.9 16 Gamma-aminobutyric acid receptor subunit gamma-3 (GABA(A) receptor subunit gamma-3) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 GBRA5 0 16 GABRA5 GBRA5_HUMAN 5.25 4.9 4.9 16 Gamma-aminobutyric acid receptor subunit alpha-5 (GABA(A) receptor subunit alpha-5) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 GBRD 0 16 GABRD GBRD_HUMAN 5.25 4.9 4.9 16 Gamma-aminobutyric acid receptor subunit delta (GABA(A) receptor subunit delta) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 GBRA4 0 16 GABRA4 GBRA4_HUMAN 5.25 4.9 4.9 16 Gamma-aminobutyric acid receptor subunit alpha-4 (GABA(A) receptor subunit alpha-4) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 GBRA1 0 16 GABRA1 GBRA1_HUMAN 5.25 4.9 4.9 16 Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) receptor subunit alpha-1) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 GBRB3 0 16 GABRB3 GBRB3_HUMAN 5.25 4.9 4.9 16 Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 GBRT 0 16 GABRQ GBRT_HUMAN 5.25 4.9 4.9 16 Gamma-aminobutyric acid receptor subunit theta (GABA(A) receptor subunit theta) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 POLK 0 4 POLK DINB1 POLK_HUMAN 5.48750277991044 4.9 4.9 4 DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.43639347275721 4.9 4.90000000000001 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 KDM4E 0 6 KDM4E KDM4DL KDM4E_HUMAN 5.41666666666667 4.9 4.9 6 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 P53 0 2 TP53 P53 P53_HUMAN 5.8 4.9 4.90000000000001 2 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 FFP 0 2 ffp sfp FFP_BACIU 4.75 4.9 4.90000000000001 2 4'-phosphopantetheinyl transferase ffp (EC 2.7.8.-) (Fengycin synthase-activating enzyme) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 LOX15 0 5 ALOX15 LOG15, Alox15 Alox12l LOX15_HUMAN, LOX15_RAT 5.956 4.9 4.9 5 Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (12/15-LO) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Probable linoleate 9S-lipoxygenase 5 (EC 1.13.11.58) (Leaf lipoxygenase) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 XDH 0 3 XDH, XDH XDHA XDH_BOVIN, XDH_HUMAN 5.60019937083107 4.9 4.9 3 Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)] 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 CYSP 0 1 CYSP_TRYCR 4.6 4.9 4.90000000000001 1 Cruzipain (EC 3.4.22.51) (Cruzaine) (Major cysteine proteinase), Trophozoite cysteine proteinase (TCP) (EC 3.4.22.-) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 RECQ1 0 3 RECQL RECQ1 RECQL1 RECQ1_HUMAN 4.88333333333333 4.9 4.90000000000001 3 ATP-dependent DNA helicase Q1 (EC 3.6.4.12) (DNA helicase, RecQ-like type 1) (RecQ1) (DNA-dependent ATPase Q1) (RecQ protein-like 1) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 CP1A1 0 1 CYP1A1 CP1A1_HUMAN 5.91 4.9 4.9 1 Cytochrome P450 1A1 (CYP1A1) (EC 1.14.14.1) (CYPIA1) (Cytochrome P450-C) (Cytochrome P450MT2) [Cleaved into: Cytochrome P450MT2A; Cytochrome P450MT2B], Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1), Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450-P1) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 FLT3 0 1 FLT3 CD135 FLK2 STK1 FLT3_HUMAN 5 4.9 4.90000000000001 1 Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase 2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Tyrosine-protein kinase receptor flk-2) (CD antigen CD135), Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase-2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Stem cell tyrosine kinase 1) (STK-1) (CD antigen CD135) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 LX15B 0 2 ALOX15B LX15B_HUMAN 4.54999951742326 4.9 4.90000000000001 2 Arachidonate 15-lipoxygenase B (15-LOX-B) (EC 1.13.11.33) (15-lipoxygenase 2) (15-LOX-2) (Arachidonate 15-lipoxygenase type II) (Linoleate 13-lipoxygenase 15-LOb) (EC 1.13.11.-) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 AL1A1 0 2 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.885 4.9 4.90000000000001 2 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 PIN1 0 1 PIN1 PIN1_HUMAN 4.84999924507786 4.9 4.90000000000001 1 Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase Pin1) (PPIase Pin1) (Rotamase Pin1) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 PFKA 0 3 pfk PFKA_TRYBB 5.32098012328077 4.9 4.90083333333334 3 ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 RUNX1 0 2 RUNX1 AML1 CBFA2 RUNX1_HUMAN 4.89999841719865 4.9 4.9 2 Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 PEBB 0 2 CBFB PEBB_HUMAN 4.89999841719865 4.9 4.9 2 Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 TRY3 0 3 PRSS3 PRSS4 TRY3 TRY4 TRY3_HUMAN 5.43 4.9 4.90000000000001 3 Trypsin-3 (EC 3.4.21.4) (Brain trypsinogen) (Mesotrypsinogen) (Serine protease 3) (Serine protease 4) (Trypsin III) (Trypsin IV) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 TRY2 0 3 PRSS2 TRY2 TRYP2 TRY2_HUMAN 5.43 4.9 4.90000000000001 3 Anionic trypsin (EC 3.4.21.4), Anionic trypsin-2 (EC 3.4.21.4) (Anionic trypsin II) (Pretrypsinogen II) (Serine protease 2), Trypsin-2 (EC 3.4.21.4) (Anionic trypsinogen) (Serine protease 2) (Trypsin II) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 TRY1 0 3 PRSS1 TRP1 TRY1 TRYP1 TRY1_HUMAN 5.43 4.9 4.90000000000001 3 Anionic trypsin-1 (EC 3.4.21.4) (Anionic trypsin I) (Pretrypsinogen I) (Serine protease 1), Cationic trypsin (EC 3.4.21.4) (Beta-trypsin) [Cleaved into: Alpha-trypsin chain 1; Alpha-trypsin chain 2], Trypsin-1 (EC 3.4.21.4) (Beta-trypsin) (Cationic trypsinogen) (Serine protease 1) (Trypsin I) [Cleaved into: Alpha-trypsin chain 1; Alpha-trypsin chain 2], Trypsin-1 (EC 3.4.21.4) (Trypsin I) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 CP1B1 0 1 CYP1B1 CP1B1_HUMAN 6.59 4.9 4.9 1 Cytochrome P450 1B1 (EC 1.14.14.1) (CYPIB1) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 UD11 0 2 UGT1A1 GNT1 UGT1 UD11_HUMAN 5.255 4.9 4.90000000000001 2 UDP-glucuronosyltransferase 1-1 (UDPGT 1-1) (UGT1*1) (UGT1-01) (UGT1.1) (EC 2.4.1.17) (Bilirubin-specific UDPGT isozyme 1) (hUG-BR1) (UDP-glucuronosyltransferase 1-A) (UGT-1A) (UGT1A) (UDP-glucuronosyltransferase 1A1) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 LEF 0 2 lef pXO1-107 BXA0172 GBAA_pXO1_0172 LEF_BACAN 5.4 4.9 4.90000000000001 2 Lethal factor (LF) (EC 3.4.24.83) (Anthrax lethal toxin endopeptidase component) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 SO1B3 0 1 SLCO1B3 LST2 OATP1B3 OATP8 SLC21A8 SO1B3_HUMAN 5.96374710820806 4.9 4.9 1 Solute carrier organic anion transporter family member 1B3 (Liver-specific organic anion transporter 2) (LST-2) (Organic anion transporter 8) (Organic anion-transporting polypeptide 8) (OATP-8) (Solute carrier family 21 member 8) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 MGA 0 1 MGAM MGA MGAML MGA_HUMAN 5 4.9 4.90000000000001 1 Maltase-glucoamylase, intestinal [Includes: Maltase (EC 3.2.1.20) (Alpha-glucosidase); Glucoamylase (EC 3.2.1.3) (Glucan 1,4-alpha-glucosidase)] 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 FEN1 0 2 FEN1 RAD2 FEN1_HUMAN 4.60000016617202 4.9 4.90000000000001 2 Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (DNase IV) (Flap structure-specific endonuclease 1) (Maturation factor 1) (MF1) (hFEN-1) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 DYR1A 0 1 Dyrk1a Dyrk DYR1A_RAT 4.84 4.9 4.90000000000001 1 Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.1) (Dual specificity YAK1-related kinase) (HP86) (Protein kinase minibrain homolog) (MNBH) (hMNB), Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.1) (Dual specificity YAK1-related kinase) (MP86) (Protein kinase minibrain homolog) (MNBH), Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.2) (Dual specificity YAK1-related kinase) (Protein kinase minibrain homolog) (MNBH) (RP86) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 EGLN1 0 2 EGLN1 C1orf12 PNAS-118 PNAS-137 EGLN1_HUMAN 5 4.9 4.90000000000001 2 Egl nine homolog 1 (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 2) (HIF-PH2) (HIF-prolyl hydroxylase 2) (HPH-2) (Prolyl hydroxylase domain-containing protein 2) (PHD2) (Fragment), Egl nine homolog 1 (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 2) (HIF-PH2) (HIF-prolyl hydroxylase 2) (HPH-2) (Prolyl hydroxylase domain-containing protein 2) (PHD2) (SM-20) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 LYAM2 0 1 SELE ELAM1 LYAM2_HUMAN 4.78000325524524 4.9 4.90000000000001 1 E-selectin (CD62 antigen-like family member E) (Endothelial leukocyte adhesion molecule 1) (ELAM-1) (Leukocyte-endothelial cell adhesion molecule 2) (LECAM2) (CD antigen CD62E) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 LYAM3 0 1 SELP GMRP GRMP LYAM3_HUMAN 5.03476210625921 4.9 4.90000000000001 1 P-selectin (CD62 antigen-like family member P) (Granule membrane protein 140) (GMP-140) (Leukocyte-endothelial cell adhesion molecule 3) (LECAM3) (Platelet activation dependent granule-external membrane protein) (PADGEM) (CD antigen CD62P) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 HIF1N 0 1 HIF1AN FIH1 HIF1N_HUMAN 5 4.9 4.90000000000001 1 Hypoxia-inducible factor 1-alpha inhibitor (EC 1.14.11.30) (EC 1.14.11.n4) (Factor inhibiting HIF-1) (FIH-1) (Hypoxia-inducible factor asparagine hydroxylase) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 ANDR 0 1 AR DHTR NR3C4 ANDR_HUMAN 4.72353819582676 4.9 4.90000000000001 1 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 LYAM1 0 1 SELL LNHR LYAM1 LYAM1_HUMAN 5.02954341234243 4.9 4.90000000000001 1 L-selectin (CD62 antigen-like family member L) (Leukocyte adhesion molecule 1) (LAM-1) (Leukocyte surface antigen Leu-8) (Leukocyte-endothelial cell adhesion molecule 1) (LECAM1) (Lymph node homing receptor) (TQ1) (gp90-MEL) (CD antigen CD62L) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 LMBL1 0 1 L3MBTL1 KIAA0681 L3MBT L3MBTL LMBL1_HUMAN 4.8 4.9 4.90000000000001 1 Lethal(3)malignant brain tumor-like protein 1 (H-l(3)mbt) (H-l(3)mbt protein) (L(3)mbt-like) (L(3)mbt protein homolog) (L3MBTL1) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 PPCE 0 7 PREP PEP PPCE_HUMAN 5.25114234840405 4.9 4.90000000000001 7 Prolyl endopeptidase (EC 3.4.21.26) (Post-proline cleaving enzyme) (Proline-specific endopeptidase) (PE) (PSE), Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme), Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme) (rPop) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 GEMI 0 1 GMNN GEMI_HUMAN 5.7862167006647 4.9 4.9 1 Geminin 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 SO1B1 0 1 SLCO1B1 LST1 OATP1B1 OATP2 OATPC SLC21A6 SO1B1_HUMAN 6.008119891066 4.9 4.9 1 Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 LOX5 0 3 ALOX5 LOG5, Alox5 LOX5_HUMAN, LOX5_RAT 4.50617131329263 4.9 4.90000000000001 3 Arachidonate 5-lipoxygenase (5-LO) (5-lipoxygenase) (EC 1.13.11.34) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 CDK1 0 1 CDK1 CDC2 CDC28A CDKN1 P34CDC2 CDK1_HUMAN 5.19 4.9 4.90000000000001 1 Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (Cell division control protein 28) (Cell division protein kinase 1), Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 CP1A2 0 1 CYP1A2 CP1A2_HUMAN 6.3 4.9 4.9 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 WRN 0 1 WRN RECQ3 RECQL2 WRN_HUMAN 5.27381905802915 4.9 4.90000000000001 1 Werner syndrome ATP-dependent helicase (EC 3.6.4.12) (DNA helicase, RecQ-like type 3) (RecQ3) (Exonuclease WRN) (EC 3.1.-.-) (RecQ protein-like 2) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 4421 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.75 5.75 5.75 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.75 actual molregno [molregno] O=C(NCCCn1ccnc1)c2occc2 4421 KDM4A 0 3 KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 KDM4A_HUMAN 4.65000022087346 5.75 5.75 3 Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) 1 5.75 actual molregno [molregno] O=C(NCCCn1ccnc1)c2occc2 4421 TSHR 0 4 TSHR LGR3 TSHR_HUMAN 5.4 5.75 5.75 4 Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R) 1 5.75 actual molregno [molregno] O=C(NCCCn1ccnc1)c2occc2 4421 0 4 NotRecorded 4.84406061900451 5.75 5.27734375 4 1 5.75 actual molregno [molregno] O=C(NCCCn1ccnc1)c2occc2 4421 THAS 0 1 Tbxas1 Cyp5 Cyp5a1 THAS_RAT 6.50965047954658 5.75 5.425 1 Thromboxane-A synthase (TXA synthase) (TXS) (EC 5.3.99.5) (Cytochrome P450 5A1) 1 5.75 actual molregno [molregno] O=C(NCCCn1ccnc1)c2occc2 7160 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 4.94999940171424 5 5 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 5 actual molregno [molregno] Clc1ccccc1NC2=Nc3ccccc3C(=O)O2 7160 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5 5 5 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5 actual molregno [molregno] Clc1ccccc1NC2=Nc3ccccc3C(=O)O2 7160 0 11 Aberrant vpr protein, NotRecorded 4.76971582294727 5 4.98863636363636 11 1 5 actual molregno [molregno] Clc1ccccc1NC2=Nc3ccccc3C(=O)O2 7160 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.71139001277257 5 5 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5 actual molregno [molregno] Clc1ccccc1NC2=Nc3ccccc3C(=O)O2 7160 C1R 0 2 C1R C1R_HUMAN 5.145 5 5 2 Complement C1r subcomponent (EC 3.4.21.41) (Complement component 1 subcomponent r) [Cleaved into: Complement C1r subcomponent heavy chain; Complement C1r subcomponent light chain] 1 5 actual molregno [molregno] Clc1ccccc1NC2=Nc3ccccc3C(=O)O2 7160 LUCI 0 1 LUCI_PHOPY 4.82098278885978 5 5 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5 actual molregno [molregno] Clc1ccccc1NC2=Nc3ccccc3C(=O)O2 7160 NPC1 0 1 NPC1 NPC1_HUMAN 5.45 5 5 1 Niemann-Pick C1 protein 1 5 actual molregno [molregno] Clc1ccccc1NC2=Nc3ccccc3C(=O)O2 7160 RAB9A 1 0 RAB9A RAB9 RAB9A_HUMAN 6.35 5 4.665625 1 Ras-related protein Rab-9A 0 5 actual molregno [molregno] Clc1ccccc1NC2=Nc3ccccc3C(=O)O2 8715 HYEP 0 2 EPHX1 EPHX EPOX, Ephx1 HYEP_HUMAN, HYEP_MOUSE 6.56 4.95 4.965 2 Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) (mEH) 1 4.95 actual molregno [molregno] Clc1ccc(NC(=O)NC2CCCCC2)cc1 8715 0 5 NotRecorded 4.80888801976042 4.95 4.96208333333333 5 1 4.95 actual molregno [molregno] Clc1ccc(NC(=O)NC2CCCCC2)cc1 8715 CP2C9 0 1 CYP2C9 CYP2C10 CP2C9_HUMAN 4.9 4.95 4.95 1 Cytochrome P450 2C9 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (EC 1.14.99.38) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase) 1 4.95 actual molregno [molregno] Clc1ccc(NC(=O)NC2CCCCC2)cc1 8715 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.93621268968233 4.95 4.95 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.95 actual molregno [molregno] Clc1ccc(NC(=O)NC2CCCCC2)cc1 8715 AMPC 0 1 ampC ampA b4150 JW4111 AMPC_ECOLI 5.1 4.95 4.95 1 Beta-lactamase (EC 3.5.2.6) (Cephalosporinase) 1 4.95 actual molregno [molregno] Clc1ccc(NC(=O)NC2CCCCC2)cc1 8715 NPC1 0 1 NPC1 NPC1_HUMAN 5.95 4.95 4.95 1 Niemann-Pick C1 protein 1 4.95 actual molregno [molregno] Clc1ccc(NC(=O)NC2CCCCC2)cc1 8715 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 4.8000008748032 4.95 4.95 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.95 actual molregno [molregno] Clc1ccc(NC(=O)NC2CCCCC2)cc1 8715 RORG 0 1 Rorc Nr1f3 Rorg Thor RORG_MOUSE 6.05 4.95 4.95 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.95 actual molregno [molregno] Clc1ccc(NC(=O)NC2CCCCC2)cc1 8715 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 5.90000876645532 4.95 4.95 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 4.95 actual molregno [molregno] Clc1ccc(NC(=O)NC2CCCCC2)cc1 8715 LUCI 0 1 LUCI_PHOPY 5.62098471330652 4.95 4.95 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.95 actual molregno [molregno] Clc1ccc(NC(=O)NC2CCCCC2)cc1 8715 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.6 4.95 4.95 1 Ras-related protein Rab-9A 1 4.95 actual molregno [molregno] Clc1ccc(NC(=O)NC2CCCCC2)cc1 8715 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.95 4.95 4.95 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.95 actual molregno [molregno] Clc1ccc(NC(=O)NC2CCCCC2)cc1 8715 CP2CJ 0 1 CYP2C19 CP2CJ_HUMAN 5.05 4.95 4.95 1 Cytochrome P450 2C19 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Mephenytoin 4-hydroxylase) 1 4.95 actual molregno [molregno] Clc1ccc(NC(=O)NC2CCCCC2)cc1 8788 LUCI 0 3 LUCI_PHOPY 5.80356609916456 5.4 5.34798611111111 3 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 ATX2 0 1 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 6.34998404752816 5.4 5.3890625 1 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 TPO 0 2 THPO MGDF TPO_HUMAN 7.4 5.4 5.3365625 2 Thrombopoietin (C-mpl ligand) (ML) (Megakaryocyte colony-stimulating factor) (Megakaryocyte growth and development factor) (MGDF) (Myeloproliferative leukemia virus oncogene ligand) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 LOX15 0 1 ALOX15 LOX15_RABIT 5.44 5.4 5.12875 1 Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (12/15-LO) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Probable linoleate 9S-lipoxygenase 5 (EC 1.13.11.58) (Leaf lipoxygenase) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 4.9 5.4 5.3125 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 AOXA 0 1 AOX1 AO AOXA_HUMAN 6.38021124171161 5.4 5.37139423076923 1 Aldehyde oxidase (EC 1.2.3.1) (Aldehyde oxidase 1) (Azaheterocycle hydroxylase) (EC 1.17.3.-), Aldehyde oxidase 1 (EC 1.2.3.1) (Azaheterocycle hydroxylase 1) (EC 1.17.3.-), Aldehyde oxidase 1 (EC 1.2.3.1) (Azaheterocycle hydroxylase 1) (EC 1.17.3.-) (Retinal oxidase), Aldehyde oxidase 1 (EC 1.2.3.1) (Azaheterocycle hydroxylase 1) (EC 1.17.3.-) (Retinal oxidase) (Retinoic acid synthase) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 P53 0 4 TP53 P53 P53_HUMAN 5.6 5.4 5.34950520833333 4 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 FFP 0 3 ffp sfp FFP_BACIU 4.65928124241724 5.4 5.39416666666667 3 4'-phosphopantetheinyl transferase ffp (EC 2.7.8.-) (Fengycin synthase-activating enzyme) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 TRXR1 0 2 Txnrd1 Trxr1 TRXR1_RAT 4.72382322328385 5.4 5.27458333333334 2 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.4 5.4 5.4 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 PMP22 0 1 Pmp22 Cd25 Pmp-22 PMP22_RAT 7.46092390120722 5.4 5.3671875 1 Peripheral myelin protein 22 (PMP-22) (Growth arrest-specific protein 3) (GAS-3), Peripheral myelin protein 22 (PMP-22) (Protein CD25) (SR13 myelin protein) (Schwann cell membrane glycoprotein) (SAG) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5.09999903484653 5.4 5.4 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 6.26139916069465 5.4 5.3365625 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 O97447 0 1 ald O97447_GIAIN 4.9 5.4 5.34166666666667 1 Putative fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 5.5 5.4 5.3890625 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 RORG 0 1 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.85 5.4 5.17833333333333 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.93621643940264 5.4 5.3365625 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 5.3 5.4 5.4 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 NPC1 0 1 NPC1 NPC1_HUMAN 5.59 5.4 5.3890625 1 Niemann-Pick C1 protein 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 CP2C8 0 1 CYP2C8 CP2C8_HUMAN 6.27875360095283 5.4 5.39326923076923 1 Cytochrome P450 2C8 (EC 1.14.14.1) (CYPIIC8) (Cytochrome P450 IIC2) (Cytochrome P450 MP-12) (Cytochrome P450 MP-20) (Cytochrome P450 form 1) (S-mephenytoin 4-hydroxylase) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 DNMT1 0 1 DNMT1 AIM CXXC9 DNMT DNMT1_HUMAN 5.78837041556533 5.4 5.26 1 DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (EC 2.1.1.37) (CXXC-type zinc finger protein 9) (DNA methyltransferase HsaI) (DNA MTase HsaI) (M.HsaI) (MCMT), DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (Met-1) (EC 2.1.1.37) (DNA methyltransferase MmuI) (DNA MTase MmuI) (M.MmuI) (MCMT) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.64 5.4 5.3890625 1 Ras-related protein Rab-9A 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 9495 ANDR 7 0 AR DHTR NR3C4, Ar Nr3c4 ANDR_HUMAN, ANDR_RAT 5.00524071766508 4.8 4.8 7 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 RORG 2 0 RORC NR1F3 RORG RZRG, Rorc Nr1f3 Rorg Thor RORG_HUMAN, RORG_MOUSE 5.23753270593052 4.8 4.8 2 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 ITAL 5 1 ITGAL CD11A ITAL_HUMAN 5.24333333333333 4.8 4.8 6 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Integrin alpha-L (CD11 antigen-like family member A) (Leukocyte adhesion glycoprotein LFA-1 alpha chain) (LFA-1A) (Leukocyte function-associated molecule 1 alpha chain) (CD antigen CD11a), Integrin alpha-L (CD11 antigen-like family member A) (Leukocyte adhesion glycoprotein LFA-1 alpha chain) (LFA-1A) (Leukocyte function-associated molecule 1 alpha chain) (Lymphocyte antigen 15) (Ly-15) (CD antigen CD11a) 0.166666666666667 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 ITB2 4 0 ITGB2 CD18 MFI7 ITB2_HUMAN 5.42 4.8 4.8 4 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Integrin beta-2 (Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta) (Complement receptor C3 subunit beta) (CD antigen CD18) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 HIF1A 3 0 HIF1A BHLHE78 MOP1 PASD8 HIF1A_HUMAN 4.7 4.8 4.8 3 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein), Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 GEMI 4 0 GMNN GEMI_HUMAN 6.15925534243358 4.8 4.8 4 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Geminin 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 HMDH 36 0 HMGCR, Hmgcr HMDH_HUMAN, HMDH_MOUSE, HMDH_RAT 6.69664568778879 4.8 4.8 36 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) (EC 1.1.1.34) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 CHLE 3 0 BCHE CHLE_HORSE 5.42 4.8 4.8 3 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Cholinesterase (EC 3.1.1.8) (Acylcholine acylhydrolase) (Butyrylcholine esterase) (Choline esterase II) (EQ-BCHE) (Pseudocholinesterase), Cholinesterase (EC 3.1.1.8) (Acylcholine acylhydrolase) (Butyrylcholine esterase) (Choline esterase II) (Pseudocholinesterase) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 MDR1 2 4 ABCB1 MDR1 PGY1 MDR1_HUMAN 4.5767365479726 4.8 4.80000000000001 6 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Multidrug resistance protein 1 (EC 3.6.3.44) (ATP-binding cassette sub-family B member 1) (P-glycoprotein 1) (CD antigen CD243) 0.666666666666667 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 NK2R 0 2 TACR2 NK2R NKNAR TAC2R NK2R_HUMAN 4.79 4.8 4.80000000000001 2 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Substance-K receptor (SKR) (NK-2 receptor) (NK-2R) (Neurokinin A receptor) (Tachykinin receptor 2) 1 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 CYSP 2 0 CYSP_TRYCR 4.6 4.8 4.8 2 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Cruzipain (EC 3.4.22.51) (Cruzaine) (Major cysteine proteinase), Trophozoite cysteine proteinase (TCP) (EC 3.4.22.-) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 HDAC6 2 0 HDAC6 KIAA0901 JM21 HDAC6_HUMAN 4.79 4.8 4.8 2 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Histone deacetylase 6 (HD6) (EC 3.5.1.98), Histone deacetylase 6 (HD6) (EC 3.5.1.98) (Histone deacetylase mHDA2) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 SO1B1 3 1 SLCO1B1 LST1 OATP1B1 OATP2 OATPC SLC21A6 SO1B1_HUMAN 5.12961114938538 4.8 4.8 4 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6) 0.25 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 HDAC2 2 0 HDAC2 HDAC2_HUMAN 4.59 4.8 4.8 2 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Histone deacetylase 2 (HD2) (EC 3.5.1.98) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 EHMT2 2 0 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 4.60000053042989 4.8 4.8 2 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 SMAD3 2 0 SMAD3 MADH3 SMAD3_HUMAN 5.19999926443762 4.8 4.8 2 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 FNTB 2 0 Fntb FNTB_MOUSE 5.95424250943933 4.8 4.8 2 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Protein farnesyltransferase subunit beta (FTase-beta) (EC 2.5.1.58) (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 FNTA 2 0 Fnta FNTA_MOUSE 5.95424250943933 4.8 4.8 2 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha (EC 2.5.1.58) (EC 2.5.1.59) (CAAX farnesyltransferase subunit alpha) (FTase-alpha) (Ras proteins prenyltransferase subunit alpha) (Type I protein geranyl-geranyltransferase subunit alpha) (GGTase-I-alpha) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 AA1R 0 2 ADORA1 AA1R_HUMAN 4.69 4.8 4.80000000000001 2 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Adenosine receptor A1 1 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 TAU 1 0 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.7 4.8 4.8 1 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 IDHC 3 0 IDH1 PICD IDHC_HUMAN 4.72414201221553 4.8 4.8 3 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 PPARD 3 0 PPARD NR1C2 PPARB PPARD_HUMAN 5.1430759717342 4.8 4.8 3 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 LMNA 2 0 LMNA LMN1 LMNA_HUMAN 5.1 4.8 4.8 2 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 FRIL 1 0 FTL FRIL_HORSE 4.55 4.8 4.8 1 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Ferritin light chain (Ferritin L subunit) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 O97447 1 0 ald O97447_GIAIN 4.8 4.8 4.8 1 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Putative fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 SC6A3 2 0 SLC6A3 DAT1 SC6A3_HUMAN 5.05 4.8 4.8 2 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Sodium-dependent dopamine transporter (DA transporter) (DAT) (Solute carrier family 6 member 3) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 SC6A2 2 0 SLC6A2 NAT1 NET1 SLC6A5 SC6A2_HUMAN 5.06 4.8 4.8 2 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Sodium-dependent noradrenaline transporter (Norepinephrine transporter) (NET) (Solute carrier family 6 member 2) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 SO1A2 1 0 SLCO1A2 OATP OATP1 OATP1A2 SLC21A3 SO1A2_HUMAN 6.27875360095283 4.8 4.8 1 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Solute carrier organic anion transporter family member 1A2 (OATP-A) (Organic anion-transporting polypeptide 1) (OATP-1) (Sodium-independent organic anion transporter) (Solute carrier family 21 member 3) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.8 4.8 4.8 1 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 HDAC1 2 0 HDAC1 RPD3L1 HDAC1_HUMAN 4.92 4.8 4.8 2 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Histone deacetylase 1 (HD1) (EC 3.5.1.98) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 APEX1 1 0 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 4.59999938302362 4.8 4.8 1 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 AKT1 1 0 AKT1 PKB RAC AKT1_HUMAN 5 4.8 4.8 1 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (AKT1 kinase) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha) (Thymoma viral proto-oncogene), RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha), RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (RAC-PK-alpha) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9841 GBRG3 31 0 Gabrg3 GBRG3_MOUSE, GBRG3_RAT 7.17365743984937 4.55 4.55 31 Gamma-aminobutyric acid receptor subunit gamma-3 (GABA(A) receptor subunit gamma-3) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 GBRA4 37 0 GABRA4, Gabra4 GBRA4_BOVIN, GBRA4_MOUSE, GBRA4_RAT 7.36279407122515 4.55 4.55 37 Gamma-aminobutyric acid receptor subunit alpha-4 (GABA(A) receptor subunit alpha-4) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 GBRG1 31 0 Gabrg1 GBRG1_MOUSE, GBRG1_RAT 7.17365743984937 4.55 4.55 31 Gamma-aminobutyric acid receptor subunit gamma-1 (GABA(A) receptor subunit gamma-1) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 GBRB1 37 0 GABRB1, Gabrb1, Gabrb1 Gabrb-1 GBRB1_BOVIN, GBRB1_MOUSE, GBRB1_RAT 7.36279407122515 4.55 4.55 37 Gamma-aminobutyric acid receptor subunit beta-1 (GABA(A) receptor subunit beta-1) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 GBRB3 31 0 Gabrb3 Gabrb-3 GBRB3_MOUSE, GBRB3_RAT 7.17365743984937 4.55 4.55 31 Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 GBRP 31 0 Gabrp GBRP_MOUSE, GBRP_RAT 7.17365743984937 4.55 4.55 31 Gamma-aminobutyric acid receptor subunit pi (GABA(A) receptor subunit pi) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 GBRA6 31 0 Gabra6 Gabra-6 GBRA6_MOUSE, GBRA6_RAT 7.17365743984937 4.55 4.55 31 Gamma-aminobutyric acid receptor subunit alpha-6 (GABA(A) receptor subunit alpha-6) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 Q91ZM7 16 0 Gabrq Q91ZM7_RAT 9 4.55 4.55 16 GABA theta subunit 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 GBRG2 37 0 GABRG2, Gabrg2 GBRG2_BOVIN, GBRG2_MOUSE, GBRG2_RAT 7.36279407122515 4.55 4.55 37 Gamma-aminobutyric acid receptor subunit gamma-2 (GABA(A) receptor subunit gamma-2) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 GBRA1 37 0 GABRA1, Gabra1 Gabra-1 GBRA1_BOVIN, GBRA1_MOUSE, GBRA1_RAT 7.36279407122515 4.55 4.55 37 Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) receptor subunit alpha-1) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 GBRA3 37 0 GABRA3, Gabra3 Gabra-3 GBRA3_BOVIN, GBRA3_MOUSE, GBRA3_RAT 7.36279407122515 4.55 4.55 37 Gamma-aminobutyric acid receptor subunit alpha-3 (GABA(A) receptor subunit alpha-3) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 GBRA5 31 0 Gabra5, Gabra5 Gabra-5 GBRA5_MOUSE, GBRA5_RAT 7.17365743984937 4.55 4.55 31 Gamma-aminobutyric acid receptor subunit alpha-5 (GABA(A) receptor subunit alpha-5) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 GBRA2 37 0 GABRA2, Gabra2 Gabra-2 GBRA2_BOVIN, GBRA2_MOUSE, GBRA2_RAT 7.36279407122515 4.55 4.55 37 Gamma-aminobutyric acid receptor subunit alpha-2 (GABA(A) receptor subunit alpha-2) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 GBRB2 16 0 Gabrb2 Gabrb-2 GBRB2_RAT 9 4.55 4.55 16 Gamma-aminobutyric acid receptor subunit beta-2 (GABA(A) receptor subunit beta-2) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 GBRE 16 0 Gabre GBRE_RAT 9 4.55 4.55 16 Gamma-aminobutyric acid receptor subunit epsilon (GABA(A) receptor subunit epsilon) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 GBRD 31 0 Gabrd GBRD_MOUSE, GBRD_RAT 7.17365743984937 4.55 4.55 31 Gamma-aminobutyric acid receptor subunit delta (GABA(A) receptor subunit delta) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 GBRT 15 0 Gabrq GBRT_MOUSE 5.22555870902203 4.55 4.55 15 Gamma-aminobutyric acid receptor subunit theta (GABA(A) receptor subunit theta) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 18 0 GABA-A receptor; anion channel, NotRecorded 5.1586560008216 4.55 4.56111111111111 18 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 AL1A1 1 0 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.55 4.55 4.75 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 RUNX1 2 0 RUNX1 AML1 CBFA2 RUNX1_HUMAN 4.89999841719865 4.55 4.55 2 Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 PEBB 2 0 CBFB PEBB_HUMAN 4.89999841719865 4.55 4.55 2 Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.55 4.55 4.75 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 GBRG3 0 223 GABRG3, Gabrg3 GBRG3_HUMAN, GBRG3_MOUSE, GBRG3_RAT 8.09841388273976 4.85000000000001 4.85000000000001 223 Gamma-aminobutyric acid receptor subunit gamma-3 (GABA(A) receptor subunit gamma-3) 1 4.85000000000001 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 GBRA4 0 229 GABRA4, Gabra4 GBRA4_BOVIN, GBRA4_HUMAN, GBRA4_MOUSE, GBRA4_RAT 8.11810609541907 4.85000000000001 4.85000000000001 229 Gamma-aminobutyric acid receptor subunit alpha-4 (GABA(A) receptor subunit alpha-4) 1 4.85000000000001 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 GBRG1 0 223 GABRG1, Gabrg1 GBRG1_HUMAN, GBRG1_MOUSE, GBRG1_RAT 8.09841388273976 4.85000000000001 4.85000000000001 223 Gamma-aminobutyric acid receptor subunit gamma-1 (GABA(A) receptor subunit gamma-1) 1 4.85000000000001 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 GBRB1 0 229 GABRB1, Gabrb1, Gabrb1 Gabrb-1 GBRB1_BOVIN, GBRB1_HUMAN, GBRB1_MOUSE, GBRB1_RAT 8.11810609541907 4.85000000000001 4.85000000000001 229 Gamma-aminobutyric acid receptor subunit beta-1 (GABA(A) receptor subunit beta-1) 1 4.85000000000001 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 GBRB3 0 268 GABRB3, Gabrb3 Gabrb-3 GBRB3_HUMAN, GBRB3_MOUSE, GBRB3_RAT 8.04002349198123 4.84999999999999 4.84999999999999 268 Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) 1 4.84999999999999 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 GBRP 0 223 GABRP, Gabrp GBRP_HUMAN, GBRP_MOUSE, GBRP_RAT 8.09841388273976 4.85000000000001 4.85000000000001 223 Gamma-aminobutyric acid receptor subunit pi (GABA(A) receptor subunit pi) 1 4.85000000000001 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 GBRA6 0 232 GABRA6, Gabra6 Gabra-6 GBRA6_HUMAN, GBRA6_MOUSE, GBRA6_RAT 8.00588920625417 4.85000000000001 4.85000000000001 232 Gamma-aminobutyric acid receptor subunit alpha-6 (GABA(A) receptor subunit alpha-6) 1 4.85000000000001 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 Q91ZM7 0 192 Gabrq Q91ZM7_RAT 8.30749999999999 4.85000000000001 4.85000000000001 192 GABA theta subunit 1 4.85000000000001 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 GBRG2 0 274 GABRG2, Gabrg2 GBRG2_BOVIN, GBRG2_HUMAN, GBRG2_MOUSE, GBRG2_RAT 8.05776020383565 4.84999999999999 4.84999999999999 274 Gamma-aminobutyric acid receptor subunit gamma-2 (GABA(A) receptor subunit gamma-2) 1 4.84999999999999 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 GBRA1 0 239 GABRA1, Gabra1 Gabra-1 GBRA1_BOVIN, GBRA1_HUMAN, GBRA1_MOUSE, GBRA1_RAT 8.15199286966932 4.85 4.85 239 Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) receptor subunit alpha-1) 1 4.85 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 GBRA3 0 238 GABRA3, Gabra3 Gabra-3 GBRA3_BOVIN, GBRA3_HUMAN, GBRA3_MOUSE, GBRA3_RAT 8.12271552878557 4.85 4.85 238 Gamma-aminobutyric acid receptor subunit alpha-3 (GABA(A) receptor subunit alpha-3) 1 4.85 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 GBRA5 1 232 GABRA5, Gabra5, Gabra5 Gabra-5 GBRA5_HUMAN, GBRA5_MOUSE, GBRA5_RAT 8.07573517532604 4.85000000000001 4.84694206008584 233 Gamma-aminobutyric acid receptor subunit alpha-5 (GABA(A) receptor subunit alpha-5) 0.995708154506438 4.85000000000001 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 GBRA2 0 238 GABRA2, Gabra2 Gabra-2 GBRA2_BOVIN, GBRA2_HUMAN, GBRA2_MOUSE, GBRA2_RAT 8.1253625876091 4.85 4.85 238 Gamma-aminobutyric acid receptor subunit alpha-2 (GABA(A) receptor subunit alpha-2) 1 4.85 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 GBRB2 0 208 GABRB2, Gabrb2 Gabrb-2 GBRB2_HUMAN, GBRB2_RAT 8.30692307692306 4.85000000000002 4.85000000000002 208 Gamma-aminobutyric acid receptor subunit beta-2 (GABA(A) receptor subunit beta-2) 1 4.85000000000002 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 GBRE 0 208 GABRE, Gabre GBRE_HUMAN, GBRE_RAT 8.30692307692306 4.85000000000002 4.85000000000002 208 Gamma-aminobutyric acid receptor subunit epsilon (GABA(A) receptor subunit epsilon) 1 4.85000000000002 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 GBRD 0 223 GABRD, Gabrd GBRD_HUMAN, GBRD_MOUSE, GBRD_RAT 8.09841388273976 4.85000000000001 4.85000000000001 223 Gamma-aminobutyric acid receptor subunit delta (GABA(A) receptor subunit delta) 1 4.85000000000001 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 NPC1 0 1 NPC1 NPC1_HUMAN 5.5 4.85 4.85 1 Niemann-Pick C1 protein 1 4.85 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 1 51 GABA-A receptor; anion channel, Nonstructural protein 1, NotRecorded 4.99592174038869 4.85 4.84990384615384 52 0.980769230769231 4.85 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 GBRT 0 31 GABRQ, Gabrq GBRT_HUMAN, GBRT_MOUSE 6.80342889841837 4.85 4.85 31 Gamma-aminobutyric acid receptor subunit theta (GABA(A) receptor subunit theta) 1 4.85 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.5 4.85 4.85 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.85 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.93621268968233 4.85 4.85 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.85 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 APEX1 0 1 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 7.05012229596313 4.85 4.91 1 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 1 4.85 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 PDE5A 0 1 PDE5A PDE5 PDE5A_BOVIN 6.1 4.85 5.0375 1 cGMP-specific 3',5'-cyclic phosphodiesterase (EC 3.1.4.35) (cGMP-binding cGMP-specific phosphodiesterase) (CGB-PDE) 1 4.85 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 LUCI 0 1 LUCI_PHOPY 4.82098278885978 4.85 4.85 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.85 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 4.7 4.85 4.85 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 4.85 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 SMN 0 2 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.85 4.85 4.85 2 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.85 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 RORG 0 2 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.95 4.85 4.85 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.85 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 10017 5HT2C 3 0 Htr2c 5ht1c Htr1c 5HT2C_RAT 8.25 5.35 4.5125 3 5-hydroxytryptamine receptor 2C (5-HT-2C) (5-HT2C) (5-HTR2C) (5-hydroxytryptamine receptor 1C) (5-HT-1C) (5-HT1C) (Serotonin receptor 2C), 5-hydroxytryptamine receptor 2C (5-HT-2C) (5-HT2C) (5-HTR2C) (Serotonin receptor 2C) 0 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 10017 5HT2B 3 0 Htr2b Srl 5HT2B_RAT 8.25 5.35 4.5125 3 5-hydroxytryptamine receptor 2B (5-HT-2B) (5-HT2B) (5-HT-2F) (NP75 protein) (Serotonin receptor 2B), 5-hydroxytryptamine receptor 2B (5-HT-2B) (5-HT2B) (5-HT-2F) (Serotonin receptor 2B) (Stomach fundus serotonin receptor), 5-hydroxytryptamine receptor 2B (5-HT-2B) (5-HT2B) (Serotonin receptor 2B) 0 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 10017 5HT2A 3 0 Htr2a Htr2 5HT2A_RAT 8.25 5.35 4.5125 3 5-hydroxytryptamine receptor 2A (5-HT-2) (5-HT-2A) (5-HT2A) (Serotonin receptor 2A), 5-hydroxytryptamine receptor 2A (5-HT-2) (5-HT-2A) (5-hydroxytryptamine receptor) (Serotonin receptor 2A), 5-hydroxytryptamine receptor 2A (5-HT-2) (5-HT-2A) (Serotonin receptor 2A) 0 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 10017 CP2CJ 0 4 CYP2C19 CP2CJ_HUMAN 5.375 5.35 5.35 4 Cytochrome P450 2C19 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Mephenytoin 4-hydroxylase) 1 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 10017 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.8 5.35 5.35 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 10017 KAT2A 0 2 KAT2A GCN5 GCN5L2 HGCN5 KAT2A_HUMAN 6.55005901122666 5.35 5.35 2 Histone acetyltransferase KAT2A (EC 2.3.1.48) (General control of amino acid synthesis protein 5-like 2) (Histone acetyltransferase GCN5) (HsGCN5) (Lysine acetyltransferase 2A) (STAF97) 1 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 10017 5HT1B 1 0 Htr1b 5ht1b 5HT1B_RAT 5.49 5.35 3.884375 1 5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B), 5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B), 5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (Serotonin receptor 1B) 0 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 10017 ATX2 0 1 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 4.84999924507786 5.35 5.35 1 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 1 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 10017 0 7 NotRecorded 4.78376359700597 5.35 4.99107142857143 7 1 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 10017 GLCM 0 2 GBA GC GLUC GLCM_HUMAN 4.89999841719865 5.35 5.35 2 Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase), Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (D-glucosyl-N-acylsphingosine glucohydrolase) 1 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 10017 P53 0 3 TP53 P53 P53_HUMAN 4.63333333333333 5.35 5.35 3 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 10017 LEF 0 2 lef pXO1-107 BXA0172 GBAA_pXO1_0172 LEF_BACAN 4.75 5.35 5.35 2 Lethal factor (LF) (EC 3.4.24.83) (Anthrax lethal toxin endopeptidase component) 1 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 10017 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5 5.35 5.35 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 10017 CP2D6 0 4 CYP2D6 CYP2DL1 CP2D6_HUMAN 6.15 5.35 5.35 4 Cytochrome P450 2D6 (EC 1.14.14.1) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase) 1 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 10017 5HT1A 1 0 Htr1a 5ht1a 5HT1A_RAT 6.07 5.35 3.884375 1 5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A), 5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (Serotonin receptor 1A) 0 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 10017 LX15B 0 1 ALOX15B LX15B_HUMAN 5 5.35 5.35 1 Arachidonate 15-lipoxygenase B (15-LOX-B) (EC 1.13.11.33) (15-lipoxygenase 2) (15-LOX-2) (Arachidonate 15-lipoxygenase type II) (Linoleate 13-lipoxygenase 15-LOb) (EC 1.13.11.-) 1 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 10017 RORG 0 1 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.5 5.35 5.35 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 10017 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.35 5.35 5.35 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 10017 CP1A2 0 2 CYP1A2 CP1A2_HUMAN 4.7 5.35 5.35 2 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 11501 HDA10 0 528 HDAC10 HDA10_HUMAN 6.26704908923481 5.84999999999995 5.85000000000002 528 Histone deacetylase 10 (HD10) (EC 3.5.1.98) 1 5.84999999999995 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 0 306 Histone deacetylase, Histone deacetylase HD1B, Histone deacetylase HD2, NotRecorded, Ribosome maturation protein SDO1 6.3054805697224 5.84999999999998 5.85000000000006 306 1 5.84999999999998 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 HDA11 0 524 HDAC11 HDA11_HUMAN 6.2508242731221 5.84999999999995 5.85000000000003 524 Histone deacetylase 11 (HD11) (EC 3.5.1.98) 1 5.84999999999995 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 HDAC6 0 559 HDAC6 KIAA0901 JM21, Hdac6 HDAC6_HUMAN, HDAC6_MOUSE 6.35591058032368 5.84999999999994 5.85000000000002 559 Histone deacetylase 6 (HD6) (EC 3.5.1.98), Histone deacetylase 6 (HD6) (EC 3.5.1.98) (Histone deacetylase mHDA2) 1 5.84999999999994 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 HDAC2 0 542 HDAC2 HDAC2_HUMAN 6.29537254449443 5.84999999999994 5.85000000000002 542 Histone deacetylase 2 (HD2) (EC 3.5.1.98) 1 5.84999999999994 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 HDAC1 0 647 HDAC1 RPD3L1, Hdac1 HDAC1_HUMAN, HDAC1_MOUSE, HDAC1_RAT 6.53020548548941 5.84999999999994 5.85 647 Histone deacetylase 1 (HD1) (EC 3.5.1.98) 1 5.84999999999994 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 HDAC9 0 525 HDAC9 HDAC7 HDAC7B HDRP KIAA0744 MITR HDAC9_HUMAN 6.24076556022092 5.84999999999995 5.85000000000002 525 Histone deacetylase 9 (HD9) (EC 3.5.1.98) (Histone deacetylase 7B) (HD7) (HD7b) (Histone deacetylase-related protein) (MEF2-interacting transcription repressor MITR) 1 5.84999999999995 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 HDAC5 0 528 HDAC5 KIAA0600, Hdac5 HDAC5_HUMAN, HDAC5_MOUSE 6.24667030135602 5.84999999999995 5.85000000000002 528 Histone deacetylase 5 (HD5) (EC 3.5.1.98) (Antigen NY-CO-9), Histone deacetylase 5 (HD5) (EC 3.5.1.98) (Histone deacetylase mHDA1) 1 5.84999999999995 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 HDAC7 0 598 HDAC7 HDAC7A, Hdac7 Hdac7a HDAC7_HUMAN, HDAC7_RAT 6.39297678933089 5.84999999999994 5.85000000000001 598 Histone deacetylase 7 (HD7) (EC 3.5.1.98) (Histone deacetylase 7A) (HD7a), Histone deacetylase 7 (HD7) (EC 3.5.1.98) (Histone deacetylase 7A) (HD7a) (Fragment) 1 5.84999999999994 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 HDAC4 0 613 HDAC4 KIAA0288, Hdac4 HDAC4_HUMAN, HDAC4_RAT 6.41137535096494 5.84999999999994 5.85000000000001 613 Histone deacetylase 4 (HD4) (EC 3.5.1.98) 1 5.84999999999994 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 HDAC3 0 607 HDAC3, Hdac3 HDAC3_HUMAN, HDAC3_RAT 6.4419862559585 5.84999999999994 5.85000000000001 607 Histone deacetylase 3 (HD3) (EC 3.5.1.98), Histone deacetylase 3 (HD3) (EC 3.5.1.98) (RPD3-2) (SMAP45) 1 5.84999999999994 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 HDAC8 0 550 HDAC8 HDACL1 CDA07, Hdac8 HDAC8_HUMAN, HDAC8_MOUSE 6.18753639360822 5.84999999999995 5.85000000000002 550 Histone deacetylase 8 (HD8) (EC 3.5.1.98) 1 5.84999999999995 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.55 5.85 5.85000000000003 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 5.85 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 Q5RJZ2 0 70 Hdac5 Q5RJZ2_RAT 7.592 5.85000000000001 5.85000000000002 70 Hdac5 protein (Fragment) 1 5.85000000000001 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 Q99P97 0 70 Hdac6 Q99P97_RAT 7.592 5.85000000000001 5.85000000000002 70 Histone deacetylase 6 (Fragment) 1 5.85000000000001 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 TF 0 20 F3, F3 Cf-3 Cf3 TF_HUMAN, TF_MOUSE 6.7855735001946 5.85 5.85000000000003 20 Tissue factor (TF) (Coagulation factor III) (CD antigen CD142), Tissue factor (TF) (Coagulation factor III) (Thromboplastin) (CD antigen CD142) 1 5.85 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 ATAD5 0 5 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.12827226020639 5.85 5.85000000000003 5 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.85 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 GRP78 0 2 HSPA5 GRP78 GRP78_HUMAN 5.40000359182699 5.85 5.85000000000003 2 78 kDa glucose-regulated protein (GRP-78) (Endoplasmic reticulum lumenal Ca(2+)-binding protein grp78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP), 78 kDa glucose-regulated protein (GRP-78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP) 1 5.85 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 HDAH 0 2 hdaH hdaH1 HDAH_ALCSD 6.035 5.85 5.85000000000003 2 Histone deacetylase-like amidohydrolase (HDAC-like amidohydrolase) (HDAH) (EC 3.5.1.-) 1 5.85 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 NCOR2 0 6 NCOR2 CTG26 NCOR2_HUMAN 6.87395637513809 5.85 5.85000000000003 6 Nuclear receptor corepressor 2 (N-CoR2) (CTG repeat protein 26) (SMAP270) (Silencing mediator of retinoic acid and thyroid hormone receptor) (SMRT) (T3 receptor-associating factor) (TRAC) (Thyroid-, retinoic-acid-receptor-associated corepressor) 1 5.85 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 SIR2 0 2 SIRT2 SIR2L SIR2L2 SIR2_HUMAN 5 5.85 5.85000000000003 2 NAD-dependent histone deacetylase SIR2 (EC 3.5.1.-) (Regulatory protein SIR2) (Silent information regulator 2), NAD-dependent protein deacetylase sirtuin-2 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2), NAD-dependent protein deacetylase sirtuin-2 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2) (mSIR2L2) 1 5.85 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 SF3B3 0 3 SF3B3 KIAA0017 SAP130 SF3B3_HUMAN 6.04013818129432 5.85 5.85000000000003 3 Splicing factor 3B subunit 3 (Pre-mRNA-splicing factor SF3b 130 kDa subunit) (SF3b130) (STAF130) (Spliceosome-associated protein 130) (SAP 130) 1 5.85 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 SMN 0 2 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.9 5.85 5.85000000000003 2 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.85 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 GLCM 0 1 GBA GC GLUC GLCM_HUMAN 4.74999985591871 5.85 5.85000000000003 1 Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase), Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (D-glucosyl-N-acylsphingosine glucohydrolase) 1 5.85 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 4.8000008748032 5.85 5.85000000000003 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 5.85 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 CFTR 0 1 CFTR ABCC7 CFTR_HUMAN 5 5.85 5.85000000000003 1 Cystic fibrosis transmembrane conductance regulator (CFTR) (ATP-binding cassette sub-family C member 7) (Channel conductance-controlling ATPase) (EC 3.6.3.49) (cAMP-dependent chloride channel) 1 5.85 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 WNT3A 0 1 Wnt3a Wnt-3a WNT3A_MOUSE 5 5.85 5.85000000000003 1 Protein Wnt-3a 1 5.85 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 14221 KS6A6 0 4 RPS6KA6 RSK4 KS6A6_HUMAN 5 4.9 4.90000000000001 4 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Ribosomal protein S6 kinase alpha-6 (S6K-alpha-6) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 6) (p90-RSK 6) (p90RSK6) (Ribosomal S6 kinase 4) (RSK-4) (pp90RSK4) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CDK2 0 92 CDK2 CDKN2 CDK2_HUMAN 6.2443740393678 4.89999999999999 4.90000000000002 92 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2) (p33 protein kinase) 1 4.89999999999999 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CCNA1 0 45 CCNA1 CCNA1_HUMAN 6.0124464804388 4.9 4.90000000000001 45 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-A1 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CCNA2 0 46 CCNA2 CCN1 CCNA CCNA2_HUMAN 5.99043677434231 4.9 4.90000000000001 46 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-A2 (Cyclin-A) (Cyclin A) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CDK7 0 20 CDK7 CAK CAK1 CDKN7 MO15 STK1 CDK7_HUMAN 6.03113175285516 4.9 4.90000000000001 20 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (P39 Mo15) (CDK-activating kinase) (CR4 protein kinase) (CRK4) (Cell division protein kinase 7) (Protein-tyrosine kinase MPK-7) (TFIIH basal transcription factor complex kinase subunit), Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (p39 Mo15) (CDK-activating kinase 1) (Cell division protein kinase 7) (Serine/threonine-protein kinase 1) (TFIIH basal transcription factor complex kinase subunit) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CCNH 0 18 CCNH CCNH_HUMAN 6.04347972539462 4.9 4.90000000000001 18 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-H (MO15-associated protein) (p34) (p37) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CDK1 0 44 CDK1 CDC2 CDC28A CDKN1 P34CDC2 CDK1_HUMAN 5.9175162973892 4.9 4.90000000000001 44 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (Cell division control protein 28) (Cell division protein kinase 1), Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CCNB1 0 37 CCNB1 CCNB CCNB1_HUMAN 5.88637338176052 4.9 4.90000000000001 37 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 G2/mitotic-specific cyclin-B1 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 STK26 0 1 STK26 MASK MST4 STK26_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase 26 (EC 2.7.11.1) (MST3 and SOK1-related kinase) (Mammalian STE20-like protein kinase 4) (MST-4) (STE20-like kinase MST4) (Serine/threonine-protein kinase MASK) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 COQ8B 0 1 COQ8B ADCK4 COQ8B_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Atypical kinase COQ8B, mitochondrial (EC 2.7.-.-) (AarF domain-containing protein kinase 4) (Coenzyme Q protein 8B) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 PKN2 0 2 PKN2 PRK2 PRKCL2 PKN2_HUMAN 5.45399866074334 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase N2 (EC 2.7.11.13) (PKN gamma) (Protein kinase C-like 2) (Protein-kinase C-related kinase 2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KPCD 0 1 PRKCD KPCD_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)], Protein kinase C delta type (EC 2.7.11.13) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)] 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 AVR2A 0 1 ACVR2A ACVR2 AVR2A_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Activin receptor type-2A (EC 2.7.11.30) (Activin receptor type IIA) (ACTR-IIA) (ACTRIIA) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MP2K1 0 3 MAP2K1 MEK1 PRKMK1 MP2K1_HUMAN 5.13904110834813 4.9 4.90000000000001 3 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1), Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (MKK1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 BRAF 0 2 BRAF BRAF1 RAFB1 BRAF_HUMAN 5 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase B-raf (EC 2.7.11.1) (Proto-oncogene B-Raf), Serine/threonine-protein kinase B-raf (EC 2.7.11.1) (Proto-oncogene B-Raf) (p94) (v-Raf murine sarcoma viral oncogene homolog B1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CCNE1 0 40 CCNE1 CCNE CCNE1_HUMAN 6.32990350070269 4.9 4.90000000000001 40 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 G1/S-specific cyclin-E1 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CLK1 0 4 CLK1 CLK, Clk1 Clk Sty CLK1_HUMAN, CLK1_MOUSE 4.7425 4.9 4.90000000000001 4 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Dual specificity protein kinase CLK1 (EC 2.7.12.1) (CDC-like kinase 1), Dual specificity protein kinase CLK1 (EC 2.7.12.1) (CDC-like kinase 1) (Protein kinase STY) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CD5R1 0 32 CDK5R1 CDK5R NCK5A CD5R1_HUMAN 6.21682301579253 4.9 4.90000000000001 32 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-dependent kinase 5 activator 1 (CDK5 activator 1) (Cyclin-dependent kinase 5 regulatory subunit 1) (TPKII regulatory subunit) [Cleaved into: Cyclin-dependent kinase 5 activator 1, p35 (p35); Cyclin-dependent kinase 5 activator 1, p25 (p25) (Tau protein kinase II 23 kDa subunit) (p23)] 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CDK5 0 38 CDK5 CDKN5 CDK5_HUMAN 6.24548253961476 4.9 4.90000000000001 38 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-dependent-like kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KPCE 0 1 PRKCE PKCE KPCE_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Protein kinase C epsilon type (EC 2.7.11.13) (nPKC-epsilon) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CDK9 0 18 CDK9 CDC2L4 TAK CDK9_HUMAN 5.79953827582066 4.9 4.90000000000001 18 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (C-2K) (Cell division cycle 2-like protein kinase 4) (Cell division protein kinase 9) (Serine/threonine-protein kinase PITALRE) (Tat-associated kinase complex catalytic subunit) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CCNT1 0 16 CCNT1 CCNT1_HUMAN 5.79698056029824 4.9 4.90000000000001 16 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-T1 (CycT1) (Cyclin-T) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 ACVL1 0 1 ACVRL1 ACVRLK1 ALK1 ACVL1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase receptor R3 (SKR3) (EC 2.7.11.30) (Activin receptor-like kinase 1) (ALK-1) (TGF-B superfamily receptor type I) (TSR-I) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 BRSK2 0 2 BRSK2 C11orf7 PEN11B SADA STK29 HUSSY-12 BRSK2_HUMAN 5.28770389827826 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase BRSK2 (EC 2.7.11.1) (Brain-selective kinase 2) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 2) (BR serine/threonine-protein kinase 2) (Serine/threonine-protein kinase 29) (Serine/threonine-protein kinase SAD-A) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CCND1 0 11 CCND1 BCL1 PRAD1 CCND1_HUMAN 4.62181818181818 4.9 4.90000000000001 11 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 G1/S-specific cyclin-D1 (B-cell lymphoma 1 protein) (BCL-1) (BCL-1 oncogene) (PRAD1 oncogene) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CDK4 0 10 CDK4 CDK4_HUMAN 4.758 4.9 4.90000000000001 10 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-dependent kinase 4 (EC 2.7.11.22) (CRK3) (Cell division protein kinase 4) (PSK-J3), Cyclin-dependent kinase 4 (EC 2.7.11.22) (Cell division protein kinase 4) (PSK-J3) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 PAK4 0 4 PAK4 KIAA1142 PAK4_HUMAN 4.52856062735983 4.9 4.90000000000001 4 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 P53 0 1 TP53 P53 P53_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 AAPK2 0 1 PRKAA2 AMPK AMPK2 AAPK2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 EGFR 0 11 EGFR ERBB ERBB1 HER1 EGFR_HUMAN 4.72727272727273 4.9 4.90000000000001 11 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Epidermal growth factor receptor (EC 2.7.10.1), Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 TEC 0 1 TEC PSCTK4 TEC_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Tyrosine-protein kinase Tec (EC 2.7.10.2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 DYR1B 0 1 DYRK1B MIRK DYR1B_HUMAN 5.96 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Dual specificity tyrosine-phosphorylation-regulated kinase 1B (EC 2.7.12.1) (Minibrain-related kinase) (Mirk protein kinase) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KIT 0 7 KIT SCFR KIT_HUMAN 4.57142857142857 4.9 4.90000000000001 7 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Piebald trait protein) (PBT) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (p145 c-kit) (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) (CD antigen CD117), Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (CD antigen CD117) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MYO3A 0 1 MYO3A MYO3A_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Myosin-IIIa (EC 2.7.11.1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 LTK 0 1 LTK TYK1 LTK_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Leukocyte tyrosine kinase receptor (EC 2.7.10.1) (Protein tyrosine kinase 1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 PDPK1 0 2 PDPK1 PDK1 PDPK1_HUMAN 5.30102999566398 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 3-phosphoinositide-dependent protein kinase 1 (hPDK1) (EC 2.7.11.1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CDK16 0 2 CDK16 PCTAIRE1 PCTK1 CDK16_HUMAN 5.5 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-dependent kinase 16 (EC 2.7.11.22) (Cell division protein kinase 16) (PCTAIRE-motif protein kinase 1) (Serine/threonine-protein kinase PCTAIRE-1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CCNB3 0 20 CCNB3 CYCB3 CCNB3_HUMAN 6.25341732867143 4.9 4.90000000000001 20 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 G2/mitotic-specific cyclin-B3 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CCNB2 0 20 CCNB2 CCNB2_HUMAN 6.25341732867143 4.9 4.90000000000001 20 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 G2/mitotic-specific cyclin-B2 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 E2AK4 0 1 EIF2AK4 GCN2 KIAA1338 E2AK4_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 eIF-2-alpha kinase GCN2 (EC 2.7.11.1) (Eukaryotic translation initiation factor 2-alpha kinase 4) (GCN2-like protein) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CAC1C 0 1 CACNA1C CACH2 CACN2 CACNL1A1 CCHL1A1 CAC1C_HUMAN 4.63 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (MELC-CC) (Mouse brain class C) (MBC) (Voltage-gated calcium channel subunit alpha Cav1.2), Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Rat brain class C) (RBC) (Voltage-gated calcium channel subunit alpha Cav1.2), Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Smooth muscle calcium channel blocker receptor) (CACB-receptor) (Voltage-gated calcium channel subunit alpha Cav1.2), Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Voltage-gated calcium channel subunit alpha Cav1.2), Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Voltage-gated calcium channel subunit alpha Cav1.2) (Fragment) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 DYRK3 0 1 DYRK3 DYRK3_HUMAN 6.50965047954658 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Dual specificity tyrosine-phosphorylation-regulated kinase 3 (EC 2.7.12.1) (Regulatory erythroid kinase) (REDK) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KC1AL 0 1 CSNK1A1L KC1AL_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Casein kinase I isoform alpha-like (CKI-alpha-like) (EC 2.7.11.1) (CK1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MK03 0 4 MAPK3 ERK1 PRKM3 MK03_HUMAN 4.8996353368201 4.9 4.90000000000001 4 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (MNK1) (Microtubule-associated protein 2 kinase) (p44-ERK1), Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (Microtubule-associated protein 2 kinase) (p44-ERK1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 DYRK2 0 1 DYRK2 DYRK2_HUMAN 5.95424250943933 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KC1A 0 7 CSNK1A1 KC1A_HUMAN 4.60776640077178 4.9 4.90000000000001 7 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Casein kinase I isoform alpha (CKI-alpha) (EC 2.7.11.1) (CK1), Casein kinase I isoform alpha (CKI-alpha) (EC 2.7.11.1) (CK1) (Fragment) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KC1G2 0 7 CSNK1G2 CK1G2 KC1G2_HUMAN 4.95714285714286 4.9 4.90000000000001 7 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Casein kinase I isoform gamma-2 (CKI-gamma 2) (EC 2.7.11.1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KC1E 0 7 CSNK1E KC1E_HUMAN 5.30571428571429 4.9 4.90000000000001 7 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Casein kinase I isoform epsilon (CKI-epsilon) (CKIe) (EC 2.7.11.1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KC1D 0 7 CSNK1D HCKID KC1D_HUMAN 5.13437176436703 4.9 4.90000000000001 7 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Casein kinase I isoform delta (CKI-delta) (CKId) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26), Casein kinase I isoform delta (CKI-delta) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KC1G1 0 7 CSNK1G1 KC1G1_HUMAN 4.90428571428571 4.9 4.90000000000001 7 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Casein kinase I isoform gamma-1 (CKI-gamma 1) (EC 2.7.11.1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KPCD3 0 1 PRKD3 EPK2 PRKCN KPCD3_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase D3 (EC 2.7.11.13) (Protein kinase C nu type) (Protein kinase EPK2) (nPKC-nu) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 STK11 0 1 STK11 LKB1 PJS STK11_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase STK11 (EC 2.7.11.1) (Liver kinase B1) (LKB1) (hLKB1) (Renal carcinoma antigen NY-REN-19) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 GSK3B 0 6 GSK3B GSK3B_HUMAN 4.55825629059045 4.9 4.90000000000001 6 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Factor A) (FA) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1), Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 TNK1 0 1 TNK1 TNK1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Non-receptor tyrosine-protein kinase TNK1 (EC 2.7.10.2) (CD38 negative kinase 1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MYO3B 0 1 MYO3B MYO3B_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Myosin-IIIb (EC 2.7.11.1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 SRMS 0 1 SRMS C20orf148 SRMS_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Tyrosine-protein kinase Srms (EC 2.7.10.2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MP2K2 0 1 MAP2K2 MEK2 MKK2 PRKMK2 MP2K2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Dual specificity mitogen-activated protein kinase kinase 2 (MAP kinase kinase 2) (MAPKK 2) (EC 2.7.12.2) (ERK activator kinase 2) (MAPK/ERK kinase 2) (MEK 2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MP2K4 0 1 MAP2K4 JNKK1 MEK4 MKK4 PRKMK4 SEK1 SERK1 SKK1 MP2K4_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Dual specificity mitogen-activated protein kinase kinase 4 (MAP kinase kinase 4) (MAPKK 4) (EC 2.7.12.2) (C-JUN N-terminal kinase kinase 1) (JNK kinase 1) (JNKK 1) (JNK-activating kinase 1) (MAPK/ERK kinase 4) (MEK 4) (SAPK/ERK kinase 1) (SEK1), Dual specificity mitogen-activated protein kinase kinase 4 (MAP kinase kinase 4) (MAPKK 4) (EC 2.7.12.2) (JNK-activating kinase 1) (MAPK/ERK kinase 4) (MEK 4) (SAPK/ERK kinase 1) (SEK1) (Stress-activated protein kinase kinase 1) (SAPK kinase 1) (SAPKK-1) (SAPKK1) (c-Jun N-terminal kinase kinase 1) (JNKK) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 SIK2 0 1 SIK2 KIAA0781 QIK SNF1LK2 SIK2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase SIK2 (EC 2.7.11.1) (Qin-induced kinase) (Salt-inducible kinase 2) (SIK-2) (Serine/threonine-protein kinase SNF1-like kinase 2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CTRO 0 1 CIT CRIK KIAA0949 STK21 CTRO_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Citron Rho-interacting kinase (CRIK) (EC 2.7.11.1) (Serine/threonine-protein kinase 21) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KS6A4 0 4 RPS6KA4 MSK2 KS6A4_HUMAN 5 4.9 4.90000000000001 4 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Ribosomal protein S6 kinase alpha-4 (S6K-alpha-4) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 4) (Nuclear mitogen- and stress-activated protein kinase 2) (Ribosomal protein kinase B) (RSKB) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MK15 0 2 MAPK15 ERK7 ERK8 MK15_HUMAN 4.91195437047216 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Mitogen-activated protein kinase 15 (MAP kinase 15) (MAPK 15) (EC 2.7.11.24) (Extracellular signal-regulated kinase 7) (ERK-7) (Extracellular signal-regulated kinase 8) (ERK-8) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 BRSK1 0 1 BRSK1 KIAA1811 SAD1 SADB BRSK1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase BRSK1 (EC 2.7.11.1) (Brain-selective kinase 1) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 1) (BR serine/threonine-protein kinase 1) (Serine/threonine-protein kinase SAD-B) (Synapses of Amphids Defective homolog 1) (SAD1 homolog) (hSAD1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 EPHB3 0 1 EPHB3 ETK2 HEK2 TYRO6 EPHB3_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Ephrin type-B receptor 3 (EC 2.7.10.1) (EPH-like tyrosine kinase 2) (EPH-like kinase 2) (Embryonic kinase 2) (EK2) (hEK2) (Tyrosine-protein kinase TYRO6) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KS6A1 0 6 RPS6KA1 MAPKAPK1A RSK1 KS6A1_HUMAN 5.50321682651553 4.9 4.90000000000001 6 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Ribosomal protein S6 kinase alpha-1 (S6K-alpha-1) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 1) (p90-RSK 1) (p90RSK1) (p90S6K) (MAP kinase-activated protein kinase 1a) (MAPK-activated protein kinase 1a) (MAPKAP kinase 1a) (MAPKAPK-1a) (Ribosomal S6 kinase 1) (RSK-1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MAPK2 0 2 MAPKAPK2 MAPK2_HUMAN 5.75482523977329 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 MAP kinase-activated protein kinase 2 (MAPK-activated protein kinase 2) (MAPKAP kinase 2) (MAPKAP-K2) (MAPKAPK-2) (MK-2) (MK2) (EC 2.7.11.1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MK12 0 3 MAPK12 ERK6 SAPK3 MK12_HUMAN 4.66521173153252 4.9 4.90000000000001 3 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Mitogen-activated protein kinase 12 (MAP kinase 12) (MAPK 12) (EC 2.7.11.24) (Extracellular signal-regulated kinase 6) (ERK-6) (Mitogen-activated protein kinase p38 gamma) (MAP kinase p38 gamma) (Stress-activated protein kinase 3) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 NEK7 0 2 NEK7 NEK7_HUMAN 5.41278795015589 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase Nek7 (EC 2.7.11.1) (Never in mitosis A-related kinase 7) (NimA-related protein kinase 7) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 LIMK2 0 1 LIMK2 LIMK2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 LIM domain kinase 2 (LIMK-2) (EC 2.7.11.1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 IRAK3 0 1 IRAK3 IRAK3_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Interleukin-1 receptor-associated kinase 3 (IRAK-3) (EC 2.7.11.1) (IL-1 receptor-associated kinase M) (IRAK-M) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 ROCK2 0 1 ROCK2 KIAA0619 ROCK2_HUMAN 5.95424250943933 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2), Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (RhoA-binding kinase 2) (p150 ROK-alpha) (ROKalpha) (p164 ROCK-2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 DAPK1 0 1 DAPK1 DAPK DAPK1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MK13 0 1 MAPK13 PRKM13 SAPK4 MK13_HUMAN 6.06069784035361 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Mitogen-activated protein kinase 13 (MAP kinase 13) (MAPK 13) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 delta) (MAP kinase p38 delta) (Stress-activated protein kinase 4) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MK01 0 5 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 4.99813783246515 4.9 4.90000000000001 5 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 PI51A 0 1 PIP5K1A PI51A_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha (PIP5K1-alpha) (PtdIns(4)P-5-kinase 1 alpha) (EC 2.7.1.68) (68 kDa type I phosphatidylinositol 4-phosphate 5-kinase alpha) (Phosphatidylinositol 4-phosphate 5-kinase type I alpha) (PIP5KIalpha) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 M3K9 0 1 MAP3K9 MLK1 PRKE1 M3K9_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Mitogen-activated protein kinase kinase kinase 9 (EC 2.7.11.25) (Mixed lineage kinase 1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 EPHB2 0 1 EPHB2 DRT EPHT3 EPTH3 ERK HEK5 TYRO5 EPHB2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Ephrin type-B receptor 2 (EC 2.7.10.1) (Developmentally-regulated Eph-related tyrosine kinase) (ELK-related tyrosine kinase) (EPH tyrosine kinase 3) (EPH-like kinase 5) (EK5) (hEK5) (Renal carcinoma antigen NY-REN-47) (Tyrosine-protein kinase TYRO5) (Tyrosine-protein kinase receptor EPH-3), Ephrin type-B receptor 2 (EC 2.7.10.1) (Neural kinase) (Nuk receptor tyrosine kinase) (Tyrosine-protein kinase receptor EPH-3) (Tyrosine-protein kinase receptor SEK-3) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 FGFR4 0 1 FGFR4 JTK2 TKF FGFR4_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (CD antigen CD334), Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (Protein-tyrosine kinase receptor MPK-11) (CD antigen CD334) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 RIOK1 0 1 RIOK1 RIOK1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase RIO1 (EC 2.7.11.1) (EC 3.6.3.-) (RIO kinase 1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 PK3CA 0 2 PIK3CA PK3CA_HUMAN 5 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (PI3-kinase subunit alpha) (PI3K-alpha) (PI3Kalpha) (PtdIns-3-kinase subunit alpha) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha) (PtdIns-3-kinase subunit p110-alpha) (p110alpha) (Phosphoinositide-3-kinase catalytic alpha polypeptide) (Serine/threonine protein kinase PIK3CA) (EC 2.7.11.1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 DCLK1 0 1 DCLK1 DCAMKL1 DCDC3A KIAA0369 DCLK1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase DCLK1 (EC 2.7.11.1) (Doublecortin domain-containing protein 3A) (Doublecortin-like and CAM kinase-like 1) (Doublecortin-like kinase 1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CDK19 0 1 CDK19 CDC2L6 CDK11 KIAA1028 CDK19_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-dependent kinase 19 (EC 2.7.11.22) (CDC2-related protein kinase 6) (Cell division cycle 2-like protein kinase 6) (Cell division protein kinase 19) (Cyclin-dependent kinase 11) (Death-preventing kinase) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MARK1 0 1 MARK1 KIAA1477 MARK MARK1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase MARK1 (EC 2.7.11.1) (EC 2.7.11.26) (MAP/microtubule affinity-regulating kinase 1) (PAR1 homolog c) (Par-1c) (Par1c) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 FES 0 1 FES FPS FES_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Tyrosine-protein kinase Fes/Fps (EC 2.7.10.2) (Feline sarcoma/Fujinami avian sarcoma oncogene homolog) (Proto-oncogene c-Fes) (Proto-oncogene c-Fps) (p93c-fes) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MARK3 0 2 MARK3 CTAK1 EMK2 MARK3_HUMAN 5.41278795015589 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1) (C-TAK1) (cTAK1) (Cdc25C-associated protein kinase 1) (ELKL motif kinase 2) (EMK-2) (Protein kinase STK10) (Ser/Thr protein kinase PAR-1) (Par-1a) (Serine/threonine-protein kinase p78) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 TXK 0 1 TXK PTK4 RLK TXK_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Tyrosine-protein kinase TXK (EC 2.7.10.2) (Protein-tyrosine kinase 4) (Resting lymphocyte kinase) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 DYR1A 0 11 DYRK1A DYRK MNB MNBH, Dyrk1a Dyrk DYR1A_HUMAN, DYR1A_MOUSE, DYR1A_RAT 5.39170280704539 4.9 4.90000000000001 11 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.1) (Dual specificity YAK1-related kinase) (HP86) (Protein kinase minibrain homolog) (MNBH) (hMNB), Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.1) (Dual specificity YAK1-related kinase) (MP86) (Protein kinase minibrain homolog) (MNBH), Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.2) (Dual specificity YAK1-related kinase) (Protein kinase minibrain homolog) (MNBH) (RP86) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 LATS2 0 1 LATS2 KPM LATS2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase LATS2 (EC 2.7.11.1) (Kinase phosphorylated during mitosis protein) (Large tumor suppressor homolog 2) (Serine/threonine-protein kinase kpm) (Warts-like kinase) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 TESK1 0 1 TESK1 TESK1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Dual specificity testis-specific protein kinase 1 (EC 2.7.12.1) (Testicular protein kinase 1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 UFO 0 1 AXL UFO UFO_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Tyrosine-protein kinase receptor UFO (EC 2.7.10.1) (AXL oncogene) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KPCD1 0 2 PRKD1 PKD PKD1 PRKCM KPCD1_HUMAN 5.47712125471966 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 FLT3 0 6 FLT3 CD135 FLK2 STK1 FLT3_HUMAN 4.5 4.9 4.90000000000001 6 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase 2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Tyrosine-protein kinase receptor flk-2) (CD antigen CD135), Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase-2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Stem cell tyrosine kinase 1) (STK-1) (CD antigen CD135) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 COQ8A 0 1 COQ8A ADCK3 CABC1 PP265 COQ8A_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Atypical kinase COQ8A, mitochondrial (EC 2.7.-.-) (Chaperone activity of bc1 complex-like) (Chaperone-ABC1-like) (Coenzyme Q protein 8A) (aarF domain-containing protein kinase 3) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CHK2 0 1 CHEK2 CDS1 CHK2 RAD53 CHK2_HUMAN 6.12338490853968 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CD11B 0 1 CDK11B CDC2L1 CDK11 PITSLREA PK58 CD11B_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-dependent kinase 11B (EC 2.7.11.22) (Cell division cycle 2-like protein kinase 1) (CLK-1) (Cell division protein kinase 11B) (Galactosyltransferase-associated protein kinase p58/GTA) (PITSLRE serine/threonine-protein kinase CDC2L1) (p58 CLK-1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 IKKE 0 1 IKBKE IKKE IKKI KIAA0151 IKKE_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Inhibitor of nuclear factor kappa-B kinase subunit epsilon (I-kappa-B kinase epsilon) (IKK-E) (IKK-epsilon) (IkBKE) (EC 2.7.11.10) (Inducible I kappa-B kinase) (IKK-i) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MAPK5 0 3 MAPKAPK5 PRAK MAPK5_HUMAN 5.09281823530292 4.9 4.90000000000001 3 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 MAP kinase-activated protein kinase 5 (MAPK-activated protein kinase 5) (MAPKAP kinase 5) (MAPKAP-K5) (MAPKAPK-5) (MK-5) (MK5) (EC 2.7.11.1) (p38-regulated/activated protein kinase) (PRAK) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 AKT3 0 1 AKT3 PKBG AKT3_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 RAC-gamma serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-3) (Protein kinase B gamma) (PKB gamma) (RAC-PK-gamma) (STK-2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 RET 0 2 RET CDHF12 CDHR16 PTC RET51 RET_HUMAN 5 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment], Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment] 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 SGK1 0 1 SGK1 SGK SGK1_HUMAN 5.47712125471966 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase Sgk1 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 ALK 0 1 ALK ALK_HUMAN 5.64 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 ALK tyrosine kinase receptor (EC 2.7.10.1) (Anaplastic lymphoma kinase) (CD antigen CD246) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 LMNA 0 2 LMNA LMN1 LMNA_HUMAN 4.7 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 RIPK1 0 1 RIPK1 RIP RIP1 RIPK1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Receptor-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (Cell death protein RIP) (Receptor-interacting protein 1) (RIP-1) (Serine/threonine-protein kinase RIP) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 PAK2 0 1 PAK2 PAK2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (PAK65) (S6/H4 kinase) (p21-activated kinase 2) (PAK-2) (p58) [Cleaved into: PAK-2p27 (p27); PAK-2p34 (p34) (C-t-PAK2)] 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 INSRR 0 1 INSRR IRR INSRR_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Insulin receptor-related protein (IRR) (EC 2.7.10.1) (IR-related receptor) [Cleaved into: Insulin receptor-related protein alpha chain; Insulin receptor-related protein beta chain] 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CCNE2 0 18 CCNE2 CCNE2_HUMAN 6.04965666811201 4.9 4.90000000000001 18 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 G1/S-specific cyclin-E2 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MK07 0 1 MAPK7 BMK1 ERK5 PRKM7 MK07_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Mitogen-activated protein kinase 7 (MAP kinase 7) (MAPK 7) (EC 2.7.11.24) (Big MAP kinase 1) (BMK-1) (Extracellular signal-regulated kinase 5) (ERK-5) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 LATS1 0 1 LATS1 WARTS LATS1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase LATS1 (EC 2.7.11.1) (Large tumor suppressor homolog 1) (WARTS protein kinase) (h-warts) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 DMPK 0 1 DMPK DM1PK MDPK DMPK_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Myotonin-protein kinase (MT-PK) (EC 2.7.11.1) (DM-kinase) (DMK) (DM1 protein kinase) (DMPK) (Myotonic dystrophy protein kinase) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 BMPR2 0 1 BMPR2 PPH1 BMPR2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Bone morphogenetic protein receptor type-2 (BMP type-2 receptor) (BMPR-2) (EC 2.7.11.30) (Bone morphogenetic protein receptor type II) (BMP type II receptor) (BMPR-II) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MRCKA 0 1 CDC42BPA KIAA0451 MRCKA_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase MRCK alpha (EC 2.7.11.1) (CDC42-binding protein kinase alpha) (DMPK-like alpha) (Myotonic dystrophy kinase-related CDC42-binding kinase alpha) (MRCK alpha) (Myotonic dystrophy protein kinase-like alpha) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 AKT2 0 2 AKT2 AKT2_HUMAN 5.3443145854989 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 RAC-beta serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-2) (Protein kinase B beta) (PKB beta) (RAC-PK-beta) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CLK4 0 2 CLK4 CLK4_HUMAN 5.175 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Dual specificity protein kinase CLK4 (EC 2.7.12.1) (CDC-like kinase 4) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 HIPK3 0 1 HIPK3 DYRK6 FIST3 PKY HIPK3_HUMAN 5.95424250943933 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Homeodomain-interacting protein kinase 3 (EC 2.7.11.1) (Androgen receptor-interacting nuclear protein kinase) (ANPK) (Fas-interacting serine/threonine-protein kinase) (FIST) (Homolog of protein kinase YAK1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 DDR1 0 1 DDR1 CAK EDDR1 NEP NTRK4 PTK3A RTK6 TRKE DDR1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Epithelial discoidin domain-containing receptor 1 (Epithelial discoidin domain receptor 1) (EC 2.7.10.1) (CD167 antigen-like family member A) (Cell adhesion kinase) (Discoidin receptor tyrosine kinase) (HGK2) (Mammary carcinoma kinase 10) (MCK-10) (Protein-tyrosine kinase 3A) (Protein-tyrosine kinase RTK-6) (TRK E) (Tyrosine kinase DDR) (Tyrosine-protein kinase CAK) (CD antigen CD167a) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 PRKX 0 1 PRKX PKX1 PRKX_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 cAMP-dependent protein kinase catalytic subunit PRKX (PrKX) (Protein kinase X) (Protein kinase X-linked) (Serine/threonine-protein kinase PRKX) (EC 2.7.11.1) (Protein kinase PKX1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 RIOK3 0 1 RIOK3 SUDD RIOK3_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase RIO3 (EC 2.7.11.1) (RIO kinase 3) (sudD homolog) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CSK22 0 4 CSNK2A2 CK2A2 CSK22_HUMAN 5.79552338026521 4.9 4.90000000000001 4 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Casein kinase II subunit alpha' (CK II alpha') (EC 2.7.11.1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MARK4 0 1 MARK4 KIAA1860 MARKL1 MARK4_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 MAP/microtubule affinity-regulating kinase 4 (EC 2.7.11.1) (MAP/microtubule affinity-regulating kinase-like 1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MYLK 0 3 MYLK MLCK MLCK1 MYLK1, Mylk MYLK_CHICK, MYLK_HUMAN 5.24005310113532 4.9 4.90000000000001 3 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Myosin light chain kinase, smooth muscle (MLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form], Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form] 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KS6A2 0 6 RPS6KA2 MAPKAPK1C RSK3 KS6A2_HUMAN 5.16333333333333 4.9 4.90000000000001 6 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Ribosomal protein S6 kinase alpha-2 (S6K-alpha-2) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 2) (p90-RSK 2) (p90RSK2) (MAP kinase-activated protein kinase 1c) (MAPK-activated protein kinase 1c) (MAPKAP kinase 1c) (MAPKAPK-1c) (Protein-tyrosine kinase Mpk-9) (Ribosomal S6 kinase 3) (RSK-3) (pp90RSK3), Ribosomal protein S6 kinase alpha-2 (S6K-alpha-2) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 2) (p90-RSK 2) (p90RSK2) (MAP kinase-activated protein kinase 1c) (MAPK-activated protein kinase 1c) (MAPKAP kinase 1c) (MAPKAPK-1c) (Ribosomal S6 kinase 3) (RSK-3) (pp90RSK3) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 NTRK3 0 1 NTRK3 TRKC NTRK3_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 NT-3 growth factor receptor (EC 2.7.10.1) (GP145-TrkC) (Trk-C) (Neurotrophic tyrosine kinase receptor type 3) (TrkC tyrosine kinase) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KS6B1 0 1 RPS6KB1 STK14A KS6B1_HUMAN 5.95424250943933 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (S6K) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA), Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (Serine/threonine-protein kinase 14A) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 SRPK1 0 2 SRPK1 SRPK1_HUMAN 5.36007965170298 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 SRSF protein kinase 1 (EC 2.7.11.1) (SFRS protein kinase 1) (Serine/arginine-rich protein-specific kinase 1) (SR-protein-specific kinase 1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 NTRK2 0 1 NTRK2 TRKB NTRK2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 BDNF/NT-3 growth factors receptor (EC 2.7.10.1) (GP145-TrkB) (Trk-B) (Neurotrophic tyrosine kinase receptor type 2) (TrkB tyrosine kinase) (Tropomyosin-related kinase B), BDNF/NT-3 growth factors receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 2) (TrkB tyrosine kinase) (Trk-B) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 PLK3 0 1 PLK3 CNK FNK PRK PLK3_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase PLK3 (EC 2.7.11.21) (Cytokine-inducible serine/threonine-protein kinase) (FGF-inducible kinase) (Polo-like kinase 3) (PLK-3) (Proliferation-related kinase) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 STK33 0 1 STK33 STK33_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase 33 (EC 2.7.11.1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 SIK1 0 1 SIK1 SIK SNF1LK SIK1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase SIK1 (EC 2.7.11.1) (Salt-inducible kinase 1) (SIK-1) (Serine/threonine-protein kinase SNF1-like kinase 1) (Serine/threonine-protein kinase SNF1LK) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CDK3 0 4 CDK3 CDKN3 CDK3_HUMAN 4.54845500650403 4.9 4.90000000000001 4 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-dependent kinase 3 (EC 2.7.11.22) (Cell division protein kinase 3) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 M3K11 0 1 MAP3K11 MLK3 PTK1 SPRK M3K11_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Mitogen-activated protein kinase kinase kinase 11 (EC 2.7.11.25) (Mixed lineage kinase 3), Mitogen-activated protein kinase kinase kinase 11 (EC 2.7.11.25) (Mixed lineage kinase 3) (Src-homology 3 domain-containing proline-rich kinase) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 AVR2B 0 1 ACVR2B AVR2B_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Activin receptor type-2B (EC 2.7.11.30) (Activin receptor type IIB) (ACTR-IIB) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KPCT 0 1 PRKCQ PRKCT KPCT_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Protein kinase C theta type (EC 2.7.11.13) (nPKC-theta) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 GEMI 0 2 GMNN GEMI_HUMAN 4.74310644979755 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Geminin 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 TLK1 0 1 TLK1 KIAA0137 TLK1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase tousled-like 1 (EC 2.7.11.1) (PKU-beta) (Tousled-like kinase 1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 TTK 0 2 TTK MPS1 MPS1L1 TTK_HUMAN 5.74 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Dual specificity protein kinase TTK (EC 2.7.12.1) (Phosphotyrosine picked threonine-protein kinase) (PYT) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 TSSK1 0 1 TSSK1B SPOGA1 SPOGA4 STK22A STK22D TSSK1 FKSG81 TSSK1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Testis-specific serine/threonine-protein kinase 1 (TSK-1) (TSK1) (TSSK-1) (Testis-specific kinase 1) (EC 2.7.11.1) (Serine/threonine-protein kinase 22A) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CDK17 0 1 CDK17 PCTAIRE2 PCTK2 CDK17_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-dependent kinase 17 (EC 2.7.11.22) (Cell division protein kinase 17) (PCTAIRE-motif protein kinase 2) (Serine/threonine-protein kinase PCTAIRE-2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 ST32C 0 1 STK32C YANK3 ST32C_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase 32C (EC 2.7.11.1) (PKE) (Yet another novel kinase 3) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MKNK2 0 3 MKNK2 GPRK7 MNK2 MKNK2_HUMAN 4.50321682651553 4.9 4.90000000000001 3 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 MAP kinase-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 2) (MAPK signal-integrating kinase 2) (Mnk2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MRCKG 0 1 CDC42BPG DMPK2 MRCKG_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase MRCK gamma (EC 2.7.11.1) (CDC42-binding protein kinase gamma) (DMPK-like gamma) (Myotonic dystrophy kinase-related CDC42-binding kinase gamma) (MRCK gamma) (MRCKG) (Myotonic dystrophy protein kinase-like gamma) (Myotonic dystrophy protein kinase-like alpha) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CSK2B 0 3 CSNK2B CK2N G5A CSK2B_HUMAN 6.06069784035361 4.9 4.90000000000001 3 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Casein kinase II subunit beta (CK II beta) (Phosvitin), Casein kinase II subunit beta (CK II beta) (Phosvitin) (Protein G5a) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CSK21 0 4 CSNK2A1 CK2A1 CSK21_HUMAN 5.79552338026521 4.9 4.90000000000001 4 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Casein kinase II subunit alpha (CK II alpha) (EC 2.7.11.1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MELK 0 2 MELK KIAA0175 MELK_HUMAN 5.43265071305127 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Maternal embryonic leucine zipper kinase (hMELK) (EC 2.7.11.1) (Protein kinase Eg3) (pEg3 kinase) (Protein kinase PK38) (hPK38) (Tyrosine-protein kinase MELK) (EC 2.7.10.2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 M4K4 0 1 MAP4K4 HGK KIAA0687 NIK M4K4_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Mitogen-activated protein kinase kinase kinase kinase 4 (EC 2.7.11.1) (HPK/GCK-like kinase HGK) (MAPK/ERK kinase kinase kinase 4) (MEK kinase kinase 4) (MEKKK 4) (Nck-interacting kinase) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 SMN 0 3 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.90000000000001 3 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 ZAP70 0 1 ZAP70 SRK ZAP70_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Tyrosine-protein kinase ZAP-70 (EC 2.7.10.2) (70 kDa zeta-chain associated protein) (Syk-related tyrosine kinase) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 SRPK2 0 1 SRPK2 SRPK2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 SRSF protein kinase 2 (EC 2.7.11.1) (SFRS protein kinase 2) (Serine/arginine-rich protein-specific kinase 2) (SR-protein-specific kinase 2) [Cleaved into: SRSF protein kinase 2 N-terminal; SRSF protein kinase 2 C-terminal] 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MET 0 1 MET MET_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 ACV1B 0 1 ACVR1B ACVRLK4 ALK4 ACV1B_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Activin receptor type-1B (EC 2.7.11.30) (Activin receptor type IB) (ACTR-IB) (Activin receptor-like kinase 4) (ALK-4) (Serine/threonine-protein kinase receptor R2) (SKR2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 PIM3 0 2 PIM3 PIM3_HUMAN 5.3443145854989 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase pim-3 (EC 2.7.11.1), Serine/threonine-protein kinase pim-3 (EC 2.7.11.1) (Kinase induced by depolarization) (Protein kinase Kid-1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 NLK 0 1 NLK LAK1 NLK_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase NLK (EC 2.7.11.24) (Nemo-like kinase) (Protein LAK1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 JAK3 0 2 JAK3 JAK3_HUMAN 5 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Tyrosine-protein kinase JAK3 (EC 2.7.10.2) (Janus kinase 3) (JAK-3), Tyrosine-protein kinase JAK3 (EC 2.7.10.2) (Janus kinase 3) (JAK-3) (Leukocyte janus kinase) (L-JAK) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 M3K10 0 1 MAP3K10 MLK2 MST M3K10_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Mitogen-activated protein kinase kinase kinase 10 (EC 2.7.11.25) (Mixed lineage kinase 2) (Protein kinase MST) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KPCZ 0 1 PRKCZ PKC2 KPCZ_HUMAN 5.65854134728041 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Protein kinase C zeta type (EC 2.7.11.13) (nPKC-zeta) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CD11A 0 1 CDK11A CDC2L2 CDC2L3 PITSLREB CD11A_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-dependent kinase 11A (EC 2.7.11.22) (Cell division cycle 2-like protein kinase 2) (Cell division protein kinase 11A) (Galactosyltransferase-associated protein kinase p58/GTA) (PITSLRE serine/threonine-protein kinase CDC2L2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 TRXR1 0 1 Txnrd1 Trxr1 TRXR1_RAT 7.42365864979421 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 EPHA1 0 1 EPHA1 EPH EPHT EPHT1 EPHA1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Ephrin type-A receptor 1 (hEpha1) (EC 2.7.10.1) (EPH tyrosine kinase) (EPH tyrosine kinase 1) (Erythropoietin-producing hepatoma receptor) (Tyrosine-protein kinase receptor EPH) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 NEK1 0 1 NEK1 KIAA1901 NEK1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1) (Renal carcinoma antigen NY-REN-55) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CAC1B 0 1 CACNA1B CACH5 CACNL1A5 CAC1B_HUMAN 4.56 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Voltage-dependent N-type calcium channel subunit alpha-1B (Brain calcium channel III) (BIII) (Calcium channel, L type, alpha-1 polypeptide isoform 5) (Voltage-gated calcium channel subunit alpha Cav2.2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MERTK 0 1 MERTK MER MERTK_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Tyrosine-protein kinase Mer (EC 2.7.10.1) (Proto-oncogene c-Mer) (Receptor tyrosine kinase MerTK) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 E2AK2 0 1 EIF2AK2 PKR PRKR E2AK2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Interferon-induced, double-stranded RNA-activated protein kinase (EC 2.7.11.1) (Eukaryotic translation initiation factor 2-alpha kinase 2) (eIF-2A protein kinase 2) (Interferon-inducible RNA-dependent protein kinase) (P1/eIF-2A protein kinase) (Protein kinase RNA-activated) (PKR) (Protein kinase R) (Serine/threonine-protein kinase TIK) (Tyrosine-protein kinase EIF2AK2) (EC 2.7.10.2) (p68 kinase), Interferon-induced, double-stranded RNA-activated protein kinase (EC 2.7.11.1) (Eukaryotic translation initiation factor 2-alpha kinase 2) (eIF-2A protein kinase 2) (Interferon-inducible RNA-dependent protein kinase) (P1/eIF-2A protein kinase) (Protein kinase RNA-activated) (PKR) (Protein kinase R) (Tyrosine-protein kinase EIF2AK2) (EC 2.7.10.2) (p68 kinase) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 ROS1 0 1 ROS1 MCF3 ROS ROS1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Proto-oncogene tyrosine-protein kinase ROS (EC 2.7.10.1) (Proto-oncogene c-Ros) (Proto-oncogene c-Ros-1) (Receptor tyrosine kinase c-ros oncogene 1) (c-Ros receptor tyrosine kinase) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MP2K6 0 1 MAP2K6 MEK6 MKK6 PRKMK6 SKK3 MP2K6_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (MAPK/ERK kinase 6) (MEK 6) (Stress-activated protein kinase kinase 3) (SAPK kinase 3) (SAPKK-3) (SAPKK3) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 TBA1A 0 1 Tuba1a Tuba1 TBA1A_RAT 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Tubulin alpha-1A chain (Alpha-tubulin 1) (Tubulin alpha-1 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain], Tubulin alpha-1A chain (Alpha-tubulin 3) (Tubulin B-alpha-1) (Tubulin alpha-3 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain] 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 FAK2 0 1 PTK2B FAK2 PYK2 RAFTK FAK2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Protein-tyrosine kinase 2-beta (EC 2.7.10.2) (Calcium-dependent tyrosine kinase) (CADTK) (Calcium-regulated non-receptor proline-rich tyrosine kinase) (Cell adhesion kinase beta) (CAK-beta) (CAKB) (Focal adhesion kinase 2) (FADK 2) (Proline-rich tyrosine kinase 2), Protein-tyrosine kinase 2-beta (EC 2.7.10.2) (Calcium-dependent tyrosine kinase) (CADTK) (Calcium-regulated non-receptor proline-rich tyrosine kinase) (Cell adhesion kinase beta) (CAK-beta) (CAKB) (Focal adhesion kinase 2) (FADK 2) (Proline-rich tyrosine kinase 2) (Related adhesion focal tyrosine kinase) (RAFTK) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 PI42B 0 1 PIP4K2B PIP5K2B PI42B_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Phosphatidylinositol 5-phosphate 4-kinase type-2 beta (EC 2.7.1.149) (1-phosphatidylinositol 5-phosphate 4-kinase 2-beta) (Diphosphoinositide kinase 2-beta) (Phosphatidylinositol 5-phosphate 4-kinase type II beta) (PI(5)P 4-kinase type II beta) (PIP4KII-beta) (PtdIns(5)P-4-kinase isoform 2-beta) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 M4K3 0 1 MAP4K3 RAB8IPL1 M4K3_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Mitogen-activated protein kinase kinase kinase kinase 3 (EC 2.7.11.1) (Germinal center kinase-related protein kinase) (GLK) (MAPK/ERK kinase kinase kinase 3) (MEK kinase kinase 3) (MEKKK 3) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KPCL 0 1 PRKCH PKCL PRKCL KPCL_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Protein kinase C eta type (EC 2.7.11.13) (PKC-L) (nPKC-eta) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MKNK1 0 2 MKNK1 MNK1 MKNK1_HUMAN 5.47712125471966 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 MAP kinase-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 1) (MAPK signal-integrating kinase 1) (Mnk1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 ACVR1 0 1 ACVR1 ACVRLK2 ACVR1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Activin receptor type-1 (EC 2.7.11.30) (Activin receptor type I) (ACTR-I) (Activin receptor-like kinase 2) (ALK-2) (Serine/threonine-protein kinase receptor R1) (SKR1) (TGF-B superfamily receptor type I) (TSR-I), Activin receptor type-1 (EC 2.7.11.30) (Activin receptor type I) (ACTR-I) (Serine/threonine-protein kinase receptor R1) (SKR1) (TGF-B superfamily receptor type I) (TSR-I) (TSK-7L) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 AURKB 0 2 AURKB AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5 AURKB_HUMAN 5.59748830160803 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Aurora kinase B (EC 2.7.11.1) (Aurora 1) (Aurora- and IPL1-like midbody-associated protein 1) (AIM-1) (Aurora/IPL1-related kinase 2) (ARK-2) (Aurora-related kinase 2) (STK-1) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase 5) (Serine/threonine-protein kinase aurora-B), Aurora kinase B (EC 2.7.11.1) (Aurora 1) (Aurora- and IPL1-like midbody-associated protein 1) (Aurora/IPL1-related kinase 2) (ARK-2) (Aurora-related kinase 2) (STK-1) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase 5) (Serine/threonine-protein kinase aurora-B) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MK06 0 1 MAPK6 ERK3 PRKM6 MK06_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Mitogen-activated protein kinase 6 (MAP kinase 6) (MAPK 6) (EC 2.7.11.24) (Extracellular signal-regulated kinase 3) (ERK-3) (MAP kinase isoform p97) (p97-MAPK) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 TGFR1 0 1 TGFBR1 ALK5 SKR4 TGFR1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (Activin A receptor type II-like protein kinase of 53kD) (Activin receptor-like kinase 5) (ALK-5) (ALK5) (Serine/threonine-protein kinase receptor R4) (SKR4) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I), TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (ESK2) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 M4K1 0 1 MAP4K1 HPK1 M4K1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Mitogen-activated protein kinase kinase kinase kinase 1 (EC 2.7.11.1) (Hematopoietic progenitor kinase) (MAPK/ERK kinase kinase kinase 1) (MEK kinase kinase 1) (MEKKK 1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 NEK5 0 1 NEK5 NEK5_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase Nek5 (EC 2.7.11.1) (Never in mitosis A-related kinase 5) (NimA-related protein kinase 5) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KPCD2 0 1 PRKD2 PKD2 HSPC187 KPCD2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase D2 (EC 2.7.11.13) (nPKC-D2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 TIE1 0 1 TIE1 TIE TIE1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MAPK3 0 1 MAPKAPK3 MAPK3_HUMAN 5.78837041556533 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 MAP kinase-activated protein kinase 3 (MAPK-activated protein kinase 3) (MAPKAP kinase 3) (MAPKAP-K3) (MAPKAPK-3) (MK-3) (EC 2.7.11.1) (Chromosome 3p kinase) (3pK) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CDK6 0 2 CDK6 CDKN6 CDK6_HUMAN 4.63 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-dependent kinase 6 (EC 2.7.11.22) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MRCKB 0 1 CDC42BPB KIAA1124 MRCKB_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CHK1 0 2 CHEK1 CHK1 CHK1_HUMAN 5.41278795015589 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Cell cycle checkpoint kinase) (Checkpoint kinase-1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KC1G3 0 1 CSNK1G3 KC1G3_HUMAN 5.54 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Casein kinase I isoform gamma-3 (CKI-gamma 3) (EC 2.7.11.1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 TNI3K 0 1 TNNI3K CARK TNI3K_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase TNNI3K (EC 2.7.11.1) (Cardiac ankyrin repeat kinase) (Cardiac troponin I-interacting kinase) (TNNI3-interacting kinase) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CLK2 0 2 CLK2 CLK2_HUMAN 6.24 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Dual specificity protein kinase CLK2 (EC 2.7.12.1) (CDC-like kinase 2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 TGFR2 0 1 TGFBR2 TGFR2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 TGF-beta receptor type-2 (TGFR-2) (EC 2.7.11.30) (TGF-beta type II receptor) (Transforming growth factor-beta receptor type II) (TGF-beta receptor type II) (TbetaR-II) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 RAF1 0 1 RAF1 RAF RAF1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 RAF proto-oncogene serine/threonine-protein kinase (EC 2.7.11.1) (Proto-oncogene c-RAF) (cRaf) (Raf-1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MK04 0 1 MAPK4 ERK4 PRKM4 MK04_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Mitogen-activated protein kinase 4 (MAP kinase 4) (MAPK 4) (EC 2.7.11.24) (Extracellular signal-regulated kinase 4) (ERK-4) (MAP kinase isoform p63) (p63-MAPK) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CDK18 0 1 CDK18 PCTAIRE3 PCTK3 CDK18_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-dependent kinase 18 (EC 2.7.11.22) (Cell division protein kinase 18) (PCTAIRE-motif protein kinase 3) (Serine/threonine-protein kinase PCTAIRE-3) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 NUAK1 0 1 NUAK1 ARK5 KIAA0537 OMPHK1 NUAK1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 NUAK family SNF1-like kinase 1 (EC 2.7.11.1) (AMPK-related protein kinase 5) (ARK5) (Omphalocele kinase 1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 VGFR1 0 1 FLT1 FLT FRT VEGFR1 VGFR1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Embryonic receptor kinase 2) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase receptor FLT), Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase FRT) (Tyrosine-protein kinase receptor FLT) (FLT) (Vascular permeability factor receptor) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 ITK 0 1 ITK EMT LYK ITK_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Tyrosine-protein kinase ITK/TSK (EC 2.7.10.2) (Interleukin-2-inducible T-cell kinase) (IL-2-inducible T-cell kinase) (Kinase EMT) (T-cell-specific kinase) (Tyrosine-protein kinase Lyk) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 M3K20 0 1 MAP3K20 MLTK ZAK HCCS4 M3K20_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Mitogen-activated protein kinase kinase kinase 20 (EC 2.7.11.25) (Human cervical cancer suppressor gene 4 protein) (HCCS-4) (Leucine zipper- and sterile alpha motif-containing kinase) (MLK-like mitogen-activated protein triple kinase) (Mitogen-activated protein kinase kinase kinase MLT) (Mixed lineage kinase-related kinase) (MLK-related kinase) (MRK) (Sterile alpha motif- and leucine zipper-containing kinase AZK) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CDK8 0 1 CDK8 CDK8_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) (Protein kinase K35) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 PLK1 0 2 PLK1 PLK PLK1_HUMAN 5.50239944144089 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CSF1R 0 1 CSF1R FMS CSF1R_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Macrophage colony-stimulating factor 1 receptor (CSF-1 receptor) (CSF-1-R) (CSF-1R) (M-CSF-R) (EC 2.7.10.1) (Proto-oncogene c-Fms) (CD antigen CD115) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 NUAK2 0 1 NUAK2 OMPHK2 SNARK NUAK2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 NUAK family SNF1-like kinase 2 (EC 2.7.11.1) (Omphalocele kinase 2) (SNF1/AMP kinase-related kinase) (SNARK) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MP2K3 0 1 MAP2K3 MEK3 MKK3 PRKMK3 SKK2 MP2K3_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Dual specificity mitogen-activated protein kinase kinase 3 (MAP kinase kinase 3) (MAPKK 3) (EC 2.7.12.2) (MAPK/ERK kinase 3) (MEK 3) (Stress-activated protein kinase kinase 2) (SAPK kinase 2) (SAPKK-2) (SAPKK2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 BLK 0 1 BLK BLK_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Tyrosine-protein kinase Blk (EC 2.7.10.2) (B lymphocyte kinase) (p55-Blk) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 EF2K 0 1 EEF2K EF2K_HUMAN 5.75332766665861 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Eukaryotic elongation factor 2 kinase (eEF-2 kinase) (eEF-2K) (EC 2.7.11.20) (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 AKT1 0 1 AKT1 PKB RAC AKT1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (AKT1 kinase) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha) (Thymoma viral proto-oncogene), RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha), RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (RAC-PK-alpha) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 WEE1 0 1 WEE1 WEE1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Wee1-like protein kinase (WEE1hu) (EC 2.7.10.2) (Wee1A kinase) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 PGFRA 0 1 PDGFRA PDGFR2 RHEPDGFRA PGFRA_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (CD140a antigen) (Platelet-derived growth factor alpha receptor) (Platelet-derived growth factor receptor 2) (PDGFR-2) (CD antigen CD140a), Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (Platelet-derived growth factor alpha receptor) (CD antigen CD140a) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 DCLK2 0 1 DCLK2 DCAMKL2 DCDC3B DCK2 DCLK2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase DCLK2 (EC 2.7.11.1) (CaMK-like CREB regulatory kinase 2) (CL2) (CLICK-II) (CLICK2) (Doublecortin domain-containing protein 3B) (Doublecortin-like and CAM kinase-like 2) (Doublecortin-like kinase 2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 TYRO3 0 1 TYRO3 BYK DTK RSE SKY TIF TYRO3_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Tyrosine-protein kinase receptor TYRO3 (EC 2.7.10.1) (Etk2/tyro3) (TK19-2) (Tyrosine-protein kinase DTK) (Tyrosine-protein kinase RSE) (Tyrosine-protein kinase TIF), Tyrosine-protein kinase receptor TYRO3 (EC 2.7.10.1) (Tyrosine-protein kinase BYK) (Tyrosine-protein kinase DTK) (Tyrosine-protein kinase RSE) (Tyrosine-protein kinase SKY) (Tyrosine-protein kinase TIF) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 TYK2 0 2 TYK2 TYK2_HUMAN 5 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Non-receptor tyrosine-protein kinase TYK2 (EC 2.7.10.2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 BMR1A 0 1 BMPR1A ACVRLK3 ALK3 BMR1A_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Bone morphogenetic protein receptor type-1A (BMP type-1A receptor) (BMPR-1A) (EC 2.7.11.30) (Activin receptor-like kinase 3) (ALK-3) (Serine/threonine-protein kinase receptor R5) (SKR5) (CD antigen CD292) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 TLK2 0 1 TLK2 TLK2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase tousled-like 2 (EC 2.7.11.1) (HsHPK) (PKU-alpha) (Tousled-like kinase 2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 ANKK1 0 1 ANKK1 PKK2 SGK288 ANKK1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Ankyrin repeat and protein kinase domain-containing protein 1 (EC 2.7.11.1) (Protein kinase PKK2) (Sugen kinase 288) (SgK288) (X-kinase) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MYLK4 0 1 MYLK4 SGK085 MYLK4_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Myosin light chain kinase family member 4 (EC 2.7.11.1) (Sugen kinase 85) (SgK085) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 DDR2 0 1 DDR2 NTRKR3 TKT TYRO10 DDR2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Discoidin domain-containing receptor tyrosine kinase 2) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 STK25 0 1 STK25 SOK1 YSK1 STK25_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CDK14 0 1 CDK14 KIAA0834 PFTK1 CDK14_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-dependent kinase 14 (EC 2.7.11.22) (Cell division protein kinase 14) (Serine/threonine-protein kinase PFTAIRE-1) (hPFTAIRE1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 ST32B 0 1 STK32B YANK2 UNQ3003/PRO9744 ST32B_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase 32B (EC 2.7.11.1) (Yet another novel kinase 2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KCC4 0 1 CAMK4 CAMK CAMK-GR CAMKIV KCC4_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Calcium/calmodulin-dependent protein kinase type IV (CaMK IV) (EC 2.7.11.17) (CaM kinase-GR) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 STK24 0 1 STK24 MST3 STK3 STK24_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)] 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KGP2 0 1 PRKG2 PRKGR2 KGP2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 cGMP-dependent protein kinase 2 (cGK 2) (cGK2) (EC 2.7.11.12) (cGMP-dependent protein kinase II) (cGKII) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 PKN1 0 1 PKN1 PAK1 PKN PRK1 PRKCL1 PKN1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase N1 (EC 2.7.11.13) (Protease-activated kinase 1) (PAK-1) (Protein kinase C-like 1) (Protein kinase C-like PKN) (Protein kinase PKN-alpha) (Protein-kinase C-related kinase 1) (Serine-threonine protein kinase N) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KGP1 0 1 PRKG1 PRKG1B PRKGR1A PRKGR1B KGP1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 HIPK2 0 1 HIPK2 HIPK2_HUMAN 5.72015930340596 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Homeodomain-interacting protein kinase 2 (hHIPk2) (EC 2.7.11.1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MUSK 0 1 MUSK MUSK_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Muscle, skeletal receptor tyrosine-protein kinase (EC 2.7.10.1) (Muscle-specific tyrosine-protein kinase receptor) (MuSK) (Muscle-specific kinase receptor) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 IGF1R 0 1 IGF1R IGF1R_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Insulin-like growth factor 1 receptor (EC 2.7.10.1) (Insulin-like growth factor I receptor) (IGF-I receptor) (CD antigen CD221) [Cleaved into: Insulin-like growth factor 1 receptor alpha chain; Insulin-like growth factor 1 receptor beta chain] 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 IKKB 0 1 IKBKB IKKB IKKB_HUMAN 5.60205999132796 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Inhibitor of nuclear factor kappa-B kinase subunit beta (I-kappa-B-kinase beta) (IKK-B) (IKK-beta) (IkBKB) (EC 2.7.11.10) (I-kappa-B kinase 2) (IKK2) (Nuclear factor NF-kappa-B inhibitor kinase beta) (NFKBIKB) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 DCLK3 0 1 DCLK3 DCAMKL3 DCDC3C KIAA1765 DCLK3_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase DCLK3 (EC 2.7.11.1) (Doublecortin domain-containing protein 3C) (Doublecortin-like and CAM kinase-like 3) (Doublecortin-like kinase 3) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14090 NFKB1 0 4 NFKB1 NFKB1_HUMAN 5.2 5.05 5.05 4 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 1 5.05 actual molregno [molregno] Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12 14090 CCNB3 0 20 CCNB3 CYCB3 CCNB3_HUMAN 5.15098039199715 5.05 5.05 20 G2/mitotic-specific cyclin-B3 1 5.05 actual molregno [molregno] Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12 14090 CDK1 0 38 CDK1 CDC2 CDC28A CDKN1 P34CDC2 CDK1_HUMAN 5.13973904282696 5.05 5.05 38 Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (Cell division control protein 28) (Cell division protein kinase 1), Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase) 1 5.05 actual molregno [molregno] Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12 14090 CCNB1 0 34 CCNB1 CCNB CCNB1_HUMAN 5.13088481257131 5.05 5.05 34 G2/mitotic-specific cyclin-B1 1 5.05 actual molregno [molregno] Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12 14090 CCNB2 0 20 CCNB2 CCNB2_HUMAN 5.15098039199715 5.05 5.05 20 G2/mitotic-specific cyclin-B2 1 5.05 actual molregno [molregno] Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12 14090 MK03 0 2 MAPK3 ERK1 PRKM3 MK03_HUMAN 4.56 5.05 5.05 2 Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (MNK1) (Microtubule-associated protein 2 kinase) (p44-ERK1), Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (Microtubule-associated protein 2 kinase) (p44-ERK1) 1 5.05 actual molregno [molregno] Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12 14090 CCNE1 0 25 CCNE1 CCNE CCNE1_HUMAN 5.13397816288384 5.05 5.05 25 G1/S-specific cyclin-E1 1 5.05 actual molregno [molregno] Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12 14090 CDK2 0 47 CDK2 CDKN2 CDK2_HUMAN 5.20036044152712 5.05 5.05 47 Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2) (p33 protein kinase) 1 5.05 actual molregno [molregno] Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12 14090 CCNE2 0 21 CCNE2 CCNE2_HUMAN 5.12927170856939 5.05 5.05 21 G1/S-specific cyclin-E2 1 5.05 actual molregno [molregno] Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12 14090 MK01 0 1 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 5.15 5.05 5.05 1 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 1 5.05 actual molregno [molregno] Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12 14090 CP2D6 2 1 CYP2D6 CYP2DL1 CP2D6_HUMAN 5.76666666666667 5.05 4.79583333333333 3 Cytochrome P450 2D6 (EC 1.14.14.1) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase) 0.333333333333333 5.05 actual molregno [molregno] Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12 14090 CCNA1 0 15 CCNA1 CCNA1_HUMAN 5.06551871998142 5.05 5.05 15 Cyclin-A1 1 5.05 actual molregno [molregno] Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12 14090 CCNA2 0 15 CCNA2 CCN1 CCNA CCNA2_HUMAN 5.06551871998142 5.05 5.05 15 Cyclin-A2 (Cyclin-A) (Cyclin A) 1 5.05 actual molregno [molregno] Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12 14090 LOX15 0 1 ALOX15 LOG15 LOX15_HUMAN 4.8 5.05 5.05 1 Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (12/15-LO) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33)